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I 
 
 Abstract 
 
Healthcare associated infections (HCAI) impose significant financial and 
environmental problems for modern healthcare settings, therefore it is important 
to develop novel strategies to combat HCAIs and the causative microorganisms.  
This study investigates the use of an encapsulated essential oil (EO) 
antimicrobial coating for textiles in the healthcare environment.  The antimicrobial 
activity of several EOs were studied, individually and in blends, against five 
microorganisms associated with HCAI (Staphylococcus aureus, methicillin 
resistant Staphylococcus aureus, Candida albicans, Escherichia coli, and 
Pseudomonas aeruginosa).  A 1:1 blend of cinnamon (CIN) and clove oils (CLO) 
containing 94.8 % (v/v) eugenol (by GC-MS) showed the highest antimicrobial 
efficacy and gave a minimum inhibitory concentration (MIC) of less than 0.25% 
(v/v).  Mesoporous silica nanoparticles (MSN) were used to encapsulate volatile 
EOs.  The MSNs displayed narrow size distribution, high surface area and pore 
size between 1.8-2.2 nm.  MSNs, directly loaded with CIN:CLO blend (72 % by 
mass of MSN), achieved bactericidal values (25-50 mg/mL) against the test 
microorganisms.  Dynamic killing profiles of the EO loaded MSNs against the 
test microorganisms were recorded.  The highest kill rates were observed during 
the first 15 minutes of contact.  Organically modified silica (ormosil) gels were 
synthesised to provide thin film coverage of synthetic fibres.  Gamma-
methacryloxypropyltrimethoxysilane (-MPS) was used to attach un-loaded 
MSNs to the ormosil coating.  A layer-by-layer treatment method provided good 
coverage of synthetic fibres with MSNs, as evidenced by scanning electron 
microscopy (SEM).  Attenuated total reflectance Fourier transform infrared 
spectroscopy (ATR-FTIR) was used to monitor the layer-by-layer treatment 
sequence.  Head space GC-MS sampling of EO loaded MSN treated textile 
coupons showed that EO was able to diffuse from the MSN mesopores after 
being bonded to the synthetic fibres.  The EO loaded MSN textile coupons were 
microbiologically challenged using a method based on AATCC 100.  The EO 
loaded MSN textile coupons displayed good antimicrobial activity over five 
washing cycles using a method based on (AATCC 61 and 135) thereby 
indicating a degree of controlled release.  
 
 
 
II 
 
Structure of Thesis 
 
The thesis details the concept of producing antimicrobial textiles via the chemical 
affixation of essential oil-loaded mesoporous silica nanoparticles to synthetic 
fibres.  The thesis begins with Chapter 1, which includes a brief overview and 
introduction to the subject area. The underlying problem is outlined and the 
project aims and objectives are summarised. Chapters 2 to 5 describe the 
research contributing towards the thesis.  These chapters comprise technique-
specific introductions, objectives, materials and methods, results and discussion 
and conclusions.  The final chapter of the thesis includes a summary of the work 
undertaken, overall conclusions and further work. 
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1.1  Healthcare associated infections 
 
The term Healthcare-associated Infection (abbreviated as HCAI) has largely 
replaced others such as Hospital-acquired Infection (HAI), nosocomial infection 
and hospital-onset infection.  HCAI is a more modern reflection of the range of 
settings in which people receive health-related attention. The term HCAI is 
defined as any infectious agent acquired as a consequence of a person’s 
treatment by a healthcare provider, or which is acquired by a healthcare worker 
in the course of their duties (From National Audit Office (NAO) report Reducing 
Healthcare-associated Infections in Hospitals in England, 2009, quoting from the 
Health Act 2006: Code of Practice for the Prevention and Control of Healthcare-
associated Infections). This has replaced the previous definition of an infection 
that was neither present nor incubating at the time of entering a hospital 
environment (NAO, 2009) (Table 1.1).  HCAIs are an important worldwide health 
problem, posing a major problem to patient safety.  The economic burden of 
HCAI is significant in terms of resources, including extended hospital stays, staff 
time and treatment costs.  Additional requirements, such as isolation and 
sterilisation of facilities and instruments used for these patients also significantly 
increase healthcare costs (Warnke, 2009).  Reported hospital costs for a patient 
with HCAI are 2.9 times higher than for an uninfected patient, equating to an 
increase of over £3000 per patient, with HCAI costing the NHS at least £1bn 
annually and causing 5000 deaths (NAO 2004; NAO, 2009).  However, the 
indirect costs of HCAI are more difficult to quantify.  These include costs for 
cleaning, additional clinical waste, microbiology and surveillance (Damani 2003). 
The Hospital Infection Society released the results of the third national 
prevalence survey in March 2007. This survey of 190 acute hospitals in England 
was conducted in 2006 and involved 58,000 patients. It was reported, in the 
latter, that 8.2% of patients have an HCAI, a reduction from 9.2%, as reported in 
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the first national prevalence survey conducted in 1980 Hospital Infection Society 
(HIS) Press Release 8thMarch 2007 (HIS, 2007).  
The Health Protection Agency (HPA) conducted a survey of 99 NHS acute trusts 
and five private-sector care organisations between September and November 
2011. In total, data from 52,433 patients was analysed and presented in the 
report. The survey included data on the type of infection (the microorganism 
involved), the location of the infection, patient characteristics and hospital 
characteristics.  Based on results from a selection of hospitals across England, 
the report indicates that there have been large reductions in both MRSA and C. 
difficile rates since the last survey was conducted in 2006. C. difficile infections 
fell from 2% of patients becoming infected in 2006 to 0.4% in the 2012 report.  
Methicillin resistant Staphylococcus aureus (MRSA) fell even more sharply, from 
1.8% of patients affected to less than 0.1% (HPA, 2011) 
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Table 1.1. Main Causes of Healthcare-associated Infections in England (National 
Audit Ofiice 2009). 
 
Type of 
Infection 
Percentage of 
all HCAI 
Risk Factors Main Causative 
Organisms 
 
Urinary Tract 
Infections 
(UTI) 
 
20%  
 
80% of HCAI UTI are 
associated with 
urinary catheters 
(method and 
duration of 
catheterisation and 
susceptibility of 
patient.) 
Gram negative 
bacteria 
especially E. coli 
 
Lower 
Respiratory 
Tract 
Infections 
 
20% Mechanical 
ventilation; cumulative risk of infection increases with 
duration of ventilation. 
Acinetobacter 
species, 
S. aureus 
 
Gastrointestin
al 
22% The gut may become 
colonised with C. 
difficile which may 
establish an infection 
if normal gut flora is 
disrupted by broad 
spectrum antibiotics. 
The elderly are at 
particular risk. 
70% of HCAI 
gastro- intestinal 
infections were 
caused by C. 
difficile 
 
Surgical Site 
 Infection 
14% Duration of surgery, 
surgical 
technique, 
preparation, presence 
of foreign material, 
length of hospital stay 
and antibiotic 
prophylaxis. 
S. aureus ~50%, 
P. aeruginosa 
Other Gram 
negative bacteria 
 
Bacteraemia 
 
7% Approx. 44% 
associated with 
invasive devices. 
E. coli and other 
Gram negative 
bacteria, S. 
aureus 
Skin & Soft 
Tissue 
10% Management of open 
wounds andpressure 
sores. 
S. aureus 
 
Other 
 
7% 
Includes infections of 
bones and joints and 
the central nervous 
system. Often linked 
to surgical or invasive 
procedures. 
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Bacteria cause the majority of HCAIs, with the public being mainly aware of 
MRSA bloodstream infections and the gastrointestinal infection caused by 
Clostridium difficile (CDI).  The July – September 2011 HPA quarterly 
epidemiology report providing mandatorily reportable MRSA bacteraemia, and C. 
difficile infection data, reported 86.2% decrease in incidences of these two 
infections, (HPA, 2011c). The report suggests that recent efforts to tackle MRSA 
transmission in hospitals have been effective at driving down the prevalence of 
these infections. Many of these are simple yet effective and include; emphasis of 
the importance of regular, thorough hand-washing and swabbing patients to test 
for MRSA as they are being admitted to hospital.  Despite these improvements, 
the HPA still emphasises there needs to be continued focus on preventative 
efforts in order to keep the number of infections low.  Considering the incidence 
and costs implications of HCAI (roughly £1 billion per annum for the NHS), it is 
not surprising that healthcare authorities around the world are continuously 
seeking new ways to control HCAIs.   
 
1.2  Antimicrobial resistance  
 
A golden age of antibiotic drug discovery occurred between the 1930’s and the 
1960’s. However, the advent of antibiotic resistance rapidly followed the 
introduction of all classes of antibiotics into clinical practice (Hogberg et al, 
2010). The need for new antibiotics to combat the threat of antimicrobial 
resistance (AMR), contrasts sharply with the lack of research and development 
of new antimicrobial compounds by pharmaceutical companies (Talbot et al, 
2006). 
Pharmaceutical companies have reduced their focus on research and 
development of new antibiotics for the following reasons (Hogberg et al, 2010): 
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 Long time lines for development;  
 Spread of antibiotic and antimicrobial resistance (that can limit the market life 
of a product);  
 Low profit margins as a result of short treatment times and the effects of 
stewardship programmes to restrict the use of new agents.  
 
The misuse of antimicrobials is one of the major driving forces in the emergence 
of antimicrobial resistance. A high level of antimicrobial consumption in a specific 
geographic region is perhaps the biggest driving force behind the emergence of 
antimicrobial resistance.  In light of this, the World Health Organisation (WHO) 
compiled an antimicrobial surveillance report, raising awareness of AMR and the 
need for appropriate surveillance systems. The European Antimicrobial 
Resistance Surveillance Network – EARS-Net is an international surveillance 
system that includes all 28 EU countries. The network includes surveillance of 
antibacterial susceptibility of eight indicator pathogens causing bloodstream 
infections and meningitis.  It also monitors variations in AMR over time and place 
(WHO 2014). 
Exposure to sub-inhibitory antimicrobial concentrations can select for a 
hypermutation phenotype, leading to the rapid accumulation of resistance 
mutations (Laureti et al, 2013). A sub-inhibitory concentration is a concentration 
of antimicrobial that is not sufficient to kill bacteria, but may alter cellular 
processes. Whether these newly acquired resistance mechanisms persist and 
disseminate within the bacterial population is dependent on the extent of damage 
to cell viability imposed.  Another major driving force in the emergence of 
antimicrobial resistance in a specific geographic region is the level of 
antimicrobial consumption in that area.  Comparison of antimicrobial 
consumption levels from 15 European countries from 1998 to 2004 and 2004 to 
 
7 
 
2005, showed that there was a significant association between antimicrobial 
resistance and antimicrobial consumption in all of the countries studied (Riedel 
2007).  As a consequence, more aggressive antibiotics are used to treat the 
infection, such as vancomycin.  These drugs tend to cause more risk to the 
patient due to increased side effects, and in general a full course of the antibiotic 
tends to be more expensive than the original drug of choice.  Bacterial resistance 
to antibiotics also increases the risk of fatality due to HCAI.  Therefore it is of vital 
importance to discover ways to reduce incidence of HCAI in patients, rather than 
treating them when they occur.  Cross-resistance of disinfectant-resistant 
bacteria to antibiotics has also developed.  This can occur as a result of 
quaternary ammonium compound (QAC) resistance genes being located within 
conserved regions of integrons, which have been shown to carry multiple 
antibiotic resistance genes (Zhang et al 2011, Zou et al 2014). 
Antibiotic resistance is either acquired through mutation, via gene exchange or is 
inherent, as seen in many environmental bacteria. Selective pressures upon the 
organisms from the hospital environment are also a factor in the acquisition of 
resistance. Antibiotic resistance has been designated as an ‘emerging’ infectious 
disease and is now considered a major public health issue. This has come as a 
result of ‘bacterial evolution finally surpassing the human capacity to create new 
antimicrobial agents’ (Rahal et al, 2002).  
 
1.3  Bacterial reservoirs, environmental cleaning and persistence 
 
Infection prevention and control are seen as the responsibility of all within the 
healthcare setting and has a level of high importance within the National Health 
Service (NHS). The latter have produced (or have had produced on their behalf) 
numerous policies and guidance documents.  National evidence-based 
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guidelines for the prevention of HCAI within the NHS were commissioned by the 
Department of Health (DH) and published in 2001. These standard principles for 
prevention of HCAI include, among others, guidance on hospital environmental 
hygiene, hand hygiene and the use of personal protective equipment. Other aids 
to HCAI prevention include surveillance, for example, mandatory reporting of 
MRSA bacteraemia in England since 2001 and Clostridium difficile in over 65’s 
since 2004 with enhanced surveillance from 2007 in all patients aged ≥2 years, 
along with auditing compliance with key policies and procedures for preventing 
HCAI.  
The regular domestic cleaning of inanimate surfaces in a healthcare environment 
is vitally important.  In addition, the behaviours of healthcare workers daily 
routine activities, such as hand washing (animate surfaces) to block or minimise 
the colonisation by microorganism strains that can cause nosocomial infection 
are equally important. The routes of transmission for microorganisms are varied. 
Bacteria may come from endogenous sources, from the patients themselves, or 
exogenously from others or the environment. Bacteria can be dispersed from 
these reservoirs (coughs and sneezes from colonised or infected patients or from 
water outlets) to susceptible hosts.  In addition to the duration of persistence of 
microorganisms in the environment, other factors influencing persistence of 
microbes have been identified.  Low temperature and high humidity were both 
associated with longer persistence for most bacteria, fungi and some viruses 
(Boyce, 2007).  It has been shown that healthcare workers’ gloved hands may 
become contaminated, and that on removal of gloves the hands may also be 
contaminated.   
P. aeruginosa can also survive on inanimate surfaces for long periods of ≤16 
months, and on a dry floor, ≤5 weeks.  This fact is in contrast to many other 
Gram-negative bacteria, which are often highly susceptible to desiccation in dry 
 
9 
 
environments (Kramer et al, 2006).  Hospital surfaces such as curtains, mattress 
covers, bed linen, staff uniforms and chair covers have been reported as a 
possible reservoir of microorganisms causing HCAI.  The most common HCAI 
pathogens such as MRSA and C.difficile can survive on inanimate hospital 
surfaces for months and can therefore be a continuous source of transmission if 
no regular preventative surface disinfection is performed (Kramer et al, 2006). 
Although patients are especially vulnerable due to their existing conditions, they 
are not the only people at risk of contracting infection in a healthcare 
environment.  Healthcare workers are frequently exposed to infectious agents via 
airborne, droplet and person-to-person transmission.  The current work will focus 
on five microorganisms associated with HCAI, namely S.aureus, MRSA, E.coli, 
P.aeruginosa and C.albicans.  Chosen to provide a range of microorganisms, 
including Gram-positive, Gram-negative and a yeast. 
The importance of P. aeruginosa as a HCAI pathogen is underlined by multi-drug 
resistance. The bacterium may possess a number of inherent or acquired 
resistance mechanisms including drug exclusion and enzymatic inactivation. 
Exclusion of antibiotics was long considered to be due to the impermeability of 
the cell, however three-component efflux pumps, comprising the pump in the 
cytoplasmic membrane, a linker lipoprotein in the periplasm and an exit portal in 
the outer membrane appear to contribute (Avrain et al  2013). Within the 
hospital, P. aeruginosa is found in numerous reservoirs including disinfectants 
(Lanini et al, 2011), bath basins (Johnson et al, 2009), water-baths used to thaw 
frozen plasma (Muyldermans et al, 1998), contaminated nebulizers (Cobben et 
al, 1996) and bronchoscopes (Diaz-Granados et al, 2009).  As can be seen from 
these examples, many of the reservoirs are aqueous or associated with high 
moisture content.  The long-term survival of potential pathogens on surfaces, 
together with increasing resistance development to disinfectants and antibiotics 
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used in treatment, highlights the need to ensure surfaces including medical 
textiles (curtains, mattress covers, sheets, uniforms, chair covers) do not pose a 
potential transmission route for the spread of HCAI.  Both water and air harbour 
microorganisms and there are strategies to prevent transmission via these 
routes. Hospital patients are frequently exposed to waterborne microorganisms 
as they can exist in many moist reservoirs. Persistence of these microorganisms 
within the hospital environment, poses a significant risk for their transmission to 
susceptible patients. Owing to the risk of patient acquisition of pathogenic 
bacteria from the hospital environment much emphasis has been placed on 
hospital cleanliness and a number of initiatives launched as a result (Table 1.2). 
Hand hygiene has very much been the focus of government and NHS guidance 
to health care workers and visitors alike. The National Patient Safety Agency 
(NPSA) launched the national “clean your hands” campaign in 2004 to improve 
hand hygiene practiced by NHS staff. The process of hand washing has evolved 
to include alcohol-based gel products along with hand washing using soap and 
water in an attempt to interrupt the transmission of infection cycle from health 
care workers to patients. Personal Protective Equipment (PPE) such as gloves, 
aprons and face masks are also available for health care workers as routine for 
many procedures and also when attending to patients nursed in source isolation, 
known as barrier nursing. 
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Table 1.2. the associated costs of the national initiatives for tackling HCAI 
adapted from the NAO’s “Reducing Healthcare Associated Infections in Hospitals 
in England” (2009). 
 
 
Initiative Aims Cost 
 
Modern Matrons 
(2004) 
The improvement of clinical care standards, ensure best practice in infection control and provide a clean environment for care. Approximat ly £56 
million per year 
(Infection control is 
30 per cent of their 
workload) 
 
Cleanyourhands 
Campaign 
(2004) 
To improve the availability of 
alcoholhand rub at the point of 
patient care, increase compliance 
with hand hygiene and also 
auditing of hand hygiene. 
 
£2.5 million 
Saving Lives 
(2006) 
To provide the tools and resources 
for hospital trusts to embed 
robust infection prevention and 
control measures across their 
organisation 
Not possible to 
separately identify 
 
The Code of 
Practice (part of 
the Health Act 
2006) 
This sets out statutory criteria by 
which managers of NHS 
organisations are to ensure that 
patients are cared for in a
 clean environment, where 
the risk of 
HCAI is kept as low as possible. 
 
Not possible to 
separately identify 
 
The 
Improvement 
Teams (2006)  
Provide support to trusts in 
achievingreductions in MRSA 
bloodstream infections. Including 
support that ranges from visits to 
telephone advice. 
 
£3 million per year 
The Deep Clean 
(2008)  
Improvements in cleanliness and 
patient confidence. 
 
£62.6 million 
Technology 
Programme 
(2008) including 
the Rapid 
Review Panel 
(2004) 
Speed up the process of 
assessment and adoption of 
technologies to furtherhelp prevent 
HCAI. 
 
£25,000 for the panel 
and £10 million per 
year from 2008-09 
onwards 
MRSA 
Screening  (from 
April 2009) 
 
 
To reduce the carriage of MRSA in 
patients admitted electively or 
acutely to hospital. 
 
Approximately£130 
million per year from 
2010-11 
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Alongside the personal hygiene responsibilities of individual healthcare workers 
and the encouragement for a similar attitude for both patients and visitors, is 
attention to the cleanliness of the hospital environment itself. In NHS 
environments, cleaning staff are issued with cleaning schedules, which list areas, 
rooms and frequencies of clean, as specified in (National specifications for 
cleanliness in the NHS 2007) which are initialed daily on completion by domestic 
staff. Domestic Supervisors undertake routine monitoring audits, and required 
frequency of cleaning. Clinical staff undertake cleaning of patient related 
equipment and clinical equipment. Identified areas with infections are cleaned 
using ‘Deep Clean’ or ‘Chlor Clean’ (1000 ppm Chlorine with cold water) 
procedures. Many novel approaches have been developed to augment 
traditional ‘domestic’ cleaning methods. These include ultra microfibre cloths, 
mops containing biocides, ultra violet UV irradiation, impregnation of materials 
with heavy metals and ionisation (Veerabadran 2010). Other interventions 
involve patient care such as cohort nursing, isolation rooms, ventilation, 
screening of patients for carriage of pathogens such as MRSA, ensuring good 
nutrition and, for prevention of C. difficile infection, administration of probiotics 
(Plummer et al 2004, Cepeda  et al  2005). Interventions to reduce acquisition of 
water-borne pathogens include point-of-use filters, thermal shock, UV-light and 
copper-silver ionisation. High-efficiency particulate air (HEPA) filtration and 
optimised ventilation can reduce the number of air-borne pathogens such as the 
fungus Aspergillus, as well as bacteria such as MRSA and P. aeruginosa (Curtis, 
2008).  However, it is very difficult to validate or instigate a risk-assessed method 
for hospital cleanliness.  
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The primary objective of this thesis was to investigate the potential for the use of 
natural antimicrobials to add antimicrobial efficacy to synthetic textiles.  It was 
envisaged that mesoporous silica nanoparticles could be used to provide a slow 
release of the antimicrobial from the textile, with any successful product being 
used in healthcare environments against the spread of healthcare associated 
infections.  
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Chapter 2 
 
Screening of essential oils for antimicrobial properties 
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2.1  Introduction 
 
The initial stage of this study was to select a range of essential oils (EO) and 
assess their antimicrobial efficacy against a number of microorganisms 
associated with healthcare associated infections.  The EOs were tested 
individually and in blends.  The most effective blend was then tested against the 
microorganisms.  The most effective EOs and blends were analysed using gas 
chromatography mass spectrometry to determine if there were any chemical 
differences between them, and their respective antimicrobial efficacies. 
 
2.1.1  Essential oils 
 
Essential oils are complex mixtures of plant secondary metabolites, mostly 
comprising volatile chemical constituents, such as terpenoids.  These chemical 
compounds are responsible for the characteristic odour, pigments and flavours in 
many plants.  They act as a defence against microbes, herbivores, plant disease 
and other ecological factors (Wallace 2004). There are approximately 4500 
individual constituents known to occur in essential oils: such chemical diversity 
does not allow a common structural definition for them.  However, 
monoterpenes, sesquiterpenes and their derivatives are the predominant 
chemical constituents.  Additional components include aliphatic hydrocarbons, 
acids, alcohols, aldehydes, acyclic esters, lactones, nitrogen and sulphur 
containing compounds, coumarins and phenylpropanoids (Giordini et al 2001).  It 
is known that many oil constituents display antimicrobial activity, with olive oil 
and virgin olive oil containing polyphenol groups displaying some antimicrobial 
activity (Brenes et al 2007).  Essential oils can be obtained from plants by 
expression, fermentation, enfleurage or extraction, but the steam distillation 
method is the most commonly used for commercial production (Van de Braak 
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and Leijten, 1999).  Evidence exists for the production of ‘fragrant waters’ from 
boiling plant material as far back as the Indus Valley civilisation, 5000 years ago 
(Williams, 1989).  The use of tea tree oil for medical remedies has been 
documented since the colonisation of Australia (Carson and Riley, 1993).  
Currently, the heaviest use of essential oils in the EU is in food, as flavourings, 
perfumes and pharmaceuticals.  The antibacterial properties of essential oils and 
their components are also exploited in commercial products, such as dental root 
canal sealers and antiseptics (Cox et al 2000).This project focuses on the 
antimicrobial bioactivities displayed by many essential oils.  
 
2.1.2 Mode of action 
 
To date, research has shown EO bacterial cell targets include the cell wall and 
membrane, consequently disrupting Adenosine tri-phosphate (ATP) production 
and pH homeostasis in the cell.  EOs can also affect the bacterial cells 
transcriptome, proteome and the cell signalling (quorum-sensing) system (Szabo 
2010). For a bacterial cell, a series of vital functions rely on an intact working 
membrane, including the energy production, nutrient uptake and processing, 
synthesis of macromolecules and secretion.  Once the cell membrane is 
disrupted by EOs, those processes will be compromised.  In prokaryotes, ATP 
production takes place in the membrane and the cytosol by glycolysis.  
Intracellular and extracellular energy production is therefore disrupted by the EO 
activity on the cell membrane.  Disruption of pH homeostasis by EOs is a 
consequence of their action on bacterial membranes, which become incapable of 
blocking proton entry.  Bacterial cells adopt a series of strategies to achieve the 
most vital of processes, when exposed to conditions that compromise their 
survival.  In particular, deoxyribose nucleic acid (DNA) transcription, protein 
synthesis and enzymatic activity (Fux et al, 2005).  Intracellular pH maintenance 
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is crucial to these processes (Iwami et al, 2002).  Reduction in intracellular pH 
has been reported in bacterial cells that are exposed to EOs (Oussalah 2006).  
Proton influx can occur in bacterial cells exposed to EOs, if proton levels exceed 
the cytoplasmic buffering capacity or overwhelm proton efflux pumps, the 
intracellular pH level decreases and essential cellular functions are subsequently 
compromised (Foster 2004).   
Quorum sensing (QS) describes the capacity of bacterial communities to 
modulate their population density via cell-cell communication and the use of small 
signalling molecules to assess the outside environment and their physiologic 
response (Camilli 2006).  Central cellular processes such as motility, biofilm 
production, stress resistance, swarming and virulence are regulated by QS 
(Gobetti et al 2007).  EOs have been studied as anti-QS products, with many EO 
molecules similar in structure to QS molecules (Szabo 2010).  The technique of 
monitoring transcription levels of QS molecules in E.coli was used.  Amongst 
those oils reported to be most active against QS were clove and geranium oil 
(Khan et al 2009). 
Diminished enzymatic activity and the appearance of coagulated material within 
the cell have been reported to result from EO activity.  Cinnamon EO has been 
reported to effect intracytoplasmic changes to E.coli and S.aureus  (Derakhshan 
2008). 
Much research has been carried out on the antimicrobial mechanism of action of 
essential oils, with more than 20,000 journal articles published on the topic since 
the year 2000, www.sciencedirect.com (keywords, essential oil, antimicrobial, 
mechanism, mode of action).  Considering the large number of different groups of 
chemical compounds found in essential oils, it is likely their antibacterial activity is 
not solely attributed to one specific mechanism, but that there are several 
different targets in the cell (Figure 2.1).  The chemical structure of the individual 
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essential oil constituent affects their precise mode of action and antibacterial 
activity (Dorman and Deans 2000).  The lipophilicity of essential oil constituents, 
lipid composition of bacterial membranes and their net surface charge are the 
major factors deciding the membrane permeability of oil constituents.  Their 
hydrophobicity enables them to incorporate into the lipid layers of the bacterial 
cell membrane, disturbing the structures and rendering them more permeable.  
Essential oil constituents may also cross the bacterial cell membrane, penetrating 
the interior of the cell and interacting with intracellular sites critical for 
antibacterial activity (Trombetta et al 2005).  
Gram-negative bacteria are less susceptible to the action of essential oils, 
compared to Gram-positive bacteria.  This is due to the presence of the outer 
membrane surrounding the cell wall, which restricts the diffusion of lipophilic 
compounds through the lipopolysaccharide covering (Mann et al 2000).  The 
seven essential oils used in this study (cinnamon, clove, eucalyptus, geranium, 
lemongrass, lime and tea tree) were selected after reviewing the literature for 
their varying reported antimicrobial activities against microorganisms reported to 
cause HCAIs. 
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Figure 2. 1.  The locations and mechanisms in the bacterial cell thought to be 
sites of action for essential oil active components (Ahmed & Aqil 2009). 
 
2.1.3  Essential oils used in this study 
 
Cinnamon leaf oil is extracted from plants belonging to the Cinnamomumgenus.  
The oil is native to Indonesia, but often cultivated in India and Sri Lanka.  The 
main chemical components of the oil distilled from the leaves are eugenol, 
eugenol acetate, cinnamic aldehyde and benzyl benzoate.  Cinnamon leaf oil 
has been shown to display antimicrobial activity against P.larvae (Gende 2008, 
Prabuseenivasan 2006). 
Clove oil (Upadhyay 2010) is extracted from the clove plant, 
Syzygiumaromaticum.  Clove oil contains a very high proportion of eugenol that 
has been shown to be highly antimicrobial (Chaieb 2007).  Clove oil was 
reported to have inhibited growth of the yeast C.albicans at 0.12 (v/v), (Hammer 
1999). 
Eucalyptus oil is distilled from leaves of the eucalyptus tree, belonging to the 
genus Eucalyptus of the plant family Myrtaceae that is native to Australia.  
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Eucalyptus oil has been shown to display antimicrobial activity with MICs of 1% 
(v/v) against C.albicans and E.coli (Hammer 1999).   
Geranium oil is isolated from plants of the genus Pelargonium and is most 
commonly produced in Algeria, Egypt and Morocco.  Geranium oil contains over 
50 % (v/v) geraniol and citronellol.  Interestingly, a study by Khalaj and Farzin 
has shown that geranium oil has antidepressant activity (Khalaj and Farzin 
2006).  Geranium oil also exhibits well-known antimicrobial properties (Rosato 
2007). 
Lemongrass oil is extracted from the plant Cymbopogoncitratus and its main 
chemical constituent is citral at 50-80% (Naik 2010). Lemongrass has displayed 
antimicrobial activity, with MICs of 0.06% (v/v) against C.albicans and 0.06% 
against E.coli (Hammer 1999).  Native to India, where it has traditionally been 
used to treat fever and infectious illnesses.  Skin sensitisation can occur when 
the oil is applied topically to the skin, this is due to the large proportion of citral, 
which can be an irritant. 
Lime oil extracted from the fruit of the Citrus aurantifolia tree has been reported 
to show antimicrobial effects (Prabuseenivasan 2006).  Lime oil was reported to 
inhibit growth of E.coli at 1% (v/v) and C.albicans and S.aureus at 2% (v/v) 
(Hammer 1999). 
Tea tree oil has been shown to disrupt the permeability barrier of microbial 
membrane structures (Cox et al 2000).  The study showed enhanced 
permeability of bacterial cytoplasmic and yeast plasma membranes at minimum 
inhibitory levels of tea tree oil.  Leakage of potassium ions was also observed 
upon adding tea tree oil to these microbial suspensions of E.coli, S.aureus and 
C.albicans.  Although a certain amount of leakage from bacterial cells may be 
tolerated without loss of viability, extensive loss of cell contents or the exit of 
critical molecules and ions will lead to cell death. 
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2.1.4  Screening of essential oils 
 
It is apparent that evaluation of the antimicrobial activities of EOs is a difficult 
task as they are complex mixtures, poorly soluble in water and in the main 
volatile (Lahlou 2004).   
While there has been an abundance of studies carried out, the use of essential 
oils in antimicrobial research has been hampered by the lack of reliable and 
standardised in vitro screening methods.  The lack of standardised methods also 
makes direct comparison of results between studies difficult.  The various 
methods of note in the literature include disc diffusion, well diffusion, agar dilution 
and broth dilution, with surfactants, such as Tween 20 and 80 used to create a 
better dispersion of the hydrophobic EOs in broth or agar. For most commonly 
isolated bacterial and fungal pathogens, antimicrobial susceptibility testing can 
be performed by routine hospital laboratories. The most common methods 
utilised are the disc diffusion susceptibility test method (also known as Kirby-
Bauer) and minimal inhibitory concentration (MIC) determination. In 2001 the 
British Society for Antimicrobial Chemotherapy (BSAC) published a standardised 
disc diffusion method, seen as the gold standard for antibiotic and antiseptic 
screening (Andrews 2001).   It should be noted that the substances normally 
tested by these methods are generally hydrophilic in nature and therefore the 
assays have been optimised for this specific condition (Burt, 2004).  This is in 
contrast to the hydrophobic nature of EOs. 
 
Most studies investigating the antibacterial properties of essential oils have 
incorporated two or more antimicrobial assays, the most popular methods being 
disc and well diffusion (Hammer et al 1999).  However, there were widespread 
differences in incubation times, materials used and the formulation of the 
systems.  Antimicrobial activity from broth dilution assays displayed enormous 
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variation in technique, methodology and choice of surfactants (necessary for 
emulsification of the hydrophobic essential oils) (Flamini et al 1999).   
The major difficulties associated with the use of essential oils seem to be: 
 
 The viscosity or hydrophobicity of the oil creates difficulty in obtaining a stable 
aqueous dispersion or suspension, 
 The problems associated with the diffusion of lipophilic oil components through 
agar media, 
 The need for neutralising agents post-incubation with EO for the determination 
of colony forming units (CFU)/mL. 
 
Among all the methods described, the broth dilution method is seemingly the 
most widely used (Prabuseenivasan et al 2006).  Most researchers cite the 
minimum inhibitory concentration (MIC) as a measure of the antibacterial 
performance of EOs.  The method to define MIC differs between publications, 
(Hammer et al 1999, Prabuseenivasan et al 2006) defines MIC as the lowest 
concentration of oil inhibiting visible growth, whereas (Kon and Rai 2012) state 
MICs were determined by measuring optical density at 570 nm and defined as 
the concentration of oil at which there was a sharp decline in the absorbance 
value.  In addition, (Loughlin et al 2008) stated MIC was read as the lowest 
concentration of antimicrobial at which no colour change occurred, indicating the 
trimethyl tetrazolium chloride was not reduced to a red colour by bacterial 
growth.  For the purposes of this project, the MIC will be defined as the lowest 
concentration inhibiting visible growth of the test organism.  Essential oils are 
volatile, insoluble in water, viscous and complex substances.  Pauli et al 
reviewed results from three antimicrobial tests; agar diffusion, dilution test and 
vapour phase test) on 28 EOs (Pauli and Schilcher 2010).  There was great 
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variability in the results, which may be explained by the following factors: natural 
variability in the composition of the EOs, natural variability in the susceptibility of 
the microorganisms, different parameters in the microbiological testing methods, 
the unknown history of the EO tested (their production, age and storage 
conditions), and insufficient knowledge about exact phytochemical composition.   
 
2.1.5  The bacterial cell 
 
All bacterial cells have an inner bi-layer membrane, comprised of phospholipids, 
which are encased in a peptidoglycan cell wall. They reproduce by binary fission 
(Tortora et al 2007). 
Bacteria are separated into two groups, differentiated by their reaction to a 
procedure containing dyes and stains. In 1884 the Danish scientist Hans 
Christian Gram discovered that certain bacterial cells retained crystal violet dye 
when washed with alcohol, whilst in others the dye was washed away.  
Initially, a bacterial sample is heat-fixed on a glass slide.  The slide is flooded 
with crystal violet, colouring all cells in the sample purple.  After 1 minute, the 
excess crystal violet is drained off and the sample is washed with distilled water.  
The sample is then covered with Gram’s iodine, which acts as a mordant to fix 
the purple colouring of the crystal violet dye.  When the iodine is washed off, 
both Gram-positive and Gram-negative cells appear deep purple.  The sample is 
then washed with 95% ethanol, acting as a decolourising agent, removing the 
crystal violet stain from some cells, but not others.  The sample is washed with 
distilled water again, then exposed to safranin, a basic red dye, which acts as the 
counter stain.  Once washed for a final time with distilled water, the sample is 
heat dried and examined.  
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The physico-chemistry of the cell wall is therefore the differentiating factor.  The 
crystal violet dye and iodine combine in the cytoplasm of each bacterium to 
colour it dark violet or purple.  The bacteria that retain this colour after the 
alcohol has attempted to decolourise them are referred to as Gram-positive, 
while the bacteria that lose the purple colouring after the alcohol treatment are 
referred to as Gram-negative. 
Gram–positive bacteria have a rigid cell wall, which is between 30 nm and 100 
nm in thickness. The peptidoglycan grows with new layers formed on the inside 
of the cell wall, next to the cell membrane, with the oldest layers at the outer 
edge. Gram-positive cell walls also contain teicholic acids that provide rigidity, 
and act as cell growth regulators (Singleton 2004).  Crystal violet and iodine 
readily enter both Gram-positive and Gram-negative cells, combining to form a 
crystal violet-iodine (CV-I) complex, that is a larger molecule than the crystal 
violet or iodine entering the cells.  Due to its size, this (CV-I) complex can not be 
washed out of the thick peptidoglycan layer of Gram-positive cells by alcohol.  
Gram–negative bacteria, in contrast, have a thin peptidoglycan layer.  The 
alcohol disrupts the outer lipopolysaccharide layer and the CV-I complex is 
washed out of the Gram-negative cells.  As a result, Gram-negative cells are 
colourless, until counter stained with safranin, after which they appear pink. 
 
2.1.6 Microorganisms 
 
Five microorganisms were selected as challenges for screening the antimicrobial 
activity of the EOs.  Two Gram-positive, two Gram-negative bacteria and one 
yeast were selected to provide a range of microorganisms, reported to cause 
HCAI, and are described briefly below. 
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2.1.6.1 Pseudomonas aeruginosa  
 
P.aeruginosa is a Gram-negative bacillus with cell dimensions of approximately 
0.5 – 0.8 µm by 1.5 – 3.0 µm.  A high proportion of P.aeruginosa strains are 
motile via a single polar flagellum.  P.aeruginosa grows well at a variety of 
temperatures (25 - 37°C) and is resistant to relatively high concentrations of salt, 
dyes, weak antiseptics and most commonly used antibiotics (Krishnan et al 
2015).  These robust characteristics allow it to survive well in many environments 
resulting in prolific transfer and contamination.   
The Health Protection Agency (HPA) described P.aeruginosa as an opportunistic 
pathogen that can cause a wide range of infections, particularly against the 
immunocompromised.  A study conducted by the HPA showed P.aeruginosa 
accounted for approximately 93% of all identified Pseudomonas spp. Infections 
reported in UK healthcare facilities (HPA 2009).  
The frequency of P.aeruginosa HCAIs make it an ideal target for any technology 
aimed at reducing the incidence of HCAI.  In a survey of most frequently 
associated microorganisms associated with HCAI, P.aeruginosa accounted for 
6% of the 3,506 cases (HPA 2011).   
 
2.1.6.2  Staphylococcus aureus 
 
S.aureus is a non-sporulating, non-motile, Gram-positive cocci with an average 
diameter of 1 µm.  They occur in grape like clusters, tetrads and sometimes in 
short chains.  S.aureus is a facultative anaerobe that is coagulase and catalase 
positive.  S.aureus occurs naturally on the skin and is part of the human mucosal 
membrane flora (Stevens 2006). 
Of all staphylococci species, S.aureus is the most important human pathogen, 
causing a wide range of infections due to its ability to produce a wide variety of 
cellular and extracellular proteins associated with virulence of the bacterium.  
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These range from skin and soft tissue infection, cellulitis, folliculitis, impetigo, 
post-operative wound infection, osteomyelitis, endocarditis and haemolytic 
pneumonia (Blomquist 2006). 
 
2.1.6.3 Methicillin resistant Staphylococcus aureus 
 
Methicillin resistant Staphylococcus aureus (MRSA) are strains of S.aureus 
which have acquired resistance to the antibiotic methicillin. Due to increasing 
antimicrobial resistance, efforts are being made to ensure the correct antibiotics 
are only administered when necessary. Important actions include preventing 
infections from happening in the first place, through better hygiene, access to 
clean water, infection control in health-care facilities, and vaccination to reduce 
the need for antibiotics. The development of new diagnostics, antibiotics and 
other tools are necessary to allow healthcare professionals to stay ahead of 
emerging resistance.  MRSA are described as opportunistic pathogens, about 
0.5 – 1 µm in diameter gram positive cocci.  Commonly found in skin infections, 
MRSA can cause osteomyelitis, septicaemia and abscesses (Cohen 1986). 
MRSA infections are difficult to treat and accounts for a 64% higher mortality rate 
in comparison to methicillin susceptible Staphylococcus aureus infection (WHO 
2014).  
 
2.1.6.4 Escherichia coli 
 
 
E.coli is a Gram-negative rod-shaped bacterium that resides in the lower 
intestine, usually motile by peritrichous flagella. E.coli is the most common cause 
of acute urinary tract infections as well as urinary tract sepsis. It has also been 
known to cause neonatal meningitis and sepsis and also abscesses in a number 
of organ systems. E.coli may also cause acute enteritis in humans as well as 
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animals and is a general cause of ‘traveller's diarrhoea’, a dysentery-like disease 
affecting humans, and haemorrhagic colitis often referred to as ‘bloody 
diarrhoea’. Virulence types of E.coli include enterotoxigenic (ETEC), 
enteroinvasive (EIEC), enteropathogenic (EPEC), and Vero cytotoxigenic 
(VTEC) (Curtis and Lawley 2003).  Moreover, E. coli are introduced into water 
bacteriology because it is a useful marker of faecal pollution and thus became an 
important marker in food and water hygiene (Percival et al 2004). 
 
2.1.6.5  Candida albicans 
 
 
Candida albicans is an opportunistic human fungal pathogen, which causes 
disease mainly in immuno-compromised patients. Activity of hydrolytic enzymes 
is essential for virulence of C.albicans and so is the capacity of these cells to 
undergo transition from yeast to mycelial form of growth.  It can grow as yeast 
cells, pseudohyphae and hyphae, and this dimorphic switching is required for full 
virulence (Yang 2003).  C.albicans cells can adhere to and colonise certain 
human tissues and prostheses, eventually leading to biofilm formation.  This 
subsequently reinforces adhesion, infection and resistance to antifungals 
(Tangarife-Castano et al 2011).  Secretion of hydrolytic enzymes such as 
proteinases and phospholipases contribute to infections such as oral candidosis, 
where overgrowth of cells of the resident microflora occurs in the mouth.  These 
enzymes are responsible for adhesion, tissue damage and invasion of host 
tissues.  The production of a range of extracellular hydrolases has been 
attributed to C.albicans pathogenicity (Tangarife-Castano et al 2011). 
Candidiasis ranges from superficial infections such as oral thrush to deeply 
invasive disease, such as the Candida bloodstream infection, candidaemia. 
Bloodstream infections are the most common form of invasive candidiasis. 
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Systemic candidiasis is a common fungal infection worldwide and associated 
with high rates of morbidity and mortality in certain groups of patients. C. 
albicans infections remain as the top source of fungal infections in immune-
compromised people. For example, in human immunodeficiency virus (HIV) 
patients, over 48% will develop a case of candidiasis (Khan et al 2012). 
Although it is known that antifungal resistance imposes a substantial burden on 
health-care systems in industrialised countries, the global burden of antifungal-
resistant Candida is unknown. Resistance to fluconazole, a common antifungal 
drug, varies widely by country and species. Resistance to the newest class of 
antifungal agents, the echinocandins, is already emerging in some countries 
(WHO 2014). C.albicans was added to the test microorganisms as a yeast in 
addition to four bacteria, providing an array of microbes that cause HCAIs. 
  
2.1.7 Gas chromatography mass spectroscopy  
 
 
Gas chromatography-mass spectrometry (GC-MS) is a combination of two 
distinct techniques used to analyse mixtures of chemicals.  The initial part of the 
analysis is to isolate the individual components of the EO samples.  In gas 
chromatography (GC) the chemical mixture is injected into an inert carrier gas, 
often helium, which is the mobile phase.  The mobile phase and the sample then 
pass through the GC column, containing chemically receptive particles (the 
stationary phase).  The components in the mixture interact with these particles at 
varying rates as they pass through the GC column (Figure 2.2).  Molecules which 
have a weaker interaction with the column particle surface will elute first, while 
molecules that interact strongly will take longer to pass through the stationary 
phase.  In this way the molecular components of the sample are separated out.  
Further separation can be achieved by adjusting temperature with low boiling 
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point molecules eluting faster at low temperature and high boiling point 
molecules eluting faster at higher temperatures.  Once the molecule has passed 
through the stationary phase it is fed into a detector, which creates an electronic 
signal.  The greater abundance of a molecule the larger the signal.  The signal is 
plotted on a linear time graph with abundance of molecules on the y-axis and 
time on the x-axis.  The area of the peak generated by the signal is a measure of 
the amount of that molecule detected and can be rationalised by the use of an 
internal standard of known concentration.   
 
Figure 2. 2.  A diagram showing gas chromatography analysis. 
 
While GC allows for determination of the number of molecular components and 
their abundance, the mass spectrometer (MS) can detect the chemical makeup 
of the molecule, allowing it to be identified.  Once the molecules have passed 
through the GC they are fed into the electron ionisation mass detector of the MS.  
Here they are bombarded with electrons, breaking them into ionised fragments of 
the original molecule.  The ionised fragments are passed through a magnet 
which focuses them onto a detector (Figure 2.3).  By varying the strength of the 
magnet, fragments of differing molecular mass can be focused onto the detector.  
The detector generates a signal for each fragment, which is plotted on a graph, 
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with molecular mass on the x-axis and abundance on the y-axis.  This graph is 
the mass spectrum of the molecule which is often unique, and by comparing the 
mass spectrum of an unknown sample to a database it is possible to identify the 
molecule (Derwich et al 2010). 
 
 
Figure 2.3.  A diagram showing mass spectrometry analysis. 
 
 
For this part of the project, GC-MS was used to analyse the chemical 
components of individual oils and then their respective blends to see if any 
changes occurred chemically and if these changes have an impact on 
antimicrobial efficacy. 
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2.2  Objectives 
 
 Select a number of EOs for their range of antimicrobial activity against 
microorganisms associated with HCAIs. 
 Screen oils alone against microorganisms associated with HCAI at <2% to avoid 
skin sensitisation, considering potential end use. 
 Test for synergy between the EOs in blends against the microorganisms. 
 Record efficacy for contact kill against the microorganisms. 
 Analyse EOs and the most potent blend using gas chromatography mass 
spectrometry to identify major chemical constituents. 
 
 
2.3  Experimental 
 
2.3.1 Materials 
 
2.3.1.1  Culture media 
 
 
Nutrient agar (Oxoid CM0003, Basingstoke, UK), Iso-Sensitest agar (Oxoid 
CM0471, Basingstoke, UK), Mueller-Hinton agar (Oxoid CM0337, Basingstoke, 
UK), Tryptone soya agar (Oxoid CM0131, Basingstoke, UK) and Columbia agar 
(Oxoid CM0331, Basingstoke, UK) were made as per manufacturer’s instructions 
and autoclaved at 121°C for 15 minutes in glass durans, then cooled to 50°C, 
before adding 5% (v/v) defibrinated horse blood for Columbia blood agar plates.  
Agar was then dispensed in 20 mL volumes in each petri dish.  All agar plates 
were stored at 4°C, any unused agar plates were discarded after 4 weeks.  
Nutrient broth (Oxoid CM0001, Basingstoke, UK) and Iso-sensitest broth (Oxoid 
CM0473, Basingstoke, UK) were made as per manufacturer’s instructions and 
dispensed in 500 mL glass bottles. 
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2.3.1.2 Microorganisms 
 
 
Escherichia coli NCIMB9001, Staphylococus aureus NCIMB8625, Candida 
albicans NCYC1363, Pseudomonas aeruginosa NCTC 6749, MRSA MMU T4.  
Stock cultures of all microorganisms were stored at -80°C. Subcultures were 
prepared from frozen isolates by streaking onto fresh agar plates.  Nutrient agar 
(NA) was used for S.aureus, MRSA, E.coli and P.aeruginosa.  Tryptone soya 
agar (TSA) was used for C.albicans.  All streaked plates were incubated at 37°C 
for 24 hours, and stored in a refrigerated cabinet at 4°C prior to use.  These 
streaked plates were replaced every four weeks, with fresh cultures being made 
before each experiment. 
2.3.1.3 Essential oils 
 
Tea Tree oil (Melaleucaalternifolia), clove oil (Syzygiumaromaticum), cinnamon 
oil (Cinnamomumzeylanicum), lime oil (Citrus aurantifolia), eucalyptus oil 
(Eucalyptus polybractea), lemongrass oil (Cymbopogoncitratus) and geranium oil 
(Pelargonium graveolens) (100 mL of each) were obtained from the on-line 
supplier www.essentialoilsdirect.co.uk. All oils were stored away from sunlight, at 
room temperature.  Sterility was checked periodically by streaking a 2% (v/v) 
dilution of the oils onto a nutrient agar plate and incubating for 24 hours, with no 
signs of microbial growth apparent. 
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2.3.2 Methods 
 
 
2.3.2.1 Preparation of cell suspensions 
 
 
Prior to each experiment an overnight suspension was prepared for each 
microbial culture.  Three well isolated colonies were taken from the streaked 
agar plate, inoculated into 10 mL of sterile Nutrient broth (NB) and incubated for 
18 hours at 37°C.  The optical density (OD) of the cell suspensions were 
adjusted to 0.1 at 600 nm and a count performed in order to determine CFU/mL. 
 
2.3.2.2 Growth curves 
 
 
Growth curves for the five chosen test organisms were undertaken to provide 
information on the stationary and exponential phases of growth, in order to 
determine appropriate incubation times when using test organisms in different 
stages of growth during time – kill assays. 
An overnight culture of each microorganism was diluted to OD 0.1 at 600 nm. A 
1:10 dilution of this culture was made, and 5 mL was added to 100 mL of 
Nutrient broth, or Sabouraud dextrose liquid medium for C.albicans and 
incubated at 37°C on a shaker at 120 rpm.  Finally, 1 mL aliquots were taken at 
timed intervals ranging from 0 minutes to 24 hours and the OD at 600 nm was 
tracked over time.   
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2.3.3 Agar dilution assay 
 
 
The agar dilution assay used in this study was based on a previously published 
method (Hammer 1999).  Tween-20 was incorporated into Isosensitest agar 
(ISA) at a final concentration of 0.5% (v/v) to enhance dispersion of the oil within 
the media (Loughlin et al 2008).  Cinnamon, clove, eucalyptus, lime, tea tree, 
lemongrass and geranium essential oils were used.  A series of two-fold dilutions 
for each oil, ranging from 2% (v/v) to 0.03% (v/v) was prepared in ISA, with 0.5% 
Tween-20.  A multi-point replicator was used to inoculate the plates with one 
spot of 1-2 µL of the standardised cell suspension of each microorganism.  
Three ISA plates, with 0.5% (v/v) Tween-20 but no essential oil were used as 
positive growth controls.  Inoculated plates were incubated at 37°C for 24 hours.  
The experiment was run in triplicate and repeated three times (n=9), with MICs 
determined as the lowest concentration of oil inhibiting visible growth of each 
microorganism on the nutrient agar plate.   
 
2.3.4 Disk diffusion assay  
 
 
Microbial suspensions were prepared as previously described and 30 μL spread 
over the plates (standard 85 mm in diameter) containing 20 mL of Mueller Hinton 
agar (MHA) using a sterile plate spreader. Under aseptic conditions sterile paper 
disks were impregnated with 5 μL of EO and left on paper towels for 5 minutes at 
room temperature to allow excess oil to soak out.  Disks were then placed on the 
inoculated MHA surface, three on each plate. A disk with no absorbed EO was 
used as a control. The Petri dishes were left for 30 minutes at room temperature 
(20-22°C) to encourage oil diffusion prior to bacterial growth and were then 
placed in an incubator at 37°C for 24 hours.  After the incubation period 
diameters of inhibition zones around the disks with EOs were measured in mm 
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using a ruler.  The experiment was run in triplicate on three separate occasions 
(n=9). 
 
2.3.5  Broth micro-dilution assay 
 
 
The method for this assay was based on that previously published (Loughlin 
2008).  Iso-Sensitest Broth (ISB) was autoclaved with double strength Tween-80 
0.5% (v/v) with a final concentration of 0.25% to enhance oil distribution in the 
broth.  The ISB Tween-80 mix was then used to dilute neat essential oil in 
doubling dilution for a final range of 2% (v/v) to 0.03% (v/v).  Clove, cinnamon, 
tea tree, lemongrass, eucalyptus, lime and geranium oil were used for this assay.  
To overcome the problem of turbidity due to emulsified essential oil, 
trimethyltetrazolium chloride (TTC) was added post autoclaving (to ISB) using a 
sterile syringe to give a final concentration of 0.005% (v/v).  TTC is a tetrazolium 
salt which is reduced by metabolically active cells to a coloured water-soluble 
formazan derivative, allowing visual identification of metabolic activity by a deep 
red colour indicating growth (Brady et al 2006).  The microorganisms to be tested 
were then added to sterile 25 mL glass bottles containing 10 mL ISB-TTC mix, 
for a final concentration of approximately 106 CFU/mL. 
Using a 96 well micro-titre plate (MTP), the ISB-TTC mix (75 µL) was added to 
column 1 wells A-E and the ISB-Tween-80 mix (75 µL) was added to column 2 
wells A-E as controls (Figure 2.9).  The ISB-Tween80-EO mix (75 µL) was then 
added to the appropriate wells.  Column 9 wells A-E containing the lowest 
concentration (0.03%), ascending to column 3 wells A-E containing the highest 
concentration (2%).  The ISB-TTC-microorganism mix (75 µL) was then added to 
all test wells apart from the negative control wells. 
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Figure 2.4.  96 well microtitre plate, demonstrating well layout. 
 
Once inoculated, the MTPs were covered using Parafilm and aerobically 
incubated at 37°C for 24 hours.  Post incubation, bacterial growth was indicated 
by TTC reduction and development of a red colour in the wells.  MICs were taken 
to be the lowest concentration of essential oil at which no visible colour change 
occurred.  The minimum bactericidal concentrations (MBCs) were determined by 
taking 10 µL aliquots using an auto pipette, from each well that showed no 
growth in the MIC test and sub culturing onto nutrient agar.  The 10 µL drops 
were left to absorb into the agar and the plates were then aerobically incubated 
at 37°C for 24 hours.  The first concentration which rendered no growth was 
taken to be the MBC.  The experiment was run in triplicate, three times (n=9). 
2.3.6  Time – Kill assay  
 
 
To provide a profile of the killing efficacy of the EOs, S.aureus MRSA, 
P.aeruginosa, C.albicans and E.coli were taken from an overnight culture in 
stationary phase.  In addition, the microorganisms were also prepared in 
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exponential growth phase, by diluting overnight bacterial cultures in fresh broth 
and incubating at 37°C until they reached exponential growth phase according to 
the growth curves (Figures 2.1 to 2.5).  In 5 mL glass bottles, 1 mL of cell 
suspension was added to 20 or 1.25 µL of EO to give final concentrations of 
0.125% and 2% (v/v), respectively.  Tween 80 was used as a surfactant, added 
to the broth containing cell cultures at a final concentration of 0.05% (v/v).  A 10 
µL aliquot was taken from the 0% EO test tube immediately after mixing to be 
used as a ‘time 0’ control.  Test tubes were then incubated at 37°C, and after 15, 
30 and 60 minutes 10 µL of suspension was removed and spread on ISA using a 
sterile plastic spreader, recording CFU/mL over time.  The experiment was run in 
triplicate (n=3). 
2.3.7  Checkerboard blend assay 
 
 
The method to assess the interaction between two EOs in a blend was carried 
out much in the same way as described previously in (Section 2.3.5), the 
difference being that instead of 75 µL of ISB-Tween80-EO mix being added to 
the appropriate wells, 37.5 µL of EO  (X) and 37.5 mL of EO  (Y) were added 
separately then mixed thoroughly using an auto pipette.  EO (X) was added in 
descending concentrations across the X axis left to right.  EO (Y) was added in 
descending concentrations down the Y axis top to bottom, as shown in Figure 
2.10 and 2.11.  The seven oils used previously were combined in equal volumes.  
75 µL of ISB-TTC-microorganism mix was then added to the appropriate wells, 
with one microorganism being tested with each MTP.  Once inoculated, the 
MTPs were aerobically incubated at 37°C for 24 hours.  Post incubation, 
microbial growth was indicated by the development of a red colour in the wells.  
Therefore, MICs were taken to be the lowest concentration of essential oil at 
which no colour change occurred.  The experiment was run in triplicate (n=3). 
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Figure 2.5.  An inoculated checkerboard micro-titre plate containing a blend of 
cinnamon and tea tree oil in various concentrations against S.aureus.  Cinnamon 
descending in concentration across the X-axis, tea tree oil descending in 
concentration down the Y-axis (2% - 0.03%).  The red colouring of the TTC dye 
in the bottom right corner indicates metabolic activity (growth) of the bacterium. 
 
Figure 2.6.  Graphical representation of method described in Section 2.3.7, 
where each essential oil had a starting concentration of 2% (v/v).  EO (X) being 
added in descending concentrations across the X axis left to right.  EO (Y) being 
added in descending concentrations down the Y axis top to bottom. 
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The level of synergistic activity was assessed using fractional inhibitory 
concentration (FIC) calculations, shown in equation 2.1: 
Equation 2.1.  FIC calculation, considering MIC values for EOs individually and in 
combination. 
 FIC =  X +  Y where 
𝑋 =  
(𝑀𝐼𝐶 𝑜𝑓 𝑋 𝑖𝑛 𝑐𝑜𝑚𝑏𝑖𝑛𝑎𝑡𝑖𝑜𝑛)
(𝑀𝐼𝐶 𝑜𝑓 𝑋 𝑎𝑙𝑜𝑛𝑒)
 
𝑌 =  
(𝑀𝐼𝐶 𝑜𝑓 𝑌 𝑖𝑛 𝑐𝑜𝑚𝑏𝑖𝑛𝑎𝑡𝑖𝑜𝑛)
(𝑀𝐼𝐶 𝑜𝑓 𝑌 𝑎𝑙𝑜𝑛𝑒)
 
 
 
 
 
When X is the first EO and Y is the second EO in the blend. 
If FIC ≤ 0.5 the relationship is synergistic 
If 0.5 < FIC ≤ 1 the relationship is additive 
If 1 < FIC ≤ 4 the relationship is indifferent 
If FIC ≥ 4 the relationship is antagonistic (Meletiadis et al 2010). 
 
The aim of using EO blends is to reduce the concentration of each oil while 
retaining an increasing antimicrobial potential. Synergism was defined as a 
positive interaction between the two EOs such that the combined effect of the 
two EOs was significantly greater than the expected additive result.  Antagonism 
was defined as a negative interaction between the two EOs such that the 
combined effect of the two EOs was significantly less than the expected additive 
result.  An additive relationship occurred when the sum of the separate effects 
was the same as the effect of EOs used in combination.  Indifference indicated 
that the effect of the EOs in combination was the same as that of the most potent 
EO individually (Meletiadis et al  2010). 
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2.3.8  GC-MS analysis of essential oils 
 
 
GC-MS analysis of the seven individual EOs and selected EO blends were 
performed using an HP 5890 Series 2 GC interfaced with a 5972 series mass 
selective detector (MSD) (Hewlett Packard co., Palo Alto, USA). 
For each EO, 1 µL was added to 10 mL of hexane solvent and vortexed for 20 
seconds.  As this EO concentration is too strong for the MSD, the method was 
setup to include a split of 20 to 1 resulting in 19 parts being discarded for every 1 
part that reaches the detector.  This way saturation of the detector is avoided 
and the MSD lifespan is increased.  Helium at a flow rate of 1 mL/min and 
69,000 Pa was used as the carrier gas.  Sample injection volume was 1 µL. 
Temperature programmes were used to allow GC runs to be completed within an 
appropriate timescale.  The initial oven temperature was 60°C for 3 minutes, 
then increased to 230°C at a rate of 4°C/min and held for 20 minutes.  After 
running all EOs with this programme it was noted that a number of peaks eluted 
around 110°C.  The GC method was subsequently altered to include an initial 
temperature ramp from 60°C to 112°C at a rate of 4°C/min, followed by a second 
temperature ramp from 112°C to 230°C at a rate of 10°C/min.  Before any test 
samples were run the injection needle was flushed several times with hexane 
and the column was run with hexane using a 16 minute programme to ensure 
the column was ready to use.  The injector and detector temperatures were 
275°C and 250°C respectively.  The MSD operating conditions were as follows: 
ionisation energy 70 eV, mass range 50 to 550 atomic mass units (a.m.u,) 
scanning rate 1.52 scans/s.  Peaks were positively identified using the Wiley 275 
mass spectral database. 
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2.4  Results and discussion 
 
2.4.1  Growth Curves 
 
 
Figure 2.7. Growth curve for C.albicans, demonstrating that the yeast enters 
exponential growth phase at approximately 3 hours. 
 
Figure 2.8.  Growth curve for E.coli demonstrating that the bacterium enters 
exponential growth phase after 1-2 hours. 
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Figure 2.9.  Growth curve for P.aeruginosa, showing that the bacterium enters 
exponential growth phase after approximately 2.5-3 hours. 
 
 
Figure 2.10.  Growth curve for S.aureus showing that the bacterium enters 
exponential growth phase after 2.5-3 hours. 
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Figure 2.11.  Growth curve for MRSA demonstrating that the bacterium enters 
exponential growth phase after 3 hours. 
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2.4.2  Disk diffusion of individual essential oils 
 
 
Each of the seven oils was initially screened for antimicrobial activity against 
S.aureus, MRSA, E.coli, P.aeruginosa and C.albicans.  The disk diffusion 
method was used and the zone of inhibition data are presented in (Table 2.1).   
 
Table 2.1.  Diameters of inhibition zones of individual oils against five 
microorganisms (mm).  Values represent the average from three replicates.  MIC 
– Minimum inhibitory concentration, SD – Standard deviation (±), (n=9). 
 
 S.aureus MRSA E.coli P.aerugin
osa 
C.albicans 
Essential oil ZOI SD ZOI SD ZOI SD ZOI SD ZOI SD 
Cinnamon 51.
0 
4.0 53.1 4.4 41.
1 
2.8 17.
1 
0.5 24.8 3.0 
Clove 22.
4 
2.5 25.0 0.9 22.
0 
3.4 13.
9 
2.1 17.1 0.7 
Eucalyptus 7.9 3.0 11.1 2.5 12.
4 
0.8 n/a n/a 3.4 1.0 
Geranium 21.
4 
2.3 27.4 1.8 12.
3 
1.1 10.
1 
1.2 16.8 2.2 
Lemongrass 34.
3 
0.4 39.3 2.4 20.
4 
0.3 11.
3 
0.9 12.9 1.1 
Lime 4.2 0.7 5.5 0.3 5.1 0.8 na na 4.0 0.3 
Tea tree 22.
5 
4.0 20.5 1.4 22.
6 
4.0 10.
9 
1.7 22.1 2.0 
 
 
The disk diffusion results show cinnamon to be the most potent oil, recording the 
largest zone of inhibition (ZOI) for each microorganism tested, with the largest 
ZOI being against MRSA at 53.1 ± 4.4 mm.  Both lime and eucalyptus oils failed 
to achieve a ZOI against P.aeruginosa. However, this gram-negative bacterium 
proved to be the most robust of the five microorganisms tested.   
 
Having confirmed the antimicrobial nature of the oils, agar dilution assays were 
conducted to obtain MICs for the individual oils. 
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2.4.3  Agar dilution of individual essential oils 
 
 
The seven EOs were tested for antimicrobial efficacy against P.aeruginosa, 
E.coli, S.aureus, MRSA and C.albicans in agar.  The minimum inhibitory 
concentration (MIC) data are presented in (Table 2.2). 
 
Table 2.2.  MIC data for agar dilution assay.  Seven essential oils (EOs) dispersed 
in ISA in a doubling dilution series from 0.03-2% (v/v) were inoculated with five 
microorganisms using a multipoint replicator.  Values represent the average from 
three replicates. SD – Standard deviation in parenthesis, (n=9). 
 S.aureus MRSA E.coli P.aeruginosa C.albicans 
 MIC (%) 
(SD) 
MIC (%) 
(SD) 
MIC (%) 
(SD) 
MIC (%) (SD) MIC (%) 
(SD) 
Cinnamon 0.50 (0.00) 0.33 
(0.14) 
0.50 
(0.00) 
>2 (0.00) 0.41 (0.14) 
Clove 0.83 (0.29) 0.50 
(0.00) 
0.50 
(0.00) 
>2 (0.00) 0.21 (0.07) 
Eucalyptus 2.00 (0.00) 2.00 
(0.00) 
1.00 
(0.00) 
>2 (0.00) 1.00 (0.00) 
Geranium 1.00 (0.00) 2.00 
(0.00) 
1.00 
(0.00) 
>2 (0.00) 1.00 (0.00) 
Lemongrass 0.33 (0.14) 0.25 
(0.00) 
0.16 
(0.07) 
>2 (0.00) 0.50 (0.00) 
Lime 2.00 (0.00) 2.00 
(0.00) 
2.00 
(0.00) 
>2 (0.00) >2    (0.00) 
Tea tree 0.83 (0.29) 0.50 
(0.00) 
0.41 
(0.14) 
>2 (0.00) 0.50 (0.00) 
 
Of the seven oils tested, lemongrass exhibited the greatest antimicrobial efficacy 
against three of the five test microorganisms; MICs of 0.33%, 0.25% and 0.16% 
(v/v) for S.aureus, MRSA and E.coli respectively.  Lime oil registered the least 
antimicrobial efficacy, recording MICs of 2% (v/v) or above for all the test 
microorganisms.  Of the five bacteria tested, P.aeruginosa displayed the most 
resistance to the oils, with no inhibition of growth at the highest oil concentration 
tested.  The least resistant was E.coli, with growth being inhibited at less than 
2% (v/v) for all oils tested, disregarding lime oil.   
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The MIC values recorded for lime and eucalyptus in (Table 2.2) correlate well 
with those in the literature, with Hammer (1999) reporting an MIC of 2% (v/v) for 
S.aureus and over 2% for P.aeruginosa. 
The MIC values for lemongrass however do not match well with those reported in 
the literature, with Hammer (1999) reporting much lower MICs for S.aureus, 
E.coli and C.albicans, all 0.06% (v/v).  This compared to 0.33, 0.16 and 0.5% 
respectively, for this study.  Some of the results for tea tree oil corresponded well 
to those found in the literature, (Carson et al 2006) published MICs of 0.08-2% 
(v/v) for tea tree against E.coli and 0.5-1.25% (v/v) against S.aureus.  Hammer 
(1999) obtained an MIC of 0.25% (v/v) for E.coli in comparison to 0.41% (v/v) for 
this study and an MIC of 0.5% for S.aureus as opposed to 0.83%, found in the 
present study.  However, agreement was found on 0.5% (v/v) for C.albicans and 
an MIC of >2% (v/v) for P.aeruginosa.  Due to, among other factors, the varying 
composition of the EO, differences in MICs found in the literature and those 
obtained in this study are to be expected.  Variation in the chemical composition 
of plant extracts and oils is related to Local climatic and environmental conditions 
the plants are grown in.  Further factors which can impact on the oil composition 
include, soil acidity, rainfall, and the time of day at which the plants are harvested 
(Janssen et al 1987, Sivropoulou et al 1995).  Therefore, batches of essential oil 
harvested from individual plants can show variation in antimicrobial activity.  
Previous research has also demonstrated the existence of multiple chemotypes 
amongst plant extracts, producing different chemical compositions of an 
essential oil (Thompson et al 2002, Chizzola et al 2008).  Hammer 1999, did not 
include the chemotype of the oils used in their study.  If the oils used in this study 
are of a different chemotype, this could explain the differences in MICs observed.  
Different strains of bacteria may also have different susceptibilities (Tenover 
2006).  
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2.4.4  Broth micro-dilution of individual essential oils 
 
 
The seven EOs were tested for antimicrobial efficacy against P.aeruginosa, 
E.coli, S.aureus, MRSA and C.albicans in broth.  The MIC data are presented in 
(Table 2.3). An image taken of the micro-titre plate of cinnamon oil inoculated 
against the test microorganisms is given (Figure 2.12). 
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Table 2. 3.  MIC and MBC data for broth microdilution assay.  Values represent the range from three replicates.  SD – Standard 
deviation, (n=9) 
 S.aureus MRSA E.coli P.aeruginosa C.albicans 
 MIC (SD) MBC 
(SD) 
MIC (SD) MBC 
(SD) 
MIC (SD) MBC 
(SD) 
MIC (SD) MBC 
(SD) 
MIC (SD) MBC 
(SD) 
Cinnamo
n 
0.17 
(0.07) 
0.50 
(0.00) 
0.17 
(0.07) 
0.67 
(0.29) 
0.21 
(0.07) 
0.50 
(0.00) 
2.00 
(0.00) 
>2 (na) 0.25 
(0.00) 
1.00 
(0.00) 
Clove 0.13 
(0.00) 
0.42 
(0.14) 
0.33 
(0.14) 
1.00 
(0.00) 
0.17 
(0.07) 
0.42 
(0.14) 
2.00 
(0.00) 
>2 (na) 0.21 
(0.07) 
0.67 
(0.29) 
Eucalyptu
s 
2.00 
(0.00) 
>2 (na) 2.00 
(0.00) 
2.00 
(0.00) 
1.00 
(0.00) 
2.00 
(0.00) 
>2 (0.00) >2 (na) 2.00 
(0.00) 
>2 (na) 
Geranium 0.33 
(0.14) 
0.50 
(0.00) 
1.67 
(0.58) 
2.00 
(0.00) 
0.25 
(0.00) 
0.67 
(0.29) 
>2 (0.00) >2 (na) 1.00 
(0.00) 
2.00 
(0.00) 
Lemongr
ass 
0.33 
(0.14) 
0.67 
(0.29) 
0.17 
(0.07) 
0.50 
(0.00) 
0.21 
(0.07) 
0.50 
(0.00) 
>2 (0.00) >2 (na) 0.25 
(0.00) 
0.50 
(0.00) 
Lime 2.00 
(0.00) 
>2 (na) 2.00 
(0.00) 
>2 (na) 1.33 
(0.00) 
>2 (na) >2 (0.00) >2 (na) 2.00 
(0.00) 
>2 (na) 
Tea tree 0.25 
(0.00) 
0.50 
(0.00) 
0.33 
(0.14) 
1.00 
(0.00) 
0.25 
(0.00) 
0.50 
(0.00) 
2.00 
(0.00) 
>2 (na) 0.50 
(0.00) 
1.00 
(0.00) 
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Figure 2.12.  Broth microdilution assay of cinnamon oil.  Column 1 containing 
positive growth controls.  Column 2 containing cinnamon oil at 2%, decreasing in 
doubling concentrations across the plate from left to right to 0.03% in column 8.  
Row A containing S.aureus, B – E.coli, C – MRSA, D – P.aeruginosa, and E – 
C.albicans. 
 
For the seven oils tested, clove oil displayed the strongest antimicrobial effect, 
recording the lowest MIC for three of the five microorganism tested.  The lowest 
MIC for the experiment was 0.13% (v/v), for clove against S.aureus.  Lime oil 
was the least efficacious, only inhibiting one microorganism, E.coli with an MIC 
of 1.3% (v/v).  The most robust microorganism was again P.aeruginosa, with all 
seven oils failing to inhibit growth of this gram negative bacterium at 
concentrations below 2% (v/v).  This high level of resistance was considered to 
be associated with the lipopoly-saccharide outer membrane, which protects the 
cytoplasmic phospholipid based membrane against antimicrobial attack, by the 
EO (Livermore 2002).  The other gram-negative bacterium, E.coli was the only 
microbe to be inhibited by all seven oils at less than 2% (v/v).  Therefore, the oils 
must be able to permeate the outer membrane and an alternative defence 
mechanism must be causing the relatively high resistance of P.aeruginosa to EO 
A 
B 
C 
D 
E 
Control
s 
EO concentration % 
(v/v) 
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action.  The loss of membrane integrity and function is characteristic of treatment 
with such oils.  The results obtained by agar and broth dilution (Figure 2.13) are 
likely to vary due to many factors differing between assays.  Microbial growth, 
solubility of essential oil, the use and concentration of an emulsifier, exposure of 
the microorganism to the oil all contribute to variability. 
The aim was to identify an essential oil that displayed antimicrobial efficacy 
against the five test microorganisms at less than 2% (v/v) in order to minimise 
the chance of skin irritation if the eventual oil laden textile were to contact and 
sensitise upper dermal layers.  The data contained in this chapter indicate that 
none of the seven oils tested inhibits P.aeruginosa below the desired 
concentration of 2% (v/v).  In order to identify an antimicrobial oil effective at 
concentrations below 2% (v/v), blends of the oils were tested using a modified 
version of the broth microdilution assay. 
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Figure 2.13.  Comparison of essential oil MIC % (v/v) results for the agar dilution (AD) and broth micro-dilution (BD)method
0
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2.5
AD BD AD BD AD BD AD BD AD BD AD BD AD BD
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%
 E
O
 (
v
/
v
) 
S.aureus MRSA E.coli P.aeruginosa C.albicans
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2.4.5  Time kill assays 
 
 
The seven essential oils were tested for their dynamic killing characteristics, 
results shown in (Tables 2.4-2.10).  For this assay, S.aureus, E.coli and 
C.albicans were used as model gram-positive, gram-negative bacteria and yeast 
respectively.  
The number of viable microorganisms in the exponential growth phase (E in 
table 2.4) was reduced, after 60 minutes, by 2.63, 3.30 and 1.04 (log10) for 
S.aureus, E.coli and C.albicans, respectively with 0.125% (v/v) cinnamon oil.  
However, addition of 2% (v/v) oil produced a reduction by 4.03, 3.77 and 1.52 
(log10) for the same respective microorganisms.  In addition, S.aureus in the 
stationary growth phase (S in Table 2.4), was reduced by 1.5 (log10) after 60 
minutes in the presence of 0.125% (v/v) cinnamon oil, and by 2.67 (log10) in the 
presence of 2% (v/v) cinnamon oil.  A slower rate of killing for stationary phase 
microorganisms was observed for all three test species.  When entering the 
stationary growth phase, cell membrane fluidity, surface charge and 
hydrophobicity change.  These alterations may account for the changed 
tolerance of the test microorganisms to EO, as the cell membrane is the main 
target of EO antimicrobial activity (Kwiecinski 2009). 
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Table 2. 4.  Change in log10 CFU/mL after incubation with cinnamon oil relative to 
that at time zero, (n=3) (Loughlin et al 2008). Standard deviation (SD) presented 
in parenthesis. 
Time 
(mins) 
Microbe 0.125%(S) 2%(S) 0.125%(E) 2%(E) 
15 S.aureus -0.71 
(0.29) 
-1.00 
(0.30) 
-1.03 
(0.51) 
-1.69 
(0.41) 
15 E.coli -0.40 
(0.32) 
-0.66 
(0.22) 
-0.77 
(0.55) 
-1.41 
(0.64) 
15 C.albicans -0.21 
(0.30) 
-0.59 
(0.18) 
-0.43 
(0.56) 
-0.97 
(0.45) 
30 S.aureus -1.17 
(0.25) 
-1.98 
(0.41) 
-1.87 
(0.40) 
-2.51 
(0.45) 
30 E.coli -0.72 
(0.17) 
-1.41 
(0.23) 
-1.31 
(0.22) 
-2.38 
(0.29) 
30 C.albicans -0.34 
(0.20) 
-1.05 
(0.41) 
-0.87 
(0.45) 
-1.34 
(0.32) 
60 S.aureus -1.50 
(0.30) 
-2.67 
(0.32) 
-2.63 
(0.35) 
-4.03 
(0.64) 
60 E.coli -1.17 
(0.25) 
-2.29 
(0.35) 
-3.30 
(0.30) 
-3.77 
(0.74) 
60 C.albicans -0.51 
(0.19) 
-1.31 
(0.35) 
-1.04 
(0.31) 
-1.52 
(0.57) 
 
For clove oil, the patterns of killing for S.aureus, E.coli and C.albicans were 
similar to those recorded for cinnamon oil.  Clove oil at 0.125% and 2% (v/v) 
produced a greater kill against the microorganisms in exponential growth phase 
compared to stationary phase.  However, S.aureus proved to be more 
susceptible to clove oil in exponential growth phase, with 2.09 (log10) reduction 
after 60 minutes in the presence of 0.125% clove oil and 3.57 for 2% (v/v).  This 
result correlates well with those in (Section 2.4.3) where clove oil recorded an 
average MIC score of 0.13%. 
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Table 2. 5.  Change in log10 CFU/mL after incubation with clove oil relative to that 
at time zero, (n=3). Standard deviation (SD) presented in parenthesis. 
Time 
(mins) 
Microbe 0.125%(S
) 
2%(S) 0.125%(E
) 
2%(E) 
15 S.aureus -0.18 
(0.38) 
-0.30 
(0.53) 
-0.54 
(0.40) 
-1.23 
(0.48) 
15 E.coli 0.06 
(0.24) 
-0.27 
(0.30) 
-0.47 
(0.50) 
-0.74 
(0.59) 
15 C.albicans -0.20 
(0.38) 
-0.30 
(0.30) 
-0.38 
(0.41) 
-0.69 
(0.54) 
30 S.aureus -0.38 
(0.24) 
-0.87 
(0.31) 
-1.45 
(0.39) 
-3.09 
(0.50) 
30 E.coli -0.25 
(0.18) 
-1.29 
(0.29) 
-1.27 
(0.49) 
-1.60 
(0.22) 
30 C.albicans -0.46 
(0.17) 
-1.00 
(0.23) 
-0.72 
(0.37) 
-1.06 
(0.22) 
60 S.aureus -0.82 
(0.28) 
-1.65 
(0.25) 
-2.09 
(0.34) 
-3.57 
(0.41) 
60 E.coli -0.43 
(0.18) 
-2.02 
(0.30) 
-1.82 
(0.27) 
-3.39 
(0.28) 
60 C.albicans -0.80 
(0.16) 
-1.38 
(0.24) 
-1.52 
(0.43) 
-2.00 
(0.49) 
 
 
Eucalyptus oil produced a much slower rate of killing in comparison to cinnamon 
and clove oil.  This was consistent with the results for the agar and broth dilution 
assays.  S.aureus in exponential phase was most susceptible to eucalyptus oil, 
with a 1.92 (log10) reduction in viable cells seen after 60 minutes with 2% (v/v) 
eucalyptus oil.  Once again, C.albicans was least susceptible, producing a 0.97 
and 1.28 (log10) reduction in viable cells after 60 minutes in the presence of 2% 
for stationary and exponential phase cells respectively. 
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Table 2. 6.  Change in log10 CFU/mL after incubation with eucalyptus oil relative 
to that at time zero, (n=3). Standard deviation (SD) presented in parenthesis.  
Time 
(mins) 
Microbe 0.125%(S
) 
2%(S) 0.125%(E
) 
2%(E) 
15 S.aureus -0.23 
(0.35) 
-0.45 
(0.49) 
-0.39 
(0.55) 
-0.88 
(0.98) 
15 E.coli 0.12 
(0.23) 
-0.18 
(0.38) 
-0.20 
(0.41) 
-0.48 
(0.55) 
15 C.albicans -0.28 
(0.23) 
-0.29 
(0.32) 
-0.32 
(0.44) 
-0.38 
(0.55) 
30 S.aureus -0.32 
(0.35) 
-0.58 
(0.38) 
-0.80 
(0.23) 
-1.22 
(0.44) 
30 E.coli -0.26 
(0.49) 
-0.49 
(0.43) 
-0.56 
(0.48) 
-1.07 
(0.49) 
30 C.albicans -0.24 
(0.50) 
-0.25 
(0.49) 
-0.50 
(0.45) 
-0.70 
(0.40) 
60 S.aureus -0.72 
(0.27) 
-0.98 
(0.23) 
-1.22 
(0.52) 
-1.92 
(0.60) 
60 E.coli -0.66 
(0.40) 
-1.00 
(0.45) 
-1.10 
(0.52) 
-1.14 
(0.95) 
60 C.albicans -0.38 
(0.39) 
-0.97 
(0.27) 
-0.77 
(0.21) 
-1.28 
(0.46) 
 
Geranium oil produced similar results for all three test organisms at the various 
oil concentrations after 60 minutes exposure.  A log10 reduction between 0.95-
1.38 was seen at 0.125% for microorganisms in stationary phase, and 1.38-1.66 
when in exponential phase.  Likewise, a log10 reduction of 1.83-1.95 was at 2% 
and 2.54-3.03 was observed in stationary and exponential phases respectively. 
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Table 2. 7.  Change in log10 CFU/mL after incubation with geranium oil relative to 
that at time zero, (n=3). Standard deviation (SD) presented in parenthesis. 
Time 
(mins) 
Microbe 0.125%(S) 2%(S) 0.125%(E) 2%(E) 
15 S.aureus -0.40 
(0.43) 
-0.77 
(0.55) 
-0.67 
(0.64) 
-0.99 
(0.38) 
15 E.coli -0.33 
(0.19) 
-0.59 
(0.20) 
-0.53 
(0.32) 
-0.79 
(0.25) 
15 C.albicans -0.25 
(0.09) 
-0.48 
(0.29) 
-0.76 
(0.33) 
-0.90 
(0.30) 
30 S.aureus -0.60 
(0.26) 
-1.29 
(0.12) 
-0.82 
(0.29) 
-1.76 
(0.23) 
30 E.coli -0.83 
(0.17) 
-1.20 
(0.10) 
-0.83 
(0.20) 
-1.68 
(0.26) 
30 C.albicans -0.62 
(0.17) 
-0.96 
(0.18) 
-1.00 
(0.21) 
-1.98 
(0.10) 
60 S.aureus -0.95 
(0.08) 
-1.91 
(0.15) 
-1.38 
(0.15) 
-2.67 
(0.21) 
60 E.coli -1.38 
(0.07) 
-1.83 
(0.20) 
-1.66 
(0.15) 
-2.54 
(0.12) 
60 C.albicans -1.16 
(0.16) 
-1.95 
(0.31) 
-1.51 
(0.28) 
-3.03 
(0.48) 
 
 
The number of viable microorganisms in exponential growth phase was reduced 
by 2.03, 1.55 and 1.26 (log10) for S.aureus, E.coli and C.albicans respectively 
with 0.125% (v/v) lemongrass oil after 60 minutes.  While addition of 2% (v/v) oil 
produced a reduction by 2.56, 2.46 and 1.89 (log10) for the same 
microorganisms.  In addition, S.aureus and E.coli cells in stationary growth 
phase were reduced by 1.63 and 1.62 (log10) after 60 minutes in the presence of 
2% (v/v) lemongrass oil, with C.albicans reduced by 1.27 (log10). 
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Table 2. 8.  Change in log10 CFU/mL after incubation with lemongrass oil relative 
to that at time zero, (n=3). Standard deviation (SD) presented in parenthesis. 
Time 
(mins) 
Microbe 0.125%(S) 2%(S) 0.125%(E) 2%(E) 
15 S.aureus -0.49 
(0.19) 
-0.83 
(0.58) 
-0.56 
(0.18) 
-1.03 
(0.40) 
15 E.coli -0.32 
(0.20) 
-0.58 
(0.14) 
-0.83 
(0.40) 
-1.11 
(0.60) 
15 C.albicans -0.37 
(0.21) 
-0.71 
(0.35) 
-0.69 
(0.42) 
-0.83 
(0.25) 
30 S.aureus -0.91 
(0.35) 
-1.09 
(0.10) 
-1.32 
(0.17) 
-1.43 
(0.16) 
30 E.coli -0.59 
(0.10) 
-1.09 
(0.20) 
-1.25 
(0.23) 
-1.51 
(0.17) 
30 C.albicans -0.27 
(0.23) 
-0.88 
(0.18) 
-0.89 
(0.08) 
-1.27 
(0.30) 
60 S.aureus -1.00 
(0.17) 
-1.63 
(0.12) 
-2.03 
(0.11) 
-2.56 
(0.23) 
60 E.coli -1.13 
(0.17) 
-1.62 
(0.14) 
-1.55 
(0.13) 
-2.46 
(0.21) 
60 C.albicans -0.68 
(0.33) 
-1.27 
(0.30) 
-1.26 
(0.26) 
-1.89 
(0.66) 
 
 
As with previous assays, lime oil produced lower levels of killing in 60 minutes 
exposure to the test microorganisms.  A log10 reduction of 1.07 for E.coli in 
exponential phase at 60 minutes with 2% (v/v) lime oil was the least observed. 
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Table 2. 9.  Change in log10 CFU/mL after incubation with lime oil relative to that 
at time zero, (n=3). Standard deviation (SD) presented in parenthesis. 
Time 
(mins) 
Microbe 0.125%(S) 2%(S) 0.125%(E) 2%(E) 
15 S.aureus -0.40 
(0.52) 
-0.43 
(0.40) 
-0.32 
(0.21) 
-0.80 
(0.75) 
15 E.coli -0.34 
(0.41) 
-0.60 
(0.51) 
-0.61 
(0.51) 
-0.95 
(0.66) 
15 C.albicans -0.26 
(0.29) 
-0.44 
(0.41) 
-0.55 
(0.43) 
-0.89 
(0.56) 
30 S.aureus -0.36 
(0.29) 
-0.66 
(0.21) 
-0.57 
(0.29) 
-0.85 
(0.56) 
30 E.coli -0.50 
(0.34) 
-0.81 
(0.42) 
-0.66 
(0.38) 
-1.06 
(0.38) 
30 C.albicans -0.39 
(0.18) 
-0.52 
(0.25) 
-0.78 
(0.45) 
-0.99 
(0.15) 
60 S.aureus -0.53 
(0.32) 
-1.03 
(0.40) 
-1.07 
(0.72) 
-1.40 
(1.04) 
60 E.coli -0.64 
(0.29) 
-0.93 
(0.22) 
-1.09 
(0.41) 
-1.07 
(0.46) 
60 C.albicans -0.60 
(0.17) 
-0.80 
(0.12) 
-1.21 
(0.34) 
-1.61 
(0.47) 
 
S.aureus cells in stationary growth phase were reduced by 1.56 (log10) after 60 
minutes in the presence of 0.125% and 2.44 (log10) in the presence of 2% (v/v) 
tea tree oil.  The slower rate of killing for stationary phase microorganisms was 
again observed for all three test species. These findings compare well with 
results previously published by (Gustafson et al 1998) who reported E.coli in 
stationary growth phase were killed by TTO at a much slower rate than cells from 
the exponential growth phase. 
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Table 2. 10.  Change in log10 CFU/mL after incubation with tea tree oil relative to 
that at time zero, (n=3). Standard deviation (SD) presented in parenthesis. 
Time 
(mins) 
Microbe 0.125%(S) 2%(S) 0.125%(E
) 
2%(E) 
15 S.aureus -0.75 
(0.54) 
-1.31 
(0.53) 
-1.33 
(0.72) 
-2.22 
(0.42) 
15 E.coli -0.31 
(0.44) 
-0.64 
(0.35) 
-0.48 
(0.40) 
-1.39 
(0.49) 
15 C.albicans -0.25 
(0.31) 
-0.58 
(0.40) 
-0.56 
(0.51) 
-0.75 
(0.20) 
30 S.aureus -1.27 
(0.67) 
-1.83 
(0.87) 
-1.60 
(0.48) 
-2.62 
(0.60) 
30 E.coli -0.65 
(0.34) 
-1.35 
(0.68) 
-1.16 
(0.67) 
-1.94 
(0.30) 
30 C.albicans -0.45 
(0.24) 
-0.96 
(0.29) 
-0.77 
(0.24) 
-1.46 
(0.45) 
60 S.aureus -1.56 
(0.80) 
-2.44 
(0.63) 
-2.22 
(0.67) 
-2.86 
(0.56) 
60 E.coli -1.17 
90.58) 
-1.75 
(0.29) 
-1.73 
(0.78) 
-2.82 
(0.84) 
60 C.albicans -1.00 
(0.20) 
-1.53 
(0.64) 
-1.63 
(0.79) 
-2.21 
(0.81) 
 
 
Kwiecinski (2009) reported a 2 (log10) reduction in viable S.aureus cells in 
exponential growth phase after incubation with 0.5% (v/v) tea tree oil after 60 
minutes.  Furthermore, a 4 (log10) reduction in viable S.aureus cells after 60 
minutes was reported, with tea tree oil at 8%. 
The results for this experiment show that bacteria in the stationary growth phase 
are more tolerant to antimicrobials, in this case essential oils compared to 
bacteria in the exponential growth phase (Gustafson et al 1998, Cox et al 1998).  
When entering the stationary growth phase, cell membrane protein composition, 
fluidity, surface charge and hydrophobicity of bacterial cells change. These 
physical alterations might account for the relative tolerance to essential oils when 
in stationary growth phase, as the cell membrane is the main target of essential 
oil antimicrobial activity (Kwiecinski 2009). 
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2.4.6  Checkerboard blending assay 
 
 
Using the method described in (Section 2.3.6) the seven oils were tested for their 
antimicrobial efficacy in blends.  Twenty-one blends were tested against the five 
microorganisms previously used in the MIC assays for the individual oils.  
However, for checkerboard assays fractional inhibitory concentrations (FICs) are 
used to determine the relationship between the two oils in a given blend.  Blends 
were classified synergistic if they had an FIC of ≤ 0.5, and FIC of between 0.99 
and 0.5 was indicative of an additive relationship.  Between 3.99 and 1, the 
relationship was said to be indifferent and finally an FIC of ≥ 4 showed the blend 
to be antagonistic.  The results of the checkerboard assays are presented in 
(Table 2.11). 
Oil blends containing cinnamon were most effective against the five 
microorganisms tested.  According to the FIC values obtained, the blend with the 
lowest FIC index for each microorganism contained cinnamon, these were: 
cinnamon-lemongrass (0.95) and cinnamon-tea tree (0.97) for S.aureus, 
cinnamon-clove (0.63) for MRSA, cinnamon-clove (0.76) and cinnamon-
eucalyptus (0.75) for E.coli, cinnamon-geranium (0.17) for P.aeruginosa and 
cinnamon-tea tree (0.85) for C.albicans.  Due to the doubling dilutions used in 
the checkerboard method, it is difficult to interpret synergy using FIC indices, due 
to the doubling gradient of well concentrations.  The majority of blends for this 
experiment for S.aureus, MRSA, E.coli and C.albicans recorded MICs between 1 
and 4, indicative of indifference.  However, many of these blends recorded lower 
MICs in combination than the oils individually, meaning less oil was needed to 
inhibit the growth of the microbe in combination compared to when tested 
individually.  For instance, the individual MICs for cinnamon and clove against 
MRSA in broth were found to be 0.17 and 0.33% (v/v), for the cinnamon-clove 
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blend, the MICs for the two oils decreased to an average of 0.07%(v/v), providing 
an FIC index of 0.63 for the blend.   
From the results, although a number of blends provided a reduced level of oil 
concentration (v/v) to inhibit growth in comparison to the individual oils, there 
were no blends that scored a synergistic FIC index for all the test 
microorganisms, although there was a reduced amount of oil concentration 
required to inhibit growth.  It is logical the reduction would decrease the cost of 
the antimicrobial and therefore it would be beneficial to use one of the blends 
which produced a reduction in MIC scores for the oils in the blend and produced 
a synergistic FIC index against the most robust test microbe (P.aeruginosa).  On 
this basis, the cinnamon-clove blend was selected for further study. 
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Table 2. 11.  Fractional inhibitory concentrations from checkerboard testing essential oil blends.  MICx denotes the MIC for oil X in the 
combination, MICy denotes the MIC for oil Y in the combination, (n=3).  Green highlight denotes most effective blends, the least 
effective in red. 
 
 S.aureus MRSA E.coli P.aeruginosa C.albicans 
 MICx MICy FIC MICx MICy FIC MICx MICy FIC MICx MICy FIC MICx MICy FIC 
CIN-CLO 0.12 0.12 1.62 0.07 0.07 0.63 0.07 0.07 0.76 0.19 0.24 0.21 0.23 0.12 1.45 
CIN-EUC 0.13 0.57 1.06 0.12 0.19 0.79 0.12 0.19 0.75 0.38 0.37 0.24 0.20 0.24 0.93 
CIN-GER 0.13 0.29 1.67 0.23 0.24 1.51 0.14 0.19 1.45 0.19 0.29 0.17 0.28 0.32 1.44 
CIN-LEM 0.10 0.12 0.95 0.10 0.12 1.27 0.12 0.12 1.10 0.38 0.38 0.29 0.17 0.23 1.61 
CIN-LIM 0.18 0.57 1.36 0.25 0.57 1.77 0.34 0.65 2.11 >2 >2 n/a 0.54 0.73 2.51 
CIN-TTO 0.09 0.12 0.97 0.12 0.12 1.04 0.11 0.11 0.99 0.12 0.12 0.23 0.14 0.14 0.85 
CLO-EUC 0.20 0.57 1.85 0.30 0.57 1.19 0.14 0.19 1.04 0.58 0.58 0.36 0.47 0.64 2.59 
CLO-GER 0.12 0.60 2.73 0.19 0.29 0.75 0.19 0.19 1.92 0.87 0.92 0.66 0.19 0.24 1.16 
CLO-LEM 0.12 0.42 2.19 0.12 0.36 2.49 0.14 0.39 2.70 0.45 0.45 0.34 0.24 0.48 3.10 
CLO-LIM 0.12 0.81 1.33 0.34 0.18 1.09 0.35 0.41 2.41 >2 >2 n/a 0.38 0.37 2.01 
CLO-TTO 0.12 0.19 1.68 0.18 0.18 1.06 0.12 0.22 1.56 0.76 0.77 0.77 0.23 0.18 1.43 
EUC-GER >2 >2 n/a 1.16 1.16 1.28 0.72 0.94 4.47 >2 >2 n/a 1.17 1.17 1.76 
EUC-LEM >2 >2 n/a 1.67 1.67 10.86 0.92 0.92 5.32 1.50 1.50 0.56 1.50 1.50 6.75 
EUC-LIM >2 >2 n/a 1.67 1.67 1.67 1.16 1.16 2.03 >2 >2 n/a >2 >2 n/a 
EUC-TTO 0.57 0.29 1.43 0.69 0.94 3.15 0.37 0.28 1.49 1.13 1.00 0.64 0.87 1.17 2.78 
GER-LEM 0.19 0.31 1.52 0.21 0.41 2.59 0.21 0.33 2.41 0.72 0.94 0.41 0.29 0.29 1.45 
GER-LIM >2 >2 n/a 1.16 1.16 1.28 1.16 1.08 5.45 >2 >2 n/a 1.50 1.50 2.25 
GER-TTO 0.57 0.23 2.63 0.57 0.43 1.62 0.57 0.54 4.42 0.92 1.17 0.81 0.91 0.84 2.59 
LEM-LIM >2 >2 n/a 1.50 1.50 9.75 1.16 1.16 6.44 >2 >2 n/a >2 >2 n/a 
LEM-TTO 0.19 0.16 1.23 0.19 0.16 1.63 0.24 0.19 1.93 0.76 0.77 0.58 0.38 0.39 2.29 
LIM-TTO 0.57 0.46 2.14 0.47 0.50 1.73 0.57 0.54 2.57 >2 >2 na 1.08 1.33 3.20 
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The mechanism of action as well as EO composition deserves to be studied in 
more detail in order to elucidate why combinations of EOs with a strong 
individual antimicrobial efficacy such as cinnamon and clove, did not show 
synergistic effects overall even though the concentrations of each oil in the 
combination required to inhibit the test microorganism decreased.  On this basis, 
the 1:1 clove and cinnamon oil combination was selected for further study. 
Lambert et al (2001), reported that carvacrol and thymol in combination had an 
additive effect against S. aureus and P. aeruginosa.  Nazer et al (2005), found 
that thymol in combination with other aromatic compounds improved inhibition, 
but no real synergistic effect was demonstrated between compounds.  As EOs 
are of similar composition, combinations may exhibit additive rather than a 
synergistic effect.  As a result, combinations with other compounds and 
antimicrobials, containing different chemical structures may improve the 
antimicrobial efficacy.  For example, synergism between carvacrol and its 
precursor p-cymene was noted by (Ultee et al 2000), or synergy between 
antibiotics and EOs (Langeveld et al 2014). 
 
It is not fully understood why certain EO blends display synergy when others do 
not.  Theories have included receptor or site modification, enzymatic 
degradation, accumulation of antimicrobial within bacterial cell, decreased outer 
membrane permeability, and attenuation of efflux pumps (Lambert et al 2001).  
Classification of synergistic interactions should be more conservatively evaluated 
taking into account inherent doubling dilutions in MIC methodology.   
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2.4.7  Gas chromatography – mass spectroscopy (GC-MS) analysis  
 
 
The seven individual EOs and blend chosen from the checkerboard assay were 
analysed by GC-MS to quantify the major chemical constituents of the oils 
(Figures 2.14 – 2.20).  The definition of a major constituent for this analysis was 
a component >1% of the oil.  All percentages of EO constituents are expressed 
as (v/v). 
Cinnamon oil comprised nine major components (Figure 2.14).  The most 
abundant molecule was eugenol, which accounts for over 70% of the oil.  Eight 
other components account for over 1% of the oil, these were:α-pinene, para-
cymene, β-caryophyllene, terpinen-4-ol, cinnamic alcohol, benzyl benzoate, 
eugenyl acetate and Caryophyllen Epoxyde.  Eugenol has been shown to have 
antimicrobial properties (Gayoso et al 2005, Nazer et al 2005) and is likely to be 
responsible for the antimicrobial efficacy of cinnamon oil.   
 
 
 
 
 
 
 
65 
 
 
Figure 2.14.  The major components of cinnamon oil, as determined by GC-MS.  The numbers in red represent the % composition 
of the chemical component.  The labels on the X-axis are the names of each chemical component. 
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The GC-MS data for clove oil revealed three chemical components that 
accounted for more than 1% of the oil (Figure 2.15).  These were β-
caryophyllene (2.65%), eugenyl acetate (11.47%) and as with cinnamon oil, 
eugenol was the most abundant component (82.85%).   
Eucalyptus oil was found to have five major components.  The most prevalent 
being 1,8-cineole, at 80.6% of the oil.  The four other major components were: α-
pinene (3.33%), β-myrcene (1.09%), d-limonene (8.62%) and para-cymene 
(3.61%).   
The Geranium oil analysed was shown to be the most complex, with thirteen 
major components.  With four components accounting for approximately 50% of 
the oil, citronellol (22.7%), geraniol (10.71%), citronellylformate (11.62%) and 
6,9-guaiadiene (8.62%). 
The data shows the lemongrass oil used in this study to contain eight major 
components (Figure 2.18).  Approximately 80% of the oil is comprised of four 
molecules, citronellol (9.29%), citronellal (15.05%), geranial (32.81%) and neral 
(24.51%).  There were four other molecules which account for over 1% of the oil, 
these were: β-myrcene, geraniol, isopulegol and linalool. 
The GC-MS data revealed eleven major components for the lime oil used.  The 
most abundant component was d-limonene (49.39%), with three other 
components over 5% of the oil: γ-terpinene (11.7%), terpinolene (8.61%) and α-
terpineol (5.88%).   
The proportion of each main constituent for tea tree oil was determined (Figure 
2.20).  Terpinen-4-ol was determined to be the most abundant constituent at 
41.8%, correlating well with GC-MS analysis of tea tree oil in the literature 
(Brophy 1989).  There were eleven other components over 1%, combining to 
account for roughly a further 50% of the oil.  Terpinen-4-ol has been reported to 
show antimicrobial properties (Cox 2001).  
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Finally, the EO blend chosen for further study was cin-clo in a 1:1 ratio.  The EO 
blend was analysed using GC-MS to determine if the main constituents of the 
respective oils had changed.  The main constituent for both cinnamon and clove 
oils was confirmed to be eugenol, at 76.39 and 82.85% respectively.  The GC-
MS report for the EO blend shows eugenol to contribute 94.84% of the blend, 
with eugenyl acetate being the only other constituent above the cut off of >1%, 
accounting for 4.75% of the EO blend (Figure 2.21).  This increase in 
concentration of the main antimicrobial constituent may explain the increased 
antimicrobial efficacy displayed by the blend against the respective 
microorganisms used in this study.
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Figure 2.15.  The major components of clove oil, as determined by GC-MS.  The 
numbers in red represent the % composition of the chemical component.  The labels 
on the X-axis are the names of each chemical component.   
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Figure 2.16.  The major components of eucalyptus oil, as determined by GC-MS.  The 
numbers in red represent the % composition of the chemical component.  The labels on the 
X-axis are the names of each chemical component. 
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Figure 2.17.  The major components of geranium oil, as determined by GC-MS.  The numbers in red represent the % composition of the 
chemical component.  The labels on the X-axis are the names of each chemical component. 
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Figure 2.18.  The major components of lemongrass oil, as determined by GC-MS.  The numbers in red represent the % composition of the 
chemical component.  The labels on the X-axis are the names of each chemical component. 
 
1.66 
9.29 
2.17 
3 
1.91 
15.05 
32.81 
24.51 
0
5
10
15
20
25
30
35
β
-m
y
rc
en
e 
ci
tr
o
n
el
lo
l
ge
ra
n
io
l
is
o
p
u
le
go
l
li
n
al
o
l
ci
tr
o
n
el
la
l
ge
ra
n
ia
l
n
er
al
%
 V
o
lu
m
e
 o
f 
le
m
o
n
g
ra
ss
 o
il
 
 
Main oil components 
 
72 
 
 
Figure 2.19.  The major components of lime oil, as determined by GC-MS.  The numbers in red represent the % composition of the 
chemical component.  The labels on the X-axis are the names of each chemical component.   
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Figure 2.20. The major components of tea tree oil, as determined by GC-MS.  The numbers in red represent the % composition of the 
chemical component.  The labels on the X-axis are the names of each chemical component.   
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Figure 2.21.  The major components of cinnamon-clove oil blend in a 1:1 ratio, as 
determined by GC-MS.  The numbers in red represent the % composition of the 
chemical component.  The labels on the X-axis are the names of each chemical 
component.   
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2.5  Conclusions 
 
 
 Seven EOs were selected as antimicrobials on the basis of the initial literature review 
to provide a range of reported antimicrobial efficacy; cinnamon, clove, eucalyptus, 
geranium, lemongrass, lime and tea tree oil. 
 Cinnamon, clove and lemongrass demonstrated good antimicrobial efficacy individually 
against most of the panel of microorganisms tested, while P.aeruginosa was the most 
robust test microorganism against individual EOs. 
 Blending the EOs allowed identification of numerous blends which displayed a 
reduction in the concentration (v/v) of oil necessary to inhibit microbial growth, and 
several blends that displayed synergy against P.aeruginosa, which has shown poor 
results with individual EOs.   
 Cinnamon-clove registering the best FIC results across the five microorganisms tested 
and produced the lowest MIC against the most robust microorganism, P.aeruginosa 
and was therefore selected for further investigation. 
 EO constituents >1% were identified using GCMS, with the major antimicrobial 
constituents changing in % total of the oil when analysing the most efficacious blend 
from the checkerboard assay.  
 For the selected blend of clove and cinnamon (1:1), the percentage of the main 
antimicrobial constituent increased from 82.85 and 76.39, respectively, to 94.84 when 
in combination. 
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Chapter 3 
 
Synthesis and characterisation of mesoporous silica nanoparticles (MSNs) 
Loading and release of essential oils from MSNs and antimicrobial testing 
of blank and essential oil loaded MSNs 
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3.1  Introduction 
 
 
3.1.1 Mesoporous silica nanoparticles  
 
Mesoporous silica nanoparticles (MSNs) as encapsulants for bioactive 
compounds are currently of great interest.  Mesoporous silicates, feature an 
ordered lattice structure of pores and are fabricated in the presence of surfactant 
or polymer that serves as a template for the polymerising tetraalkoxysilane.  After 
polymerisation of the silica, the organic template can be removed by heating at 
elevated temperatures (calcination), resulting in a porous structure (Figure 3.1).  
The term mesoporous describes materials that exhibit pores with a diameter in 
the  range (2 – 50 nm).  Attractive features of MSNs include high surface area 
(up to 1200 m2 g-1), ordered pore structure and modifiable surfaces (Trewyn et al 
2007).  The latter are likely to enable the adsorption of substantial amounts of 
antimicrobial. 
 
 
 
Figure 3.1.  Schematic showing the formation of ordered mesoporous materials;  
At a critical concentration the rod-shaped micelles self-assemble into the 
hexagonal array.  The tetraethoxysilane (TEOS) then adsorbs on the accessible 
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surfaces of this array, then polymerises into silica.  The surfactant array is then 
removed by calcination leaving the Mobil Composition of Matter No. 41 (MCM-
41) (Beck et al 1992).  The synthesis of mesoporous materials is a development 
that is of great interest due to the large number of potential applications, such as 
sustained drug delivery (Salonen et al 2008).  
 
For this study, MCM41 silica nanoparticles were synthesised using Liquid Crystal 
Templating (LCT) procedure.  Figure 3.1 shows three main steps that result in 
mesoporous silica and its characteristic uniformly ordered mesopore channels.  
The surfactant used here was cetyltrimethylammonium bromide (CTAB), which 
consists of a long hydrophobic carbon chain with a hydrophilic ammonium end, 
giving the molecule a positive charge.  These micelles then organise themselves 
into a hexagonal mycellar rod array.  TEOS adsorbs on the accessible surfaces 
of this array, then polymerises into silica resulting in a silica matrix surrounding 
the rods.  The surfactant template can then be removed via calcination, a 
process in which the surfactant is thermal oxidatively degraded (i.e. burnt away), 
leaving a porous end product. 
The synthesis of mesoporous silica is based on the formation of liquid-crystalline 
mesophases of amphiphilic molecules (surfactants) that serve as templates for 
the in situ polymerisation of TEOS. The synthesis of MSNs is performed at a low 
surfactant concentration to make the assembly of the ordered mesophases 
strongly dependent upon the interaction between the cationic surfactant and the 
growing anionic oligomers of orthosilicic acid, which in turn limits the assembly of 
mesophases to small sizes. Once the TEOS is added to the colloidal dispersion, 
where the anionic silicates electrostatically interact with the cationic surface and 
are adsorbed on to the now regular array of micelle rods (Trewyn et al 2007).   
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Following filtration and washing of the precipitated particles, the surfactant 
template must be removed.  The template removal can be done one of two ways. 
If the particles have not been functionalised, calcination can be carried out.  This 
involves heating the particles to 550°C for several hours.  The other method of 
template removal consists of an acid extraction under reflux for 18 hours.  Unlike 
calcination, this technique would preserve any modifications to the nanoparticles 
that may have been incorporated into the synthesis process (Yanagisawa et al 
1990).  
 
The resulting mesoporous material will have a structure of well-ordered, uniform 
pores with large surface areas and pore volume.  Additionally, by altering the 
reaction conditions and substrates used, the morphology and characteristics of 
the material can be tailored to the specific application the particles are intended 
for.  For example, the pore size can be tuned using surfactants with different 
chain length during synthesis (Horcajada et al 2004).  This can enable tuning of 
the pore size to the molecular size of the antimicrobial and / or tuning the rate of 
antimicrobial release. 
 
The controlled release of the natural antimicrobial allylisothiocyanate (AITC) via 
two different mesoporous silica structures (MCM-41 and Santa Barbara 15 (SBA-
15)) was tested for capacity and feasibility of slow release (Park and Pendleton 
2012).  Pore filling by vapour phase AITC approached 100%, and controlled 
release was observed as 90% of the available AITC desorbed over 96 hours.  
The release from SBA-15 silicates occurred as a ‘burst release’ with 65% 
desorbed in the first 12 hours compared with only 20% from the MCM-41 
silicates.   
Reduction of rate of release of active molecules from MSNs can be 
accomplished relatively easily by decreasing the pore diameter of the silica 
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material, as demonstrated in previous studies looking at drug release rates from 
ordered silicates (Lu et al 2007).  The mesophases based on micelles as the 
building blocks vary in structure depending on many factors with the surfactant 
geometry. Therefore, based on the orientation of surfactant templates, a variety 
of mesophases can be obtained by using different surfactant molecules or 
changing the packing parameters of a surfactant, adjusting the composition or 
introducing an additive.  For example, the addition of hydrophobic organic 
molecules increases the hydrophobic volume of the surfactant, and increases the 
pore size.   The retention of active molecules is likely influenced by the surface 
chemistry of the pores, which could be affected by the high temperatures 
associated with removal of the surfactant during calcining (Deng et al 2013). 
 
3.1.2  Characterisation methods 
 
 
A number of different techniques were used to characterise the nanoparticles.  
Nanoparticle size and morphology were investigated using electron microscopy.  
The hydrodynamic size and dispersion stability were examined using a Malvern 
Zetasizer.  The porous silica nanoparticles used in this study were also analysed 
by nitrogen (N2) adsorption that provides particle surface area and pore size 
distribution.  It is vitally important to comprehensively characterise nanoparticles 
before using them for a specific application as it allows for a greater 
understanding of the underlying factors that may affect potential applications.   
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3.1.2.1  Scanning electron microscopy  
 
SEM produces highly detailed images with wide depth of focus of conductive and 
non-conductive materials.  Magnification can be up to 105 times with a maximum 
resolution of ca. 3 nm.  Non-conductive samples are usually coated with a 
sputtered / vapour deposited conductive film of metal or carbon to prevent 
electric charge building up in the sample and deflecting the electron beam, 
resulting in a phenomena known as charging.  In order to enable unimpeded 
electron travel SEM is usually carried out in a high vacuum which prevents 
imaging of moist and oily samples.  Modern SEMs, however, can image such 
samples, as they are able to operate under lower vacuum conditions.   
 
The high-energy electron beam is often created using a tungsten filament.  The 
electrons produce a signal relating to the surface topography by interacting with 
the atoms in the sample.  The two types of signal produced by this SEM are 
secondary electron and backscattered electrons.  Backscattered electrons 
consist of high-energy electrons originating in the electron beam, which are 
reflected or backscattered out of the specimen interaction volume by elastic 
scattering interactions with specimen atoms.  The most common detection is 
secondary electron imaging, where electrons are produced by the ionisation of 
the atoms in the sample.  The term ‘secondary’ refers to the electrons not being 
generated by the primary source of radiation.  The primary source of radiation is 
from the electron beam generated by the tungsten filament, which ionises the 
surface atoms on the sample to produce secondary electrons.  Back-scattered 
electrons are detected by deflection of electron wave into the direction they 
originated from.  As the electrons are scattered the reflection is diffused 
(Pennycook and Nellist 2011). 
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3.1.2.2  Electrophoretic light scattering 
 
A Malvern Zetasizer Nano ZS was used to record the electrophoretic Zeta 
potential of the MSNs in MeOH solution.  The fundamental physical principle is 
that of electrophoresis.  A dispersion is introduced into a cell containing two 
electrodes. An electrical field is applied to the electrodes, and particles or 
molecules that have a net charge, or more strictly a net zeta potential will migrate 
towards the oppositely charged electrode with a velocity, known as the mobility, 
that is related to their zeta potential in millivolts (mV). The greater the zeta 
potential from 0 mV, the less likely the sample will aggregate (Shaw 1992). 
 
 
3.1.2.3  Nitrogen adsorption 
 
 
Gas adsorption is usually the method of choice for determination of specific 
surface area and pore characteristics of particulate materials, the technique 
measures the amount of gas adsorbed and desorbed onto the particulate solid 
and thus gives a measure of the surface area.  The difference between the 
adsorption and desorption behaviour can be used to determine pore size 
distribution (Groen et al 2003)(Othman, 2012). 
The surface area analyses of particulate solid materials are measured using the 
Brunauer-Emmett-Teller (BET) isotherm, characterised by a type II isotherm 
shown in Figure 3.2.  To determine the surface area, solid samples are 
pretreated by applying a vacuum, or flowing gas to remove adsorbed 
contaminants acquired (typically water and carbon dioxide) from atmospheric 
exposure.  The solid is then cooled, under vacuum, usually to cryogenic 
temperature (77 K).   An adsorptive (in this case nitrogen) is dosed to the solid in 
controlled increments.  After each dose of adsorptive, the pressure is allowed to 
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equilibrate and the quantity adsorbed is calculated.  The quantity adsorbed at 
each pressure, and temperature defines an adsorption isotherm, from which the 
quantity of gas required to form a monolayer over the external surface of the 
solid is determined.  With the area covered by each adsorbed gas molecule 
known, the surface area can be calculated.  The N2 adsorption analysis was 
conducted using a Micromeritics ASAP 2020 BET surface area and porosity 
instrumentation.  
Pore size can be calculated using the Barret, Joyner and Halenda (BJH) method, 
using adsorption isothems and the Kelvin model of pore filling.  It applies only to 
the mesopore and small macropore size range.  Surface area determinations 
involve creating the conditions required to adsorb an average monolayer of 
molecules onto a sample.  By extending this process so that the gas is allowed 
to condense in the pores, the sample’s fine pore structure can be evaluated.  As 
pressure increases, the gas condenses first in the pores with the smallest 
dimensions.  The pressure is increased until saturation is reached, at which time 
all pores are filled with liquid.  The adsorptive gas pressure then is reduced 
incrementally, evaporating the condensed gas from the system.  Evaluation of 
the adsorption and desorption branches of these isotherms and the hysteresis 
between them reveals information about the size, volume, and area.  The 
Isotherms produced can be classified using the International Union of Pure and 
Applied Chemistry classification (IUPAC), mesoporous materials usually fall into 
the class IV isotherm which can be seen in Figure 3.2 (Donohue and Aranovich, 
1998). 
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Figure 3.2.  IUPAC adsorption isotherm classification (Donohue and 
Aranovich1998). 
 
3.1.2.4  Thermogravimetric analysis 
 
Thermogravimetric analysis (TGA) is a thermal analytical method used to 
determine mass loss as a function of increasing temperature.  The 
thermogravimetric (TG) instrumentation usually consists of four major 
components; the furnace, sample holder, the data acquisition system and the 
sensors which detect the samples properties dependent on temperature.  These 
components produce a TG curve, representative of mass change against 
temperature, where the temperature usually increases uniformly or is kept 
constant.  The TG curve for a sample that displays single stage decomposition 
will contain two characteristic temperatures, Ti and Tf.  Ti is the lowest 
temperature at which the mass change is detectable by the thermobalance at the 
selected settings.  Tf is the temperature once the decomposition has been 
completed.  The difference between Ti and Tf is defined as the reaction interval.  
The mass change of a sample due to increasing temperature is defined as 
dynamic thermogravimetry.  Alternatively, when temperature is kept constant and 
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the change of mass is measured it is defined as isothermal or static 
thermogravimetry.  This analytical technique provides information on the purity of 
a sample and its specific modes of transformation, dependent on the 
temperature range (Kealey and Haines 2002). 
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3.2  Objectives 
 
 
 Synthesis of mesoporous silica nanoparticles (MSN). 
To achieve MSNs of high surface area and mono-disperse size, with uniform 
pores for release of essential oils. 
 Characterisation of nanoparticles. 
The size and characteristics of nanoparticles will be determined using specialist 
analytical apparatus, such as electrophoretic light scattering and nitrogen 
adsorption. 
 Determination of the level of essential oil (EO) adsorption on MSNs and the 
rate of release of essential oil from MSNs. 
MSN will be loaded with a 1:1 blend of cinnamon (CIN) and clove (CLO) EOs via 
deposition from solution in a volatile solvent and by immersion of MSN in the EO 
blend followed by solvent washing.  Thermal gravimetric analysis will be used to 
determine the loading level of EO.  Gas chromatography coupled with mass 
spectrometry will be used to analyse the oil release from the MSN. 
 To determine the antimicrobial activity of MSNs loaded with EO and whether 
blank MSNs exhibit any antimicrobial action. 
Bacteriostatic, bactericidal and time – kill assays will be set up using blank 
nanoparticles and nanoparticles loaded with essential oil to determine if they 
display contact kill against microorganisms associated with HCAIs.  
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3.3  Materials 
 
 
3.3.1  Chemicals 
 
 
Tetraethoxysilane (TEOS) and Methyltriethoxysilane (MTEOS) were purchased 
from Sigma – Aldrich (UK).  Cetyltrimethyl ammonium bromide (CTAB), sodium 
hydroxide (NaOH), and methanol (MeOH) were purchased from Fisher-Scientific 
(UK).  Purified water from a Millipore Elix® 5 bench-top treatment unit was used 
throughout the study.  The water treatment system was maintained according to 
manufacturer guidelines.  
 
3.3.2  Media, microbes and EOs  
 
 
Vide supra Section 2.3.1.1 – 3, all five test microorganisms were used, along 
with cinnamon and clove essential oils, in a 1:1 blend. 
 
3.4  Experimental 
 
 
3.4.1  MSN fabrication 
 
 
Initially, CTAB (1.00g) was dissolved in distilled water (480 mL).  To which, 2.0M 
NaOH (3.5 mL) was pipetted into the solution and the temperature was raised to 
80°C.  Tetraethyl orthosilicate (TEOS) (4 mL) was pipetted into a small beaker 
then added drop wise to the solution, using a Pasteur pipette.  This solution was 
stirred continuously for 2 hours at 80°C, producing a white dispersion of MSNs.  
The MSNs were isolated from the dispersion by centrifuging for 15 minutes at 
14,000 rpm, using a Beckman J2-21 Series centrifuge and 250 mL centrifuge 
bottles.  The resulting supernatant was stored and the pellet was washed three 
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times with methanol.  To remove the CTAB surfactant template from the MSNs, 
the product was dried at 60°C until the methanol had evaporated.  The sample 
was then calcined in air for 5 hours at 550°C. 
 
 
3.4.2  Characterisation of MSN  
 
 
3.4.2.1  Zeta potential  
 
 
The particle size and Zeta – potential measurement (surface charge) of the 
MSNs were measured using a Malvern Zetasizer Nano ZS.  Zeta – potential was 
calculated by Laser Doppler Electrophoresis (LDE) and size by dynamic light 
scattering (DLS).  Before analysis, the samples were sonnicated for 15 minutes 
to adequately disperse the nanoparticles.  The sample was then diluted with 
methanol (ratio 1:10) and added to the cuvette for DLS or the micro-
electrophoresis cell for LDE.  
 
3.4.2.2  SEM 
 
 
To assess the morphology of the MSNs, the samples were observed using a 
JEOL JSM-5600LV scanning electron microscope (SEM) with a 20 kV 
acceleration voltage.  Before analysis, the samples were sonnicated for 15 
minutes to adequately disperse the nanoparticles.  The sample was then diluted 
with methanol (ratio 1:10) and a drop from a Pasteur pipette was added to a 
SEM metal stud.  Once dry, the metal studs were coated with gold using an 
EMITECH SC7460 sputter coater.  The SEM studs were placed in the sputter 
chamber, with the argon gas supply set at 0.7 bar.  The chamber was evacuated 
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to a pressure of < 0.06 mbar, voltage set to 800 V and current at 20 mA.  The 
studs were then gold sputtered for 2 minutes.  Images of the MSNs were taken 
at 20,000 – 50,000x. 
 
3.4.2.3  Nitrogen adsorption 
 
 
A Micromeritics ASAP 2020 surface area and porosity analyser was used to 
evaluate the surface area of the MSNs using an automated nitrogen adsorption-
desorption method.  The calcined samples were placed in an analysis tube, 
weighed, dehydrated and finally degassed at 300°C for 12 hours.  The samples 
were then re-weighed and the difference between the two masses recorded. 
Commonly, for gas adsorption measurements of solid materials they must 
initially undergo a process whereby the majority of previously adsorbed gases 
and vapours are removed. This process is referred to evacuation where the solid 
is outgassed to c. 10-4 Torr for several hours in order to remove the physical 
adsorbed gas and majority of the chemisorbed gas.  The adsorption of gas or 
vapour onto the sample is measured by introducing a known volume of 
adsorbate, which is then determined using volumetric or gravimetric analysis. 
The gas is held within a burette and the pressure is measured using a 
manometer.  The volumes within the apparatus are calibrated in order for the 
amount of gas adsorbed by the absorbent sample to be determined via the 
pressure at equilibrium.  The adsorption isotherm is calculated from a 
progression of readings obtained at different pressures.  The cumulative surface 
area, average pore diameter and mesopores were obtained from pore size 
distribution curves.  This allowed the calculation of the surface area using BET 
volumetric analysis.  The porous sample was degassed and exposed to known 
volume of nitrogen.  The amount of gas absorbed by the sample can be 
quantified by subtracting the volume of gas once the pressure is equilibrated 
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from the initial volume of gas injected within the system. Pore size was also 
calculated via the BJH procedure. 
 
3.4.2.4  Thermal gravimetric analysis 
 
 
A Perkin Elmer TGA 4000 instrument was used to confirm the absence of 
surfactant template in post calcined MSNs (temperature increase of 10°C/min 
under nitrogen) and to produce residue fraction (RF) values for subsequent 
calculation of EO blend loading.  The TG instrumentation normally consists of 
four components; the furnace, sample holder, sensors which detect the sample 
properties dependent on temperature and the data acquisition system. 
Commonly, the furnace is operated electrically and upon sample analysis it is 
purged with appropriate gases to allow the sample to decompose as it reacts 
and/ or burns. The temperature is either measured by a thermocouple or 
resistance sensor, while mass is measured by a thermobalance. The 
thermobalance is a highly sensitive electrical device that is capable of measuring 
small changes in mass (1 μg). The sample is placed in an inert crucible, such as 
aluminium, platinum or ceramic.  The percentage weight and derivative TGA 
data was then recorded as a function of increasing temperature . 
 
3.4.3  Loading of EO blend into MSNs  
 
 
Two methods were utilised for loading of EO blend (CIN:CLO 1:1) into the 
nanoparticle mesopores.  Initially, a solvent evaporation method was used, 
whereby 0.1g of MSN sample was placed in a crucible along with 0.1g of EO and 
5 mL of MeOH.  The crucible was placed in a fume cupboard (flow rate 0.77 
m/sec-1) and the solvent was allowed to evaporate. 
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Secondly, 0.1g of MSN sample was immersed in 2 mL of EO and placed in a 
glass bottle on a table top shaker for 24 hours at 200 rpm.  The excess EO was 
drained from the sample and all samples were lightly washed with MeOH and 
allowed to dry before use, to ensure the nanoparticles were free of surface EO.  
TGA was used to produce residue fractions for blank MSN samples and 
percentage load of EO on dry MSN was calculated for EO loaded MSN samples 
to discern the loading level relative to a blank MSN sample, using equation 3.1. 
 
Equation 3.1.  Residue fraction calculation, allowing EO loading percentages to 
be determined. 
(𝑖)𝐴𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑀𝑆𝑁 𝑚𝑖𝑛𝑢𝑠 𝐸𝑂 =  
% 𝑤𝑒𝑖𝑔ℎ𝑡 𝑟𝑒𝑠𝑖𝑑𝑢𝑒 𝑎𝑡 900°C
𝐸𝑂 𝑓𝑟𝑒𝑒 𝑀𝑆𝑁 𝑟𝑒𝑠𝑖𝑑𝑢𝑒 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛
 
(𝑖𝑖)𝐴𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝐸𝑂 𝑖𝑛 𝑠𝑎𝑚𝑝𝑙𝑒 = % weight at 110°C − Amount of MSN minus EO 
(𝑖𝑖𝑖)% 𝐸𝑂 𝑜𝑛 𝑑𝑟𝑦 𝑀𝑆𝑁 =
𝐴𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝐸𝑂 𝑖𝑛 𝑠𝑎𝑚𝑝𝑙𝑒
% 𝑤𝑒𝑖𝑔ℎ𝑡 𝑎𝑡 110°C
 
  
Subsequent MSN samples (EO loaded or blank as required) were prepared at 
four different MSN concentrations in ISB at double strength allowing for 
subsequent dilution by the test culture in broth, as follows; 200 mg/mL by adding 
0.2g of the EO loaded MSNs to 10 mLs of ISB, 100, 50 and 25 mg/mL EO 
loaded MSN concentrations by adding 0.1, 0.05 and 0.025g to 10 mLs of ISB, 
respectively. 
 
3.4.4  Release of EO from MSNs 
 
 
EO blend loaded MSNs (0.1g) were placed on filter paper in a Buchner funnel, 
attached to a flask under vacuum and washed with MeOH (3 x 10 mL).  After 
each washing, the solvent was recovered and an aliquot (1 mL) was taken for 
subsequent GC-MS analysis to assess EO release from the MSN. 
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3.4.5  Molecular modelling of EO antimicrobial components 
 
 
Scigress software (Fujitsu) was used to model the main chemical constituents of 
the EOs attributed with antimicrobial action.  The molecular structure was 
computed using molecular mechanics calculations (MM3 and Scigress version 
3.1.9).  Geometry labels were assigned to determine the size or length of the 
molecules to confirm if they would fit in the nanoparticle mesopores.  The area of 
contact for eugenol with the MSN surface was also assigned using geometry 
labels allowing an estimated monolayer coverage to be calculated. 
 
3.4.6  Antimicrobial testing of blank and EO loaded MSNs 
 
 
The MSNs were tested for their antimicrobial properties. The microorganisms 
were challenged with blank and EO loaded MSNs, growth inhibition, and time-kill 
assays were performed using the method described in (Section 2.3.6). 
Growth inhibition studies aim to determine the minimum inhibitory concentration 
of an antimicrobial agent that will suppress the capacity of a given 
microorganism to divide and propagate, without causing cell death.  With these 
experiments it was intended to elucidate the potential bacteriostatic activity of the 
blank MSNs, and what concentrations of 2% (v/v) CIN-CLO blend loaded MSNs, 
were capable of preventing the growth and multiplication of the microorganisms 
tested.  
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3.4.7  Growth inhibition assays of blank MSNs 
 
 
The OD of the ISB bacterial cultures were adjusted to 0.1 at 540 nm with ISB, 
and 10 mL of each were added to 20 mL glass bottles.  Four concentrations of 
blank MSNs (10 mL) were inoculated into the broth suspended microorganisms 
(12.5, 25, 50 and 100mg/mL).  Immediately after inoculation, a ‘time 0’ OD 
reading was recorded for all control and test bottles. In order to ensure an 
intimate contact between the microorganisms and the nanoparticles, each test 
bottle was incubated at 37°C with shaking (200 rpm) for 24 hours, at which time 
1 mL of sample was removed and OD was recorded for this sample against that 
of a control culture with no blank MSNs present.  The experiment was run in 
triplicate (n=3).  
For this type of growth inhibition study, the principle is based upon the increase 
in optical density that results from an increase in bacterial cell numbers due to 
multiplication.  If growth occurs, the OD will increase, however if it does not, the 
OD will remain in-line with the ‘time 0’ OD values.  A decrease in optical density 
is not expected.  Suppression of bacterial cell division capability, or even cell 
death, still leaves the dormant / dead cells in suspension such that their 
contribution to increasing optical density remains.  Only in the case of cell lysis 
would the OD decrease.  An increase in the OD is therefore indicative of 
bacterial growth with no bacteriostatic effect being observed, as indicated by the 
growth curve experiments (Section 2.3.2.2).  No change in OD would suggest, 
bacteriostatic or bactericidal action.  
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3.4.8  Bactericidal assays  
 
 
Essential oil (2% CIN-CLO blend) loaded MSN suspensions at 12.5, 25, 50 and 
100mg/mL of MSNs were prepared using ISB. Samples were sonicated for 15 
minutes before use and appeared uniform.  The five test microorganisms were 
grown overnight in 10 mL of ISB.  After ensuring that no growth had occurred in 
the negative control tube (non-inoculated ISB), the optical density of the cultures 
was adjusted to 0.1 at 540 nm.  Then, 10 mL of culture were added to test 
bottles containing 10 mL of each of the corresponding nanoparticle suspensions 
containing EO loaded MSNs.  These were then incubated with agitation (200 
rpm) overnight at 37°C.  A test bottle containing 1 mL of nanoparticle free ISB 
was inoculated and a blank MSN control was used.  Following the overnight 
incubation, 10 µL of each culture was removed to be inoculated on nanoparticle 
free ISA plates. These were put in the incubator overnight and finally growth was 
checked. The bactericidal concentrations were determined based upon a 
growth/no growth basis.  The experiment was run in triplicate (n=3). 
 
3.4.9  Time-kill assays  
 
 
The dynamic killing capacity of the EO loaded MSNs was investigated (based on 
Hetrick et al 2007).  The MSN concentrations that produced no growth in the 
bactericidal assay were used for this experiment.  They were as follows; 
S.aureus, MRSA and E.coli 25 mg/mL 
P.aeruginosa and C.albicans 50 mg/mL 
Overnight cultures were taken and adjusted to 0.1 OD at 540 nm using ISB as 
diluents if necessary. In addition, the microorganisms were also prepared in 
exponential growth phase, by diluting overnight bacterial cultures in fresh broth 
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and incubating at 37°C until they reached exponential growth phase (as shown 
previously in Section 2.3.2.2). 
Then, 1 mL of uninocuIated ISB was added to 1 mL of the stock EO loaded 
MSNs and sonicated until dispersed. The broth-MSN suspension was then 
transferred into the respective test bottle containing 100 µL of each 
microorganism at exponential or stationary phase and incubated at 37°C while 
shaking (200 rpm).  In addition, at time 0, 100 µL of the OD adjusted cultures 
were mixed with 1 mL of the control (nanoparticle free ISB).  Aliquots of 10 µL 
were taken from test and control mixtures at time 0, 15, 30 and 60 serially diluted 
in PBS and 10 µL pipetted onto ISA incubated at 37°C for 24 hours, enabling 
tracking of CFU/mL over time. 
The determination of bacteriostatic and bactericidal concentrations disregard the 
time required for the antimicrobial agent to demonstrate an effect.  With the use 
of time-kill assays it was intended to obtain an understanding of how the EO 
loaded MSNs exert their antimicrobial effects over time.  The experiment was run 
in triplicate (n=3).   
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3.5  Results and Discussion 
 
 
3.5.1  Characterisations of MSN  
 
 
Initially, MSNs were prepared using the method of Trewyn et al (2007), which 
reported nanoparticles of roughly 100-200 nm diameter and mesopores of 2 nm 
in diameter.  Using this method, nanoparticles were characterised, with five 
samples subsequently used in experiments.  Ideally, mono-dispersed MSNs of 
roughly 100-200 nm in diameter, with high surface area and uniform mesopores 
large enough to accommodate the main constituents of the EOs used would be 
fabricated for release of the antimicrobial.  In order to produce a surfactant free 
MSN, the CTAB template must be removed, the template can be removed via 
calcination and confirmed via TGA. 
 
3.5.1.1  Thermogravimetric analysis (TGA) 
 
 
TGA was used to confirm the removal of the surfactant template post calcination 
(Figure 3.3).  For each MSN batch, a small sample pre and post calcination was 
analysed to show the thermal decomposition of the template in the pre-calcined 
sample.  Any fluctuations in the derivative data at room temperature to 110 °C 
was due to water molecules evaporating from the pores of the nanoparticles.  
The mass loss between 110°C - 400°C was due to the decomposition of the 
surfactant template molecules that are still within the MSNs.  The mass loss 
above 400°C may be due to condensation of water from the silanol groups 
(Verhaegh et al 1994).  The % mass loss between key temperature ranges for 
the five MSN samples are displayed in (table 3.1). 
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Table 3.1.  Showing mass loss between key temperature ranges for five MSN 
samples. With template (WT) and without template (WOT). 
Sample No. Mass % loss 
between 110-400 
(WT) 
Mass % loss between 
110-900 (WT & WOT) 
% surfactant on dry 
MSN  
1 WT 46.5 50.89 46.41 
1 WOT  6.61  
2 WT 47.5 54.56 40.60 
2 WOT  17.14  
3 WT 46.5 50.89 46.41 
3 WOT  6.61  
4 WT 46.5 50.89 44.31 
4 WOT  9.71  
5 WT 47.5 54.56 46.19 
5 WOT  9.27  
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(A)
 
(B) 
 
Figure 3.3.  Thermogravimetric analysis (solid line) and derivative 
thermogravimetric curve (dotted line) of surfactant intact MSN sample 1 (A) and 
MSN sample 1 post calcination (B). 
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3.5.1.2  Zeta potential  
 
 
Figure 3.4.  Zeta potential for the five MSN samples used for further 
experimentation. 
 
The Zeta potential of the MSNs (Figure 3.4) displayed good electrophoretic 
potential in methanol.  The five MSN samples recorded Zeta potentials between -
30.6 – -35.4 (mV), indicating that the samples will have good aqueous dispersion 
stability. 
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3.5.1.3  Scanning electron microscopy 
 
 
The SEM analysis (figure 3.5 – 3.7) confirmed the desired size and dispersion of 
the MSN samples.  ImageJ was used to record nanoparticle diameter, a sample 
of 100 nanoparticles were measured for each batch of MSNs.  Sample 1 
recorded an average size of 94.58 ± 11.72 nm and values of 102.63 ± 14.79, 
101.35 ± 10.8, 109.71 ± 9.76, 95.36 ± 13.83 were obtained for samples 2-5 
respectively. 
 
Figure 3.5.  Scanning electron microscope images of calcined MSNs (Sample 1). 
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Figure 3.6.  Scanning electron microscope images of calcined MSNs, B and C, 
samples 2 and 3, respectively. 
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Figure 3.7.  Scanning electron microscope images of calcined MSNs, D and E, 
samples 4 and 5, respectively. 
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3.5.1.4  Nitrogen Adsorption of MSNs 
 
 
Nitrogen adsorption analysis was conducted to confirm the porosity of the MSN 
samples.  (Figure 3.8 – 3.10) displays the N2 sorption of MSN samples 1-5.  The 
isotherm curves follow the general type-IV classification of mesoporous 
materials. 
 
Figure 3..8.  Nitrogen sorption isotherm for gas adsorption (blue line) and 
desorption (maroon line) at 77K and pore size distribution graph (Sample 1). 
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Figure 3.9.  Nitrogen sorption isotherm for gas adsorption (blue line) and 
desorption (maroon line) at 77K and pore size distribution graph B and C, 
(Sample 2 and 3, respectively). 
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Figure 3.10.  Nitrogen sorption isotherm for gas adsorption (blue line) and 
desorption (maroon line) at 77K and pore size distribution graph D and E  
(Sample 4 and 5, respectively). 
 
The objective of synthesising porous nanoparticles was achieved.  The MSN 
samples 1-5 have a pore diameter between 1.8-2.2 nm as shown in the pore size 
distribution graphs (Figure 3.8 – 3.10).  The sharp peaks confirm that the ordered 
mesoporous nanoparticles have a narrow size distribution around 2 nm (Trewyn 
et al 2007, Deng et al 2013, Hong et al 2007).  For the intended MSN 
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application, the large surface area along with narrow pore size confers the 
desired characteristics (Table 3.2) 
Table 3.2.  Summary of mesoporous silica nanoparticle sample 
characterisations. 
MSN 
sample 
Diameter (nm) 
(SEM images) 
Surface area 
(m²/g) 
Pore size 
(nm) 
Zeta potential 
(mV) 
1 94.58 ± 11.72 980 ± 77 2.2 -30.6 
2 102.63 ± 14.79  1161 ± 76. 2.2 -31.9 
3 101.35 ± 10.8 894 ± 44 2.2 -35.4 
4 109.71 ± 9.76 759 ± 19 1.8 -34.6 
5 95.36 ± 13.83 654 ± 12 2.1 -30.7 
 
3.5.2  Molecular modelling of major EO constituents 
 
 
Scigress software was used to model the main antimicrobial constituents to 
determine their length and enable assessment as to whether they would 
physically fit in the nanoparticle mesopores.  The molecular model presented in 
(Figure 3.11) shows that the major EO constituent of the CIN:CLO blend 
(eugenol) is 0.922 nm in length, for ball and stick and space filling models 
respectively and would therefore fit in the MSN pores, which ranged from 1.8-2.2 
nm in diameter. 
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Figure 3.11.  Eugenol (represented as a space filling molecular model with stick 
model overlaid) is the major constituent of clove oil and cinnamon oil. 
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3.5.3  Loading of EOs into MSNs, solvent evaporation studies. 
 
3.5.3.1  Solvent evaporation loading 
 
 
Figure 3.12.  TGA trace of blank MSNs before oil loading.  (Red line) Percentage 
mass loss plotted against increasing temperature °C, (Blue line) derivative of 
mass loss. 
 
There were two separate instances of mass loss for the blank MSN samples 
used in this study.  Mass loss from 0°C to 110°C was the loss of water absorbed 
by the mesopores.  Mass loss in the temperature range 110°C - 900°C is 
associated with the structural decomposition of the silica nanoparticles.  The 
percentage mass remaining at 900°C for the blank MSN sample which was used 
to determine the residue fraction, would be used to determine the loading levels 
of EO via evaporation and immersion using Equation 3.1 (Section 3.4.3).  The 
residue fraction for sample 1 (Figure 3.12) was determined by dividing the % 
mass residue (85.39) by the % mass after water loss (92), providing a residue 
fraction of 0.928.  The TGA traces for EO loaded samples treated with solvent 
evaporation are shown in (figures 3.13 – 3.15). 
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Figure 3.13.  TGA of CLO-CIN loaded MSN sample after evaporation of MeOH.  
No subsequent solvent washing.  (Red line) Percentage mass loss plotted 
against increasing temperature °C, (Blue line) derivative of mass loss. 
 
Figure 3.14.  TGA of CLO-CIN loaded MSN sample after primary MeOH washing 
and evaporation.  (Red line) Percentage mass loss plotted against increasing 
temperature °C, (Blue line) derivative of mass loss. 
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Figure 3.15.  TGA of CLO-CIN loaded MSN sample after second round of 
washing with MeOH.  (Red line) Percentage mass loss plotted against increasing 
temperature °C, (Blue line) derivative of mass loss. 
 
 
It is significant that the MeOH did not actually wash any EO from the samples 
and may reflect the strength of the EO – MSN interactions relative to MeOH – 
MSN interaction.  The % loading levels for the EO evaporation and subsequent 
solvent washing are shown in (Table 3.3) 
 
Table 3.3.  Loading levels for EO evaporation and subsequent solvent washing 
(methanol)  
Experimental condition % EO load 
EO evaporation 33.64 
1st solvent wash 35.40 
2nd solvent wash 38.19 
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It was decided the solvent evaporation method for EO loading was not providing 
a high enough oil loading percentage and therefore anticipated EO concentration 
available at the textile surface, to justify further experimental investigation in this 
study.   An alternative method for loading the EO into the MSNs was sought, Lu 
showed the potential for MSNs as a viable carrier for hydrophobic anti-cancer 
drugs (camptothecin) that are similar to essential oils, as camptothecin is 
isolated from the bark and stem of the Camptotheca acuminate tree. Both 
camptothecin and EO molecules are hydrophobic and contain hydrocarbon 
structures (Lu et al 2007).  Using this method, blank MSNs were immersed in 
essential oils, with agitation and stirring, before draining excess essential oil and 
lightly washing the sample with MeOH and allowing to dry before use.  The TGA 
traces for the five MSN samples are presented in (figures 3.16 – 3.20).   
 
3.5.3.2  EO immersion loading 
 
 
Figure 3.16.  Sample 1 TGA trace of EO loaded MSNs.  (Red line) Percentage 
mass loss plotted against increasing temperature °C, (blue line) derivative of 
mass loss. 
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There were three instances of mass loss from the EO loaded MSN sample 
during the TGA heating process.  For mass loss occurring up to 110°C, as with 
the blank MSN samples, this was loss of molecular water.  The mass remaining 
at this point was the mass post free water loss used in Equation 3.1. 
The second mass loss occurred between 110°C and 254°C, the boiling point for 
eugenol which constitutes >90% of the CIN-CLO blend used.  The rate of % 
mass loss between 110°C - 160°C was greater than % mass loss between 
160°C - 254°C, this could be explained by the relative strength of interaction of 
the EO molecules with the MSN surface.  
The final mass loss occurred between 254°C - 900°C and was attributable to the 
loss of structural water in the silica nanoparticles.  The mass remaining at the 
end of the TGA heating program is taken as the mass after volatile loss used in 
(Equation 3.1). 
The TGA traces for EO loading via solvent evaporation (Section 3.5.3.1) and EO 
immersion, display the same mass loss events over the three temperature 
ranges described above. 
  
Figure 3.17.  Sample 2 TGA trace of EO loaded MSNs.  (Red line) Percentage 
mass loss plotted against increasing temperature °C, (blue line) derivative of 
mass loss. 
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Figure 3.18.  Sample 3 TGA trace of EO loaded MSNs.  (Red line) Percentage 
mass loss plotted against increasing temperature °C, (blue line) derivative of 
mass loss. 
Figure 3.19.  Sample 4 TGA trace of EO loaded MSNs.  (Red line) Percentage 
mass loss plotted against increasing temperature °C, (blue line) derivative of 
mass loss. 
114 
 
 
 
Figure 3.20.  Sample 5 TGA trace of EO loaded MSNs.  (Red line) Percentage 
mass loss plotted against increasing temperature °C, (blue line) derivative of 
mass loss. 
 
TGA was used to determine the level of oil present in the mesopores of the 
nanoparticles. Fernandes et al have shown in some cases, the relative levels of 
weakly bound and strongly bound surfactants can be highlighted via the use of 
mass loss data (Fernandes et al 2015).  The strongly bound surfactant is 
attributed to the EO molecules bound to the substrate via hydrogen bonding, 
dipole-dipole interactions and possibly pi-electron interactions, whereas the 
weakly bound surfactant is attributed to bonding to other surfactant molecules.  It 
follows, that strongly bound oil molecules will release from the sample at a higher 
temperature than the weakly bound.  The blank MSN RFs and their respective 
loading levels are presented in (Table 3.4).  It is interesting to consider 
theoretical monolayer coverage of the main EO blend constituent (eugenol) on 
the MSNs.  The area of a molecules footprint on a substrate can be used to 
calculate the theoretical number of molecules adsorbing onto a given substrate 
surface area (Liauw et al 1995). The area of the footprint for a eugenol molecule 
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in the anticipated orientations for adsorption were calculated (0.42 and 1.11 nm2 
for vertical and flat adsorption, respectively) using a rectangle enclosing the 
molecule and is shown in (Figure 3.21).  In the proposed vertical adsorption 
orientation of eugenol, there would be interaction between the phenolic OH 
group and possibly the ether oxygen with the MSN surfaces.  In the flat 
adsorption orientation of eugenol, there would be interaction between the π 
electron cloud of the phenyl ring, the phenolic OH group and the π electrons of 
the double bond, with the MSN surfaces.  The eugenol molecules would project 
0.927 nm into the mesopores in the vertical adsorption mode, as shown in 
(Section 3.5.2).  Assuming adsorption is radial in the pores, the tails of the 
molecules would not collide, considering the mesopores for MSN samples 1,2,3 
and 5 were measured to be 2.1 – 2.2 nm in diameter.  The mesopores for 
sample 4 were measured to be 1.8 nm, leading to possible altered adsorption 
orientation or packing of coverage in the pores.   
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Figure 3.21.  A eugenol molecule modelled using Scigress software, in the two 
possible orientations of adsorption, (A) vertically and (B) flat.  
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The theoretical monolayer coverage in the vertical adsorption orientation was 
calculated using equation 3.2 as follows: 
Equation 3.2.  Theoretical monolayer coverage for eugenol on MSN surfactant in 
proposed orientations of adsorption. 
Theoretical number of molecules adsorbing per gram of MSN =  
980 (m2g−1)
4.208 𝑥 10−19 (m2)
 
        = 2.329 x 1021 molecules 
 
Theoretical number of moles of molecules adsorbing per gram of MSN
=  
2.329 𝑥 1021
6.022 𝑥 1023
 
        = 3.867 x 10-3 moles 
As   
Number of moles =  
𝑚𝑎𝑠𝑠
𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑚𝑜𝑙𝑎𝑟 𝑚𝑎𝑠𝑠
 
 
The theoretical mass of Eugenol adsorbed per gram of MSN = molar mass of 
eugenol x the number of moles estimated to adsorb = 164.2 x (3.867 x 10-3) 
       = 0.635 g 
Therefore the theoretical adsorption level for Eugenol on MSN is 635 mg g-1.  Or 
about 63.5 wt.%, based on initial mass of MSN.   
 
The theoretical monolayer coverage in the flat adsorption orientation was 
calculated as follows: 
Theoretical number of molecules adsorbing per gram of MSN =  
980 (m2g−1)
1.110 𝑥 10−18 (m2)
 
        = 8.828 x 1020 molecules 
 
118 
 
Theoretical number of moles of molecules adsorbing per gram of MSN
=  
8.828 𝑥 1020
6.022 𝑥 1023
 
        = 1.466 x 10-3 moles 
As   
Number of moles =  
𝑚𝑎𝑠𝑠
𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑚𝑜𝑙𝑎𝑟 𝑚𝑎𝑠𝑠
 
 
The theoretical mass of Eugenol adsorbed per gram of MSN = molar mass of 
eugenol x the number of moles estimated to adsorb = 164.2 x (1.466 x 10-3) 
       = 0.241 g 
Therefore the theoretical flat adsorption level for Eugenol on MSN is 241 mg g-1.  
Or about 24.1 wt.%, based on initial mass of MSN.   
 
 
Theoretical monolayer coverage was estimated to be 635 mg/ 1 g MSN and 241 
mg/ 1 g MSN for vertical and flat adsorption, respectively.  The two projected 
areas indicate the upper bound and lower bound estimates for the theoretical 
monolayer level of loading.  The results were based on a MSN surface area of 
980 m²/g-1 (sample 1), and the assumptions that the EO blend reaches all parts 
of the MSN and all surfaces of the MSN sample have equal reactivity.  
Considering the tacky nature of the EO evaporation and EO immersion samples 
that were analysed for EO loading level, it can be speculated that some of the 
EO molecules had adsorbed on the external surfaces of the MSNs.  It follows 
that the loading levels obtained did not represent true monolayer coverage, 
borne out by the theoretical monolayer calculations.  It is interesting that the 
theoretical loading level for flat adsorption is close to the EO loading level result 
for EO evaporation and the theoretical loading level for vertical adsorption is 
close to the EO loading level result for EO immersion (Table 3.4).  It was 
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speculated from this, at lower EO loading levels (solvent evaporation), the flat 
orientation for adsorption was favoured. While at higher EO loading levels (EO 
immersion) there could be some vertically adsorbed eugenol molecules on the 
external surfaces of the MSNs, with the remainder adsorbed on top of this 
(Figure 3.22). 
 
 
Figure 3.22.  The anticipated orientations of attachment to the MSN surface for 
eugenol. (i) Vertical, dual-point attached, (ii) flat, multi-point attached. 
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Table 3. 4.  Residue fractions of blank MSN samples and % EO load via 
immersion and shaking for samples 1-5. 
MSN sample Blank 
MSN Rf 
% EO load Surface 
area 
(m²/g-1) 
Pore size 
(nm) 
1 0.97 71.24 980 ± 77 2.2 
2 0.819 66.89 1161 ± 76. 2.2 
3 0.928 73.38 894 ± 44 2.2 
4 0.893 74.4 759 ± 19 1.8 
5 0.904 72.65 654 ± 12 2.1 
 
 
3.5.3.3  EO release from loaded MSNs 
 
MSN sample 1 (0.5g) was loaded with CIN:CLO EO blend using the immersion 
method described in (Section 3.4.3).  The sample was washed with 3 x 10 mL 
MeOH using a Buchner filtration setup.  The aliquots taken after each wash were 
analysed using GCMS to ensure the antimicrobial constituents were able to 
release from the mesopores (Figure 3.23).   
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Figure 3.23.  Chromatographs of MeOH Extract from three EO loaded MSN 
samples after increasing solvent washing with MeOH.  (i) After 10 mL, (ii) 20 mL 
and (iii) 30 mL of washing with MeOH.  Peaks assigned as follows: (a) eugenol 
(b) beta caryophylene (c) eugenyl acetate (d) benzyl benzoate.  Eugenol peak 
max height (i) 1.1 x 108,(ii) 9 x 107, (iii) 8 x 107. 
 
The data obtained from these experiments indicated that the mesoporous silica 
nanoparticles could be used as an encapsulant for the EOs.  The MSN batches 
used in this study and for further experimentation displayed a high surface area, 
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with pores large enough in diameter to allow the antimicrobial constituents of the 
EOs to be accommodated.  The TGA of EO loaded MSN samples displayed the 
loading level of oil in the mesopores relative to the residue fraction of the blank 
MSNs.  Finally, GCMS analysis of solvent washed EO immersion loaded MSNs 
confirmed the ability of the EOs to leave the mesopores.  Interestingly, with each 
round of solvent washing of the EO evaporation method, sample 1 recorded a 
slightly increased level of EO composition when TGA was conducted (33.64, 
35.40 and 38.19%, respectively).  This is in contrast to the EO release observed 
with solvent washing of the EO immersed sample (originally 70.28% EO load) via 
GCMS analysis.  It is possible at higher loading levels in the MSN pores, some 
EO molecules are not interacting with the MSN surface and are therefore more 
easily washed from the MSN sample.   
 
3.5.4  Antimicrobial testing of blank and EO loaded MSNs 
 
 
3.5.4.1  Blank MSNs growth inhibition assay 
 
 
The following graph (Figure 3.24) shows the effect of the blank MSNs at varying 
concentrations on the growth of the five test microorganisms after 24 hour 
exposure. 
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Figure 3.24.  The capacity of blank MSNs at 12.5, 25, 50 and 100 mg/mL to 
prevent growth of five test microorganisms over a 24 hour period based on 
optical density readings.  Results are expressed as a percentage of ‘time 0’ OD 
values.  Standard deviation bars are displayed (n=3). 
 
The optical density of the negative control (nanoparticle free ISB) did not vary 
throughout the experiment, whereas it increased in the positive growth control 
bottles (not included in figure 3.24).  Also, the blank (uninoculated) MSN 
suspensions were shown to be uncontaminated as no colonies grew on the ISA 
plates inoculated with 10 µL of each after overnight incubation at 37°C. 
At all four concentrations of blank MSN suspensions, there was no inhibition of 
microbial growth, relative to the OD values recorded at the beginning of the 
experiment for each test bottle.  However, the increasing OD shown with 
increasing blank MSN concentration could be due, partly to turbidity of the 
suspension due to the light scattering effect of aggregated MSNs.  As a result, 
10 µL of each test sample was plated on ISA and incubated overnight at 37°C to 
check for growth.  All samples returned growth, therefore it can be said the blank 
MSNs do no exert an antimicrobial effect on the test microorganisms.  Any 
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antimicrobial effect shown by EO loaded MSNs can be considered solely to be 
the action of the oils.   
 
3.5.4.2  Bactericidal activity of EO loaded MSNs  
 
 
Table 3.5 shows the minimum EO loaded MSN concentration necessary to 
cause cell death, which was verified by the absence of growth on agar plate after 
overnight incubation at different nanoparticle concentrations (12.5, 25, 50 and 
100 mg/mL).  
 
Table 3.5.  Bactericidal activity of EO loaded MSNs at four concentrations.  ‘G’ 
represents the occurrence of growth, ‘NG’ represents the occurrence of no 
growth (n=3). 
MSN conc 
(mg/mL) 
S.aureus E.coli C.albicans MRSA P.aeruginosa 
100 NG NG NG NG NG 
50 NG NG NG NG NG 
25 NG NG G NG G 
12.5 G G G G G 
 
All positive control bottles produced growth, while the negative controls free of 
MSNs and microorganisms produced no growth when plated.  At 12.5 mg/mL all 
five test microorganisms produced growth when plated, while at 25 mg/mL the 
microorganisms previously shown to be less robust (S.aureus, E.coli, and 
MRSA) did not grow.  Above this concentration, at 50 and 100 mg/mL there was 
no growth, demonstrating bactericidal capacity at these concentrations.  In such 
cases, a bactericidal value can be assigned, shown in (table 3.6). 
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Table 3.6.  The bactericidal concentrations (mg/mL) for each test microorganism. 
Microorganism EO loaded MSN concentration 
(mg/mL) 
S.aureus 25 
E.coli 25 
C.albicans 50 
MRSA 25 
P.aeruginosa 50 
 
The determination of bactericidal concentrations of the EO loaded MSNs was 
important as a lower nanoparticle concentration implies reduced cost, and a 
minimisation of potential irritation to the epidermis if the final product is to be 
worn or come into contact with the skin.  The antimicrobial capacity of 
nanoparticles is concentration–dependent; i.e. the higher the nanoparticle 
concentration, the greater the volume of EO blend available, the greater the 
bactericidal activity.  The antimicrobial activity of nanoparticles is also dependent 
on initial bacterial concentration (Sondi and Salopek-Sondi 2004, Pal et al 2007, 
Nair et al 2009).  
 
3.5.4.3  Time-kill assays 
 
 
The five test microorganisms were tested against EO loaded MSNs at the given 
bactericidal concentrations for each microbe (Section 3.5.4.2). The 
microorganisms were prepared in both stationary and exponential growth phases 
(Section 3.4.9).  The following Figures (3.25 – 3.29) display the CFU/mL 
decrease over time when treated with 2% CIN:CLO 1:1 blend, EO loaded MSNs 
at the determined bactericidal concentrations for each microorganism. 
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Figure 3.25.  CFU/mL versus time plots for S.aureus in the static (S) and 
exponential growth (E) phases, both with and without 25 mg/mL of EO loaded 
MSNs.  Standard deviation bars are shown (n=3). 
 
 
 
 
Figure 3.26.  CFU/mL versus time plots for E.coli in the static (S) and exponential 
growth (E) phases, both with and without 25 mg/mL of EO loaded MSNs.  
Standard deviation bars are shown (n=3). 
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Figure 3.27.  CFU/mL versus time plots for C.albicans in the static (S) and 
exponential growth (E) phases, both with and without 50 mg/mL of EO loaded 
MSNs.  Standard deviation bars are shown (n=3). 
 
 
Figure 3.28. CFU/mL versus time plots for MRSA in the static (S) and 
exponential growth (E) phases, both with and without 25 mg/mL of EO loaded 
MSNs.  Standard deviation bars are shown (n=3). 
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Figure 3. 29.  CFU/mL versus time plots for P.aeruginosa in the static (S) and 
exponential growth (E) phases, both with and without 50 mg/mL of EO loaded 
MSNs.  Standard deviation bars are shown (n=3). 
 
At bactericidal concentrations determined using the method described in 
(Section 3.4.8), the time – kill graphs show the effect of EO loaded MSNs to be 
time dependent, with the highest rate of killing occurring during the first 15 
minutes of exposure.  As seen previously, the gram – positive bacteria are more 
susceptible to the antimicrobial action of the main constituent in the CIN: CLO 
1:1 EO blend (eugenol).  In addition, the gram – negative P.aeruginosa and the 
yeast C.albicans displayed a more robust response to the antimicrobial, with a 
slower rate of killing and still demonstrating viability after 60 minutes of exposure.  
From these results, it is clear the loading of EO into the mesopores of the 
nanoparticles does not attenuate the antimicrobial efficacy of the oil.  These are 
interesting findings, as is the fact that the EO loaded into MSNs retain their 
potent antimicrobial capacity in a nutrient – rich environment. It is therefore 
reasonable to propose that this activity would not be hampered in an 
environment conducive to bacterial or fungal growth. 
Interestingly, it has been reported that gram-negative species are more readily 
killed by the nanoparticles than the gram-positive, reinforcing the extended idea 
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that the thicker cell wall of this second group of bacteria provides a defence 
mechanism against silver nanoparticles that the gram-negative lack (Feng et al 
2000).  Although silver nanoparticles and silver ions are capable of entering 
bacterial cells, membranes are the first barrier with which interaction is 
established. Consequently, it is easy to hypothesise that the greater thickness of 
the cell wall in gram-positive bacteria constitutes a defence mechanism against 
silver nanoparticles (Kim et al 2007).  This is in contrast to results published for 
the effect of essential oils on gram-positive and negative bacteria.  Gram-
negative bacteria are less susceptible to the action of essential oils, compared to 
Gram-positive bacteria.  This is due to the presence of the outer membrane 
surrounding the cell wall, which restricts the diffusion of lipophilic compounds 
through the lipopolysaccharide covering (Mann et al 2000). 
Despite the relatively slim chance of bacterial resistance developing to 
nanoparticles loaded with antimicrobials (particularly EO), the possibility should 
not be ignored, particularly if such approaches are to be widely and routinely 
used.  However, it is widely known the natural variance in essential oil chemical 
composition (particularly an EO blend), even for the same type of oil batch to 
batch, is the reason bacteria, fungi and viruses cannot easily develop resistance 
to these natural plant derived antimicrobials (Becerril et al 2012).  In addition, 
these complex mixtures display antimicrobial activity by more than one 
mechanism (Cox et al 2000).   Treatments and medical equipment, such as 
wound dressings and urinary catheters impregnated with silver nanoparticles are 
already being used.  In order to minimise the possibility of resistance developing, 
nanoparticles should be used only when necessary, and ensure a rapid killing of 
microorganisms.  For example, Yamanaka et al (2005) challenged E. coli with 
0.9 – 112 µg/mL silver ion solutions, and although a significant rate of killing was 
documented, it required over 14 hours.  Due to the controlled release behaviour, 
this long length of time would only encourage resistance to develop, using a 
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single agent at possibly sub-lethal concentrations.  Throughout the course of this 
investigation, the variation in methods used to assess the performance of nano-
particle based antimicrobials has hampered comparison of data from diverse 
studies.  A standardised method for the latter is urgently needed if the data from 
research groups active in this field are to be meaningfully compared.    
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3.6  Conclusions 
 
 
The conclusions are written below in the context of the initial objectives: 
 Synthesis of nanoparticles. 
Mesoporous silica nanoparticles of high surface area and largely mono-disperse 
size distribution, with uniformly dimensioned pores, were successfully 
synthesised, with five samples being used for further study. 
 Characterisation of nanoparticles. 
The size and characteristics of nanoparticles were successfully determined by 
the use of specialist analytical apparatus.  Image J was used to confirm the MSN 
samples were roughly 100 nm in diameter, while nitrogen adsorption 
measurements confirmed the high surface area of the nanoparticles (654 – 1161 
m²/g-1) and mesopore diameter (1.8 – 2.2 nm). 
 Loading level and release rate of essential oil from nanoparticles. 
TGA was used to determine the loading level of essential oil (66.89 – 74.40%) 
using the EO immersion method.  While gas chromatography coupled with mass 
spectrometry was used to confirm the major antimicrobial molecules could 
release from the nanoparticle mesopores. 
 To determine the antimicrobial activity of MSNs loaded with EO and whether 
blank MSNs exhibit any antimicrobial action. 
The blank MSNs were shown to have no antimicrobial effect on the test 
microorganisms.  Bactericidal concentrations of EO loaded MSNs for each test 
microorganism were determined (25 mg/mL for S.aureus, MRSA and E.coli, 50 
mg/mL for P.aeruginosa and C.albicans).  The dynamic killing profiles for these 
bactericidal values were investigated for all five test microorganisms (S.aureus 
and MRSA in exponential growth phase being killed in 30 minutes exposure). 
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Chapter 4 
 
Affixation of mesoporous silica nanoparticles to synthetic textiles 
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4.1  Introduction 
 
 
4.1.1  Organically modified silicates (Ormosils) 
 
 
Ormosils have applications in coating, adsorption, separation media, sensors, 
drug-delivery supports, and oil-spill clean-up (Brinker and Scherer 1990).  
Another attractive property is that they are relatively easy to make and highly 
cost effective (Mackenzie and Bescher, 1998).  It was speculated that an ormosil 
covering the synthetic fibres would provide a matrix conducive to the chemical 
affixation of the MSNs to the textiles. 
Ormosils are produced via the sol-gel method and many different type of 
ormosils can be produced, ranging from tough and durable to rubbery and 
bendable films (Hench and West, 1990) (Bescher and Mackenzie, 2003) 
(McDonagh et al, 1998).  The sol–gel process involves the evolution of inorganic 
networks through the formation of a colloidal suspension of solid species in a 
liquid sol, which is converted into a gel through polycondensation of the sol.  A 
gel is an interconnected, rigid network with polymeric chains, whose average 
length is greater than a micrometre, and pore width of nanometer dimensions.  
Hydrogels are formed from aqueous solutions, whereas alcogels are formed 
from alcoholic solutions.  The most widely used silanes are the alkoxysilanes, 
such as tetraethoxysilane (TEOS) and methyltriethoxysilane (MTEOS).  The first 
step in the synthesis is hydrolysis of the precursor followed by condensation of 
the hydrolysed species.  The hydrolysis reaction that initiates the process may 
be acid or base catalysed and the rate of hydrolysis is pH dependant (Curran 
and Stiegman 1999).  Drying of the gel is also a critical step. During drying, 
shrinkage of the gel occurs due to capillary pressure.  When the pore liquid is 
removed at or near ambient pressure by thermal evaporation and shrinkage 
occurs, the material is termed a xerogel.  When the pore liquid is removed as a 
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gas phase from the interconnected solid gel network under supercritical 
conditions, the network does not collapse and a low density aerogel is produced.  
The type of silica produced is solely dependent on the composition (i.e. 
structures (functionalities) of the components and the molar ratios) (Hench and 
West, 1990)(McDonagh et al, 1998).  The structure and porous texture of 
xerogels synthesised using TEOS as a precursor is dependent on synthesis 
conditions, namely, pH, temperature, and the precursor:solvent:water molar ratio 
(Echeverria et al 2010, Estella et al 2007,Musgo et al 2009).  The amount of 
porosity and the size distribution of the latter is also affected by ageing and 
drying conditions (Estella et al 2007). Many studies on the production of ormosils 
with a wide range of targeted properties have been carried out.  These mainly 
involve mixing the TEOS with other silane precursors such as MTEOS and 
ethyltriethoxysilane (ETEOS) at different ratios with the addition of water and 
hydrochloric acid to adjust the pH (McDonagh et al, 1998) (Wencel et al, 2007). 
 
4.1.2  Silane coupling linkers 
 
Organo-functional silanes such as 3-(trimethoxysilyl)propylmethacrylate) (-MPS) 
(Figure 4.1) are widely used for grafting into ormosil structures as they contain 
silicon–alkoxy functionality and a double-bond end-group (Pardal et al 2009). 
The latter will interact with a variety of addition polymerisation systems (including 
free radical), thereby producing strong interaction between the ormosil particles 
an addition polymerised matrix.  For this study, it was hoped a silane could be 
used to allow the MSNs to be chemically bound to the ormosil matrix covering 
the synthetic fibers 
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Figure 4.1.  The silane coupling linker trimethoxysilylpropylmethacrylate (-MPS), 
contains an acrylic carbon-carbon double bond (C=C) and methoxysilane groups 
(SiOCH3). 
 
Silica-polymer nanocomposites are a promising new class of materials that have 
many possible applications in aerospace materials, structural materials 
electronics, sensors, and other areas (Xiangling et al 2003).  Three main 
synthetic routes have been developed for the production of such 
nanocomposites.  The first approach involves mixing polymers with silica 
particles or silica precursors directly.  For example, composites containing silica 
nano-particles that are produced in-situ.  Such composites are often based on 
poly(methylmethacrylate), poly(ethyleneglycol), and polyurethane and have been 
prepared by mixing these polymers with silica precursors, such as 
tetraalkoxysilanes that hydrolyse and condense to form silica within the polymer 
matrix (Petrovic et al 2000).  The second synthesis approach usually involves 
direct mixing of the polymer monomers with silica particles followed by 
polymerisation of the monomers (Lu and Huang 2002).  For example, silica 
colloids in solution have been mixed with organic monomers such as styrene, 
methylmethacrylate, ethylacrylate,and 2-hydroxyethylmethacrylate.  Subsequent 
polymerisation of these monomers led to the formation of silica nanocomposites. 
The third synthesis approach involves mixing both silica precursors, such as 
TEOS and MTEOS with addition polymerisable monomers, followed by 
simultaneous polymerisation of the precursors and monomers (Hajji et al 1999).  
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4.1.3  Gas chromatography 
 
Vide supra Section 2.1.7 
 
4.1.4  Attenuated total reflectance Fourier transform infrared spectroscopy (ATR 
FTIR) 
 
 
Once an affixation technique was chosen, it was hoped the different chemical 
environments of the affixation technique could be analysed and profiled using 
ATR FTIR.  In ATR sampling the IR beam is directed into a crystal of relatively 
higher refractive index.  ATR FTIR speeds up the analysis of samples, as little 
preparation is needed.  The IR beam reflects from the internal surface of the 
crystal, with a single bounce and creates an evanescent wave, which projects 
orthogonally into the sample in intimate contact with the ATR crystal (Figure 4.2).  
Some of the energy of the evanescent wave is absorbed by the sample and the 
reflected radiation (some now absorbed by the sample) is returned to the 
detector.  As the infrared (IR) beam reaches the detector it is analysed by the 
Fourier transform mathematical operation, producing a spectrum of the 
wavelengths absorbed. 
 
Figure 4.2.  The internal instrument setup for single reflection ATR FTIR 
analysis. 
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The wavelength of IR absorption is unique to the vibration frequency of a specific 
chemical group, therefore the FTIR spectrum can be used to determine the 
chemical make-up of a sample.  As a result, FTIR can be used to analyse the 
interactions between molecules and substrates (Estella et al 2007).  
Furthermore, FTIR can be used to record shifts in peaks due to changes in the 
chemical environment of a sample.  Such peak shifts could potentially be used to 
monitor the layer-by-layer treatment of textiles (Table 4.1). 
 
Table 4.1.  FTIR adsorption frequencies of note for the organo-silicon species 
used in this study (Estella et al 2007, Pardal et al  2009). 
Wavenumber cm-1 Bond 
1100 – 900  Si-O-Si stretch 
1760 – 1665  C=O stretch 
2900 C-H stretch 
 
4.1.5  Scanning electron microscopy  
 
Vide supra Section 3.1.3.1 
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4.2  Objectives 
 
 
 To investigate the use of organically modified silicates (ormosils) and silane 
coupling linkers to provide thin film coating of synthetic fibres and thence 
chemical affixation of MSNs. 
 To determine conditions that achieve optimal coverage of synthetic fibres 
with MSNs. 
 To analyse the release of EO from MSNs attached to synthetic fibres. 
 To profile synthetic textile coupons in order to identify any chemical / 
chemical environment changes occurring at each stage of treatment using 
FTIR. 
 
4.3  Materials 
 
4.3.1  Chemicals 
 
 
Tetraethoxysilane (TEOS) 99%, Methyltriethoxysilane (MTEOS) 90% and 3-
(Trimethoxysilyl)propyl methacrylate (-MPS) 98% were purchased from Sigma 
Aldrich (UK).  Hydrochloric acid (HCl) was used in the synthesis of organically 
modified silicates (Fisher-Scientific UK).  Purified water from a Millipore Elix® 5 
bench-top treatment unit was used throughout the study.  The water treatment 
system was maintained according to manufacturer guidelines.  
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4.3.2  Solvents 
 
MeOH, toluene and acetone were purchased from Fisher-Scientific (UK). 
Hexane was used for all GC-MS analyses of EO release from the treated textile 
coupons and was purchased from Sigma Aldrich (UK).   
 
4.3.3  Media, microbes and EOs  
 
Vide supra Section 2.3.1.1 – 3, all five test microorganisms were used, along 
with cinnamon and clove essential oils, in a 1:1 blend. 
 
4.4  Experimental 
 
4.4.1  Ormosil synthesis and textile stiffness 
 
The required amounts of precursors (TEOS and MTEOS), reactant volumes are 
summarised in (Table 4.2), and MeOH (25 mL) were mixed in a glass beaker 
(250 mL) using a magnetic stirrer.  Whilst stirring, distilled water (5 mL) was 
added drop-wise, and the solution was adjusted to pH 2 by drop-wise addition of 
0.1 M Hydrochloric acid (HCl).  Once the desired pH was achieved, the solution 
was left to stir for 1 hour at ambient temperature.  Finally, samples were 
decanted into 250 mL screw top glass bottles and placed in an oven at 70°C for 
18 hours.  Hydrolysis and condensation polymerisation forming the ormosil 
should occur over this time period.   
Three synthetic textile coupons (65% polyester 35% cotton, supplied by 
Alexandra) measuring 200 mm x 50 mm were immersed in each ormosil sol 
(42 mLs), containing different precursor ratios (presented in Table 4.2) and 
stirred continuously for 1 hour.  The coupons were removed, flattened and left to 
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dry on a plastic tray at ambient temperature before further treatment.  Once dry 
the fifteen coupons were tested for stiffness, relative to an untreated control.  
The method was based on the (BS 3356 Method for Determination of Bending 
Length and Flexural Rigidity of Fabrics, British Standards Institution, London, 
UK, 1990) (Perera et al  2013).  A synthetic textile coupon was placed on the 
laboratory bench, with one (50mm) edge at the end of the bench.  A ruler was 
placed over the sample and pushed forward until 10 cm of the sample was 
unsupported by the bench. The distance between the still horizontal ruler and the 
end of the sample was measured as the droop from horizontal.  The average 
values of the droop from horizontal were recorded.  
 
Table 4.2.  Summary of the reactant volumes (mL) for ormosil synthesis at 
various precursor ratios. 
MTEOS:TEOS MTEOS TEOS pH MeOH H 2O 
Control 
(untreated textile) 
0 0 0 0 0 
1:1 6 6 2 25 5 
2:1 8 4 2 25 5 
3:1 9 3 2 25 5 
1:2 4 8 2 25 5 
1:3 3 9 2 25 5 
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4.4.2  Affixation methods 
 
 
4.4.2.1  One pot synthesis 
 
 
Ormosil gel was prepared using the method described in (Section 4.4.1), with a 
3:1 MTEOS:TEOS precursor ratio.  Three synthetic textile coupons (65% 
polyester 35% cotton, supplied by Alexandra) measuring 20 mm x 20 mm were 
immersed in the ormosil sol (42 mLs) and stirred continuously for 1 hour.  The 
coupons were removed, flattened and left to dry on a plastic tray at ambient 
temperature before further treatment.   
The coupons were then immersed in a continuously stirred dispersion of blank 
MSNs (0.1 g) in MeOH (100 mL).  The silane coupling agent, -MPS, (2 mL) was 
then added to the dispersion.  The immersed coupons were left to stir for 1 hour, 
before removal and drying at ambient temperature.  The treated textile coupons 
were washed three times by immersion in methanol with stirring for five minutes, 
to ensure the MSNs were tightly bound to the fibres and then allowed to dry for 1 
hour before SEM analysis.  Samples were cut into circles of 10 mm diameter to 
fit the SEM sample stubs, and fixed to the latter using 12 mm diameter 
conductive carbon loaded double-sided adhesive tabs (Agar Scientific).  Finally, 
samples were gold sputtered in preparation for SEM analysis (as described in 
Section 3.1.3.1). 
. 
4.4.2.2  Silane grafted MSNs 
 
 
Instead of adding the reactants into one pot, this method was used to initially 
expose the MSNs to -MPS before the synthetic textile coupons.  Initially, ormosil 
gel was prepared using the method described in Section 4.4.1, with 3:1 
precursor ratio (MTEOS:TEOS).  Three synthetic textile coupons (65% polyester 
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35% cotton supplied by Alexandra) measuring 20 mm X 20 mm were 
immersed in the ormosil sol (42 mL) and stirred continuously for 1 hour.  The 
coupons were left to dry on a plastic tray at ambient temperature before further 
treatment. 
-MPS (2 g) was added in excess to a suspension of silica (1.9 g), in toluene (48 
g).  The mixture was stirred at room temperature for 30 minutes.  The mixture 
was then heated to 110°C for 24 hours, during which time the -MPS 
methoxysilane groups interact and bond with the free silanol groups on the 
MSNs surface, concluding the grafting of -MPS to the MSNs.  Finally, the -MPS 
grafted silica nanoparticles were washed three times by centrifugation with 
acetone and dried under vacuum (Pardal et al 2009).   
The ormosil treated coupons were then immersed in a continuously stirred 
dispersion of silane grafted MSNs (0.1 g) in of MeOH (100 mL).  The immersed 
coupons were left to stir for 1 hour, before removal and drying at ambient 
temperature.  The treated textile coupons were washed three times with 
methanol, to ensure the MSNs were tightly bound to the fibres and allowed to dry 
before SEM analysis.  Samples were cut into circles (10 mm diameter) and fixed 
to SEM sample stubs using 12 mm diameter conductive carbon loaded double-
sided adhesive tape (Agar Scientific).  Finally, samples were gold sputtered in 
preparation for SEM analysis (as described in Section 3.1.3.1). 
 
4.4.2.3  Layer by layer treatment 
 
 
Three synthetic textile coupons were treated sequentially with the ormosil gel, -
MPS and finally the MSNs, in MeOH.  This method attempted to isolate the 
individual stages of MSN affixation to the synthetic textile fibres and so create a 
layered structure.  Initially, ormosil gel was prepared using the method described 
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in (Section 4.4.1), with 3:1 precursor ratio (MTEOS:TEOS).  Three synthetic 
textile coupons (65% polyester 35% cotton supplied by Alexandra) measuring 
20 mm x 20 mm were immersed and stirred continuously for 1 hour.  The 
coupons were left to dry on a plastic tray at ambient temperature before further 
treatment.   
The Ormosil treated coupons were then immersed in a solution of -MPS (20 mL) 
and MeOH, while being stirred continuously for 1 hour.  The silane treated 
coupons were then immersed in a continuously stirred dispersion of blank MSNs 
(1 g) in MeOH (100 mL) for 1 hour.  Samples were then left to dry on a plastic 
tray at ambient temperature.  The treated textile coupons were washed three 
times with immersion in methanol to ensure the MSNs were tightly bound to the 
fibres and allowed to dry before SEM analysis.  Samples were cut into circles of 
1 cm diameter and fixed to SEM sample stubs as previously described.  Finally, 
samples were sputtered with gold in preparation for SEM analysis (see Section 
3.1.3.1).  A schematic representation of the anticipated structure produced by 
this method is shown in (Figure 4.3). 
 
Figure 4.3.  Schematic representation of the anticipated structure produced using 
the layer-by-layer method for chemically affixing MSNs to synthetic fibres. 
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4.4.2.4  Analysis of optimal MSN coverage of synthetic fibres  
 
 
Using the method described in (Section 4.4.2.3) to treat the textile coupons, nine 
textile samples were made to determine the effects of increasing concentration 
by weight of MSNs in suspension and increasing time of exposure on MSN 
coverage of the synthetic fibres.  Briefly, coupons were stirred in MeOH (100 mL) 
dispersions with 0.1, 0.5 or 1 g of MSNs for 10 minutes, 1 hour or 18 hours (as 
summarised in Table 4.3). 
 
 
 
Table 4.3.  Summary of the amount of MSN and time of exposure textile samples 
encountered to determine optimal coverage of synthetic fibres. 
Sample No. MSN by weight (g) 
Length of exposure 
(hours) 
1 0.1 0.17 
2 0.1 1.00 
3 0.1 18.00 
4 0.5 0.17 
5 0.5 1.00 
6 0.5 18.00 
7 1 0.17 
8 1 1.00 
9 1 18.00 
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4.4.3  EO release from loaded textiles 
 
 
EO loaded (CIN:CLO 1:1) MSN treated textile coupons (20 mm x 20 mm, 
supplied by Alexandra) and blank MSN control coupon were placed into 
separate 10 mL headspace vials (supplied by Sigma-Aldrich, UK with a 15 mm 
diameter screw-top and 8 mm diameter septum).  The MSNs were loaded via EO 
immersion as described in (Section 3.4.3).   
The vials were sealed and placed in an incubator at 25°C for 1 hour.  A 
headspace sample of 1 mL was taken, using a gas syringe, for GC-MS analysis.  
Further samples were taken after 12 and 24 hours at 25°C.  It should be noted 
the vials were left open between readings, in order to simulate the anticipated 
service environment for these antimicrobial textiles as closely as possible.  The 
vials were sealed with a screw top an hour before headspace gas samples were 
taken. 
The GC-MS system used is described previously in (Section 2.1.7).  The 
temperature programme used for this method was as follows; the initial oven 
temperature of 60°C was ramped to 280°C at a rate of 10°C per minute.  The 
temperature was held at 280°C for 15 minutes, with injector port temperature of 
275°C and detector port temperature 250°C. 
 
4.4.4  Attenuated total reflectance (ATR) FTIR analysis of affixation layers 
 
 
Synthetic textile coupons at each stage of the layer-by-layer affixation process 
(Table 4.4) were analysed using ATR FTIR.  The samples were clamped using 
a pressure tower with specification 10,000 psi and analysed between 4000 and 
500 cm-1 wavenumbers.  The Nicolet 380 was fitted with a Smart iTR ATR unit 
(Thermo), which is a single bounce unit, with a diamond window (ZnSe lens) and 
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DTGS detector.  The resulting spectra were made up of 16 scans, no replicates, 
with resolution set to 4 cm-1.  
Table 4.4.  Displaying the five synthetic textile samples and their respective 
layer-by-layer treatment, for ATR FTIR analysis. 
Sample Stage of layer-by-layer treatment 
1 Untreated 
2 Ormosil 
3 -MPS 
4 Blank MSNs 
5 EO loaded MSNs 
 
4.4.5  SEM 
 
 
Vide Supra Section 3.4.2.2 
The synthetic textile samples were examined at different magnifications and 
areas to ensure coverage of the different treatments was consistent across the 
samples. 
4.5  Results and discussions 
 
 
4.5.1  Ormosil treated textile stiffness  
 
A standard synthetic textile of 65% polyester and 35% cotton (Figure 4.4) was 
chosen for use (supplied by Alexandra).  Ormosil was used to provide thin film 
coating of fibres onto the textile, thence allowing the silane-coupling agent (-
MPS) to chemically bond MSNs to the synthetic textile.  To achieve an ormosil 
gel that would form a thin film around the synthetic fibres it was necessary to 
experiment with a range of different ratios of MTEOS:TEOS precursor.   
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Figure 4.4.  SEM images of untreated synthetic textile (65% polyester, 35% 
cotton). 
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A range of ormosil gels were synthesised using different ratios of MTEOS:TEOS 
precursor and to test the stiffness or ‘droop’ of the resultant treated textiles 
against an untreated control, results presented in (Table 4.5).  The samples (200 
mm x 50 mm) were cut from the treated textile sheets for purpose of this test, as 
described in (Section 4.4.1).  
 
Table 4.5.  Results of stiffness testing of synthetic textile coupons treated with 
ormosil gels ranging in MTEOS:TEOS concentration.  Droop results an average 
of three repeats (n=3).  
 
MTEOS:TEOS pH MeOH (mL) Water (mL) Droop from 
horizontal 
(mm) 
Gelation 
time 
(hours) 
Control 
(untreated 
textile) 
na na na 45 18 
1:1 2 25 5 20 18 
2:1 2 25 5 28.67 18 
3:1 2 25 5 38.93 18 
1:2 2 25 5 27.93 18 
1:3 2 25 5 20.5 18 
 
 
The increase in the relative amount of MTEOS used in the synthesis of ormosil 
gels leads to a decrease in skeletal (crosslink) density (Estella et al 2006).  The 
entry of methyl groups into the network leads to xerogels that are less dense, but 
more compact as the methyl groups are not hydrolysable.  The reduction of the 
cross-linking leads to less rigid structures, which can bend without cracking, as 
shown in (Figure 4.5 – 4.7).  Xerogels formed from a higher relative level of 
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MTEOS should have reduced porosity.  Therefore, providing a more 
homogenous surface for coverage by MSNs (Rios 2011). 
The 3:1 formulation was used for further experiments, as this gel provided a thin 
film coating round the synthetic textile fibres, without sticking or clumping the 
fibres together (Figure 4.8).  In addition, this formulation produced the least 
stiffening of the treated coupons, relative to the untreated control, presented in 
(Figure 4.4). 
 
Figure 4.5.  SEM images of ormosil treated synthetic textile samples at differing 
precursor ratios MTEOS:TEOS A) 1:1. 
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Figure 4.6.  SEM images of ormosil treated synthetic textile samples at differing 
precursor ratios MTEOS:TEOS, B) 2:1 C) 3:1. 
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Figure 4.7.  SEM images of ormosil treated synthetic textile samples at differing 
precursor ratios MTEOS:TEOS, D) 1:2  E) 1:3. 
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Figure 4.8.  Ormosil treated sample 3:1 MTEOS:TEOS 1 hour stir, air dried. 
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In HCl-catalysed reactions, hydrolysis occurs at a faster rate than condensation 
(Meixner and Dyer 1999), and alkyl-substituted trialkoxysilanes hydrolyse faster 
than the corresponding tetraalkoxysilanes (Himmel et al 1990).  In particular, 
MTEOS hydrolyses faster than the TEOS monomer during each sequential 
hydrolysis reaction (Jitianu et al 2003).  The replacement of of an alkoxy species 
by a non-hydrolysable species leads to higher hydrolysis rates because the 
inductive effect of these radicals reduces the positive charge on the silicon atom 
and increases the negative charge on the oxygen atoms (Devreux et al 1990).  
Due to the rapid hydrolysis rate, the formation of siloxane bonds via silanol-
alkoxy and silanol–silanol condensation is the rate-determining step, which in 
acidic media increases exponentially with time.  The presence of methyl groups 
decreases the condensation rate as they reduce the net charge on the silicon 
atom, which is the key parameter for the nucleophilic condensation process 
above the isoelectric point of pH 2 (Iler 1979).  As MTEOS concentration 
increases, condensation kinetics slow down because the dimerisation rate of 
hydrolysed species from MTEOS is slower than that of species from TEOS (Fyfe 
and Aroca 1997), which confers well with the SEM analysis of ormosil treated 
synthetic coupons with differing MTEOS:TEOS ratios. 
 
4.5.2  Affixation methods 
 
 
The following experiments (4.5.2.1 – 4.5.2.4) were conducted using blank MSNs 
as SEM was used to analyse the treated textile coupons.  The addition of EO 
was not carried out as it will evaporate in the high vacuum within the SEM 
chamber and potentially damage the instrument. 
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4.5.2.1  One pot synthesis 
 
As described in (Section 4.4.2.1) ormosil treated textile coupons were immersed 
in a sol containing -MPS and MSNs dispersed in MeOH.  The samples were 
analysed using SEM (Figure 4.9).  The SEM analysis shows 
agglomeration/aggregation of the MSNs, on the surface of the synthetic fibres.  
From this result, it is clear -MPS will bond to both the Ormosil coating on the 
fibres and the MSNs.  However, there is no control over the distribution of MSNs 
on the surface of the fibres.  The occlusion of the nanoparticle mesopores 
caused by the aggregation is likely to hinder the release of the EO blend.  As 
such, it was thought the grafting of -MPS onto MSNs prior to exposure to 
ormosil coated coupons would produce a more uniform coverage of MSNs on 
the fibres. 
 
 
Figure 4.9.  SEM image of one pot synthesis on synthetic textile. 
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4.5.2.2  Silane grafted MSNs 
 
Figure 4.10.  Grafting of silane coupling linkers onto MSNs based on (Pardal et 
al 2009, Bartholome et al 2003).  Image reproduced from Pardal et al 2009. 
 
Figure 4.10 shows the chemical formula of a -MPS molecule that contains a 
carbon-carbon double bond and methoxylsilane groups (SiOCH3).  The former 
group is suitable for free radical polymerisation and the latter group can form a 
three-dimensional silica network through hydrolysis and condensation reactions.  
In an attempt to improve the coverage of MSNs on the surface of the synthetic 
fibres, -MPS was grafted to the MSNs, as described in (Section 4.4.2.2). 
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Figure 4.11.  TMSPMA grafted MSNs attached to ormosil coating on synthetic 
textile fibres. 
 
The SEM results (Figure 4.11) suggest the MSN/-MPS grafted composites are 
composed of polymer that threads through the mesoporous silica particles and 
among the MSNs on the ormosil coated synthetic fibre surface.  It can be said 
the MSNs serve as pseudo-cross-linking points within the MSN/-MPS 
composite.  Hydrolysis and condensation of MSNs and -MPS in a solvent result 
in sols containing organically modified silicate species (Pardal et al 2009).  
Polymerisation of monomer surrounding and adsorbed within particles results in 
inhomogeneous, chemically bonded hybrid inorganic-organic composites.  Since 
the polymerisation may occur within both the pore channels and among the 
particles, as-synthesised composites may contain dispersed particles with 
polymer chains threaded within their pore channels. 
Figure 4.11 also shows aggregation of the silane grafted MSNs, leading to fewer 
open mesopores for release of the EOs, possibly harming the antimicrobial 
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efficacy of the textile.  It was speculated that treating the ormosil dried textile 
samples alone with -MPS first and then with MSNs dispersed in MeOH using a 
layering approach would provide a more uniform affixation of the MSNs to the 
ormosil coating via the silane coupling linker. 
 
4.5.2.3  Layer-by-layer 
 
The SEM analysis for the synthetic textile coupons treated via the layer-by-layer 
method (Section 4.4.2.3) produced good attachment of the MSNs to the fibres, 
(samples were washed three times in MeOH before analysis).  The MSNs 
appear to be dispersed relatively uniformly on the surface of the fibres with 
minimal aggregation.  The decision to initially isolate the coupling-linker from the 
MSNs and instead treat the ormosil coated textile coupons with -MPS appears 
to provide a favourable route to the chemical affixation of the MSNs to the fibres, 
as represented in (Figure 4.12). 
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Figure 4.12.  SEM image showing MSNs affixed to synthetic textile fibres after 
layer-by-layer treatment. 
 
4.5.2.4  Optimal MSN coverage of synthetic fibres analysis 
 
 
SEM images, shown in (Figure 4.13) indicate the coverage of MSNs increases 
with increasing MSN concentration, and time exposure with stirring in MeOH, the 
method described in (Section 4.4.2.4).  The coverage is clearly time and 
concentration dependant, with the best results occurring with dispersion of MSN 
(1g) in MeOH (100 mL) after 18 hours of stirring.  With the ormosil coating 
formulation resolved and the layer-by-layer affixation process selected (Section 
4.4.2.3); the next stage of the work was to affix EO loaded MSNs to the synthetic 
fibres.  Following the latter, the release of the antimicrobial EO blend from the 
nanoparticle mesopores will be investigated. 
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Figure 4.13.  SEM images of MSN coverage on individual synthetic fibres, representative of coverage on textile coupons treated with three 
different concentrations of blank MSNs (0.1, 0.5 and 1g).  With three different lengths of exposure (0.167, 1 and 18 hours). 
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4.5.3  EO release from loaded textile 
 
 
Figure 4. 14.  Extracts from GCMS spectra showing EO release at three different 
time points from EO loaded MSNs affixed to synthetic fibres.  (a) Eugenol, (b) 
eugenyl acetate.  Gas samples were taken at 1 hour (i), 12 hours (ii), and 24 
hours (iii).  Y axis scales (i) and (ii) (Counts (AU x 104)), (iii) (Counts (AU x 103)). 
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The main function of using mesopores to adsorb the essential oil was to prolong 
the antimicrobial efficacy of the textile, by slowing the release of the EO 
molecules.  In (Section 3.5.3.3) the EO loaded MSNs were studied for EO 
release from the mesopores, charting leaching of the EO molecules into an 
organic solvent.  It was decided this was not desirable for the loaded textile 
coupons as it would not mimic real world conditions for the end product.  A 
gaseous environment would be best suited to analyse the release of volatile EO 
molecules from the mesopores.  However, traditional headspace sampling 
involves heating of the sample to quantify the molecules in a sample.  Again, the 
real world conditions for the end product would most likely be room temperature.  
As such, samples were placed in an incubator set at 25°C to mimic a constant 
room temperature, with the glass vials being closed an hour before each reading 
to give an indication of the release of EO molecules from the mesopores over a 
24 hour period, described in (Section 4.4.3).  Again, 24 hours was chosen as the 
longest sampling time as any medical textile would likely be washed or discarded 
after a day of use. 
Figure 4.14 shows a peak for eugenol, 70000 counts high, recorded after 1 hour, 
with a much reduced count at 12 hours and baseline levels after 24 hours.  
Interestingly, a greater peak for eugenyl acetate (4.75% in the CIN-CLO blend) 
was recorded at 12 and 24 hours compared to the most abundant molecule in 
the CIN-CLO blend (eugenol >94%).  Considering the decline in the amount of 
eugenol evolved over the sampling period, it is possible that after an hour, the 
dual-point attached, multi-point attached or molecules attached in the pore 
entrance could have diffused, while those EO molecules deep in the pores or 
multi-point attached would not evolve from the sample.   
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4.5.4  ATR FTIR analysis of affixation layers 
 
The ATR FTIR spectra obtained, using the method described in (Section 4.4.4) 
for different stages of the layer-by-layer method followed the same basic pattern 
for all five samples, with some shifting and broadening of peaks.  The following 
figures (4.15 – 4.18) show spectra for each stage of the chosen affixation 
method with the subsequent stage, for comparison. 
 
 
Figure 4.15.  FTIR spectra for textile coupon samples at the first stage of 
treatment.  Untreated (blue) and ormosil treated (red), 
 
The FTIR spectra for the ormosil treated textile coupon (Figure 4.15, red line), 
displays some peak intensity differences from the untreated coupon around 
1100-900 cm-1.  These more intense peaks recorded for the ormosil treated layer 
could be attributed to the asymmetric stretching vibration of the Si-O-Si bond, 
which constitutes the skeletal SiO2 network of the xerogel (Estella 2007).   
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Figure 4.16.  FTIR spectra for textile coupon samples at each stage of treatment.  
Ormosil treated (blue) and silane treated (red). 
 
The FTIR spectra for the ormosil treated coupon and the -MPS -MPS treated 
coupon follow roughly the same pattern of absorbance (Figure 4.16), with some 
differences in peak intensity at 1716 cm-1.  This could be attributed to -MPS -
MPS C=O carbonyl groups and also, changes around 2900 cm-1 corresponding 
to aliphatic carbons of -MPS -MPS moieties (Pardal 2009).   
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Figure 4.17.  FTIR spectra for textile coupon samples at each stage of treatment. 
TMSPMA treated (blue) and blank MSN treated (red). 
 
The spectra for TMSPMA and blank MSN treated textile coupons (Figure 4.17) 
do not display a great deal of variation, layer to layer.  A very slight increase in 
intensity at 1243 cm-1 can be seen for the coupons treated with blank MSNs, the 
relative decrease for -MPS -MPS can be attributed to the C(=O)-O-C stretch of 
the ester of the gamma MPS linker.  The spectra comparing blank MSN and EO 
loaded MSN treated textile coupons (Figure 4.18) in theory would provide 
differences due to the addition of peaks characteristic of EO, in this case a blend 
of clove and cinnamon oil (>94% eugenol).  The C–H stretch vibrations in the 
3000 cm-1 – 2800 cm-1 range (CH2 2875 cm
-1 and CH3 2995-2936) could be 
attributed to the presence of EO in the MSN pores.  In addition, the peak at 1600 
cm-1 for the EO loaded MSNs, is indicative of C-C stretching in phenyl ring 
containing structures, such as eugenol.  Furthermore, the differences in spectra 
at 1243 cm-1 can be assigned to the Ar-O-C stretch of the eugenol ether. 
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Figure 4.18.  FTIR spectra for textile coupon samples at each stage of treatment.  
Blank MSN treated (blue) and EO loaded MSNs (red). 
 
It was speculated that the individual layers were too thin to provide better defined 
spectra.  ATR FTIR is noted for sample penetration between 0.5 – 2 µm, 
although this is dependant on the wavelength of light, the angle of incidence and 
the indices of refraction for the ATR crystal and the medium being probed 
(Queiroz et al 2012).  
 
 
 
 
 
 
 
 
 167 
4.6  Conclusions 
 
 
 A 3:1 formulation of ormosil precursors (MTEOS:TEOS) at pH 2 was chosen 
to provide a flexible yet robust thin film coverage of the synthetic fibres, 
allowing bending of the textile and a large surface area for MSNs to attach on 
to. 
 -MPS coupling linker allowed the MSNs to adhere and bond to the ormosil 
coating on the synthetic fibres. 
 Although the reflux method for chemically affixing MSNs to -MPS in toluene 
was successful, the simpler, less time intensive and therefore more cost 
effective layer-by-layer method produced good MSN coverage on the 
synthetic fibres. 
 MSN coverage on the synthetic fibres increased with increased MSN 
concentration and with increasing duration of exposure. 
 Headspace gas samples from sealed bottles containing untreated, and EO 
loaded MSN treated textile coupons were analysed using GC-MS. EO was 
able to diffuse from the MSN pores after being affixed to the synthetic fibres. 
 FTIR spectra characterising the different layers of the layer-by-layer affixation 
method were produced, displaying the changes in chemical environment 
between sequential treatments on the synthetic textile coupons.  
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Chapter 5 
 
Challenge testing and wash durability of antimicrobial textile 
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5.1  Introduction 
 
 
5.1.1  Textiles and the skin 
 
 
Aside from clothing, textiles are used in household, medical and hygiene, 
agricultural, automotive, aeronautics and marine applications (Horrocks and 
Anand 2004).  Development areas of the textile industry constantly focus on 
integrating improved physical features, such as insulation properties, elasticity, 
stiffening, or novel features, such as static, crease, water resistance, fire 
retardant, and antimicrobial properties into or onto textiles (Schindler and Hauser 
2004).  These are achieved by means of chemical or mechanical finishes given 
to fabrics.  A trend in the fabrication of hygiene textiles has evolved with 
consumers seeking low maintenance textile products, which increases the 
market potential for durable antimicrobial finishes (Perera 2013).  Antimicrobial 
finishes on fabrics are developed to protect the consumer, patient or carer 
against infection, disease or odour causing microorganisms.  The growth of 
microorganisms not only cause hygiene (cross-infection) issues, but also affects 
the functional and aesthetic properties of the material by producing rot, mold or 
mildew (Gao and Cranston 2008).  There is a significant need for antimicrobial 
finishes to meet the market demands in preventing unpleasant odours on 
intimate apparel, socks and sportswear.  Most importantly, health care settings, 
schools, hotels or any other crowded public area where protection from diseases 
should be addressed (Windler et al 2013).  Fabrics support temperature and 
humidity balance for the human body’s comfort. The human skin and fabrics are 
in direct contact for prolonged periods.  The human skin is a complex 
bionetwork, sheltering microorganisms such as bacteria, viruses and fungi that 
live in different habitats on the skin.  The amount of bacteria present on the skin 
out-numbers the number of human skin cells by a factor of ten. (Elsner 2006).  
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While evidence exists that the use of antimicrobial substances may change the 
ecology of resident bacteria in the gut, leading to overgrowth of pathogenic 
bacteria, such as E.coli, there is no such data for the ecology of the skin 
(Sullivan et al 2001).  Because of the direct contact of fabrics with human skin, 
most bacteria can transfer and propagate between the two.  Further, bacteria 
can reside on fabrics causing fabric discoloration, skin diseases and unpleasant 
odours, providing necessity for antimicrobial finishes on clothing that is also 
appropriate for intimate contact with the skin for daily use.  Indeed, it has been 
reported 60% of physician and nurse clothing carried disease-causing bacteria, 
including methicillin-resistant S. aureus, at a hospital in Israel (Wiener-Well et al 
2011).  Natural fibres such as cotton can act as a host to many microorganisms 
because of its hydrophilic nature, which means it easily picks up body sweat and 
water-borne stains.  Synthetic fibres, such as polyester, can propagate microbes 
on the skin due to their hydrophobic nature as they block evaporation of sweat, 
making a wet environment on the skin, conducive to microbial growth (Elsner et 
al 2003).  Therefore, there is great need for effective antimicrobial textiles that 
are skin friendly. 
 
5.1.2  Challenges faced by the use of natural agents on textiles  
 
There are several common limitations expressed in the literature regarding the 
use of natural antimicrobial agents on textiles.  The plant products are in their 
natural chemical structure, and not all the chemical components possess 
antibacterial activity.  Therefore, the selective isolation of the active constituents 
is a possible solution to reducing the effective dose of the antimicrobial.  The 
exact mechanism of bactericidal action of the different essential oils is still to be 
elucidated (Hyldgaard et al 2012).  The dissolution of the agents for textile 
application is also a major challenge as essential oils are not soluble in water.  
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This challenge is addressed by the use of MSNs in the present work.  It is of vital 
importance that there is no loss of antimicrobial activity due to blocking of 
functional groups, during the textile attachment or finishing process, leading to 
diminished antimicrobial activity.  Although synthetic antimicrobial agents are 
very effective against a range of microbes and provide a relatively long-lasting 
effect on textiles, they also exhibit a range of unwanted side effects, such as 
action on non-target microorganisms and water pollution (Joshi et al 2008).  
Hence, the need for antimicrobial textiles that utilise natural agents, such as 
essential oils to combat the negative/potentially harmful effects associated with 
microbial growth on or contamination of textiles (Joshi et al 2008).   
 
5.1.3  Antimicrobial textile finishes  
 
The antimicrobial activity of EOs has potential to be utilised to help reduce the 
bioburden of pathogenic microbes in healthcare environments.  This may be 
achieved via application of EOs to textiles and surfaces that are frequently 
touched.  Technical textiles, describe the growing variety of products and 
manufacturing techniques being developed primarily for their technical properties 
and performance rather than their appearance or other aesthetic characteristics 
(Milwich et al 2006).  The rapid growth in technical textiles and their end uses 
has generated many opportunities for the application of innovative finishes.  
Antimicrobial textiles with improved functionality are useful in a wide range of 
applications, from infection control in a medical setting, to odour control for 
outdoor apparel (Nelson, 2001).  A number of antimicrobial treatments are now 
available that can kill bacteria and enable garments to remain smelling fresh for 
longer (Holme 2007).  Although there are many natural products rich in 
antimicrobial agents, including essential oils, research into their use in textiles is 
relatively limited and not extensively documented.  Most of the published 
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research in this area tends to focus on synthetic antimicrobials, for example, 
textiles treated with triclosan (Orhan et al 2006).   
 
Silver has also been used in antimicrobial products, either in the form of fibres / 
yarns, or as nanoparticles (Dubas et al 2006).  Silver impregnated textiles are 
used as wound dressings for infected wounds or wounds at high risk of infection.  
Padycare™ is a product that contains silver particles, incorporated into the fibre 
during formation.   
 
Quaternary ammonium salts have a positively charged nitrogen ion that can 
interact with the negatively charged groups of anionic dyes.  These 
intermolecular interactions inside fibres serve as binding forces to enhance the 
durability of the biocidal agents once attached.  Dye molecules can be used as 
bridges to bind functional antimicrobial groups to chemically stable synthetic 
polymers.  Quantitative antimicrobial evaluation of these treated fabrics reveal 
significant reductions in bacterial load on surface contact (Kim & Sun, 2000).  
Amicor™ is an example of a polyacrylic fibre that has an organic biocide blended 
into the polymer before melt spinning of the fibres (Mahltig et al 2004).   
 
Due to the volatile nature of EOs, it would be ineffective to simply apply them 
directly to fabrics as they would quickly evaporate, rendering the fabric 
unprotected.  Encapsulation of the EO in organic, inorganic or organic-inorganic 
hybrid media, may lead to sustained release of the EO, and hence prolong the 
duration of antimicrobial activity.  Research into the encapsulation of EOs 
predominantly focuses on using organic media.  Maji et al. (2007) used gelatine 
to encapsulate Zanthoxylum limonella oil, the gelatine surrounded the oil in 
coacervates that were then cross-linked using gluteraldehyde.  They were able 
to achieve a maximum encapsulation efficiency of 98% by varying the 
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proportions of the three components.  This was calculated by dividing the actual 
amount of oil encapsulated in a known amount of microcapsules by the amount 
of oil introduced in the same amount of microcapsules.  The release rate of 60% 
of the oil over 70 hours was determined by cumulative oil release from the 
microcapsules, analysed spectrophotometrically.  The best release rate obtained 
was 90% oil release over 70 hours, with an encapsulation efficiency of 78% (Maji 
et al 2007). 
 
Zein nanospheres, fabricated from a hydrophobic protein found in corn have 
been used to encapsulate oregano, red thyme, and cassia oils.  This was 
achieved by adding the oil and zein to 85% ethanol and dispersing with high 
speed mixing into water containing 0.01% silicone fluid.  The solution containing 
the encapsulated oil particles was lyophilised to obtain a dry powder.  Release 
rates in phosphate buffered saline (PBS), and PBS with 24% ethanol, ranged 
from 60-80% over 50 hours depending on the EO (Pariss et al 2005). 
 
When compared to organic polymer coatings and encapsulation media, the 
advantages of inorganic sol–gel coatings and encapsulation media are 
substantial.  The advantages of the latter include good mechanical, chemical and 
thermal stability, high transparency and photo-stability, biological inertness 
controllable porosity and hence controllable release of encapsulated agents 
(Mahltig et al 2010).  Interestingly, it is also possible to encapsulate / intercalate 
liquids, oils (or more viscous compounds) to loadings of up to 30 % wt., in sol–
gel matrices and layered structures, by simple admixture with silica nanosols.  
After gelling and drying, they form dry, non-sticky composite materials.  The 
release of encapsulated liquids from the silica film can be controlled by 
regulating the mass ratio of silica to agent, by chemically modifying the silica 
matrix, by adding soluble or swellable pore-forming substances and by 
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controlling the preparation conditions.  The use of encapsulated products offers 
greater convenience and the controlled release of the encapsulated organic 
substances.  For example, insect resistant treatments and flame retardant 
finishes demonstrate higher levels of performance if encapsulated.  Ideally, the 
boiling points of the liquids to be encapsulated should be higher than 150°C and 
they must differ sufficiently to the boiling point of the sol solvent.  When 
incorporating hydrophobic oils, the sol should have low water content.  The 
inclusion of biocidal compounds into modified silica matrices using the sol-gel 
technique offers new interesting prospects for antimicrobial coatings with 
controlled release effects.  Studies using sol-gel coatings encapsulating bioactive 
liquids, such as essential oils, have encountered problems with wash fastness 
and oxidation stability of the coated textiles whilst in storage (Haufe et al 2008). 
In order to increase the robustness of antimicrobial action to textile washing 
processes, a number of approaches can be utilised, dependent on the chemical 
nature and mode of action of the antimicrobial agent.  Fibre treatment with 
resins, condensates or fibre crosslinking agents have been studied, along with 
microencapsulation of the antimicrobial agent and durable binding of the 
microcapsules to the fibre (Gao and Cranston 2008).  For the present work, EOs 
(cinnamon and clove oil blend) were loaded into MSNs for slower release of the 
antimicrobial over time. 
5.1.4  Methods commonly used to test antimicrobial textile finishes 
 
The American Association of Textile Chemists and Colorists (AATCC) 
antimicrobial test standards are used globally for demonstrating a product's 
performance against common microbial challenges.  The antibacterial activity 
assessment of textile materials: Parallel Streak Method (AATCC 147) is a quick 
and relatively inexpensive method for determining if a textile sample displays 
antimicrobial activity.  Textile samples are laid onto agar plates that have been 
 175 
inoculated with test microorganisms, in parallel streaks across the width of the 
agar plate.  A weakness of this method is its non-quantitative nature, making 
results difficult to compare to other antimicrobial finishes.  However, it is an 
introductory method, designed to quickly establish if a textile sample has 
antimicrobial capability.  Changing the method to incorporate spreading of the 
microbial inoculum across the surface of the agar plate allows for a zone of 
inhibition (ZOI) to be determined.  This allows quantitative data to be recorded, 
and allows comparisons to be made between antimicrobial textile finishes.  A 
clear weakness for both agar diffusion methods is that they cannot differentiate 
growth inhibition of the test microorganism from killing. 
American Society for Testing and Materials (ASTM) E2149 and AATCC 100 
methods allow quantitative testing of a samples capacity to kill test 
microorganism inoculum.  Textile samples are saturated or immersed in dilute 
test inoculum, with bacterial enumerations recorded at the start of the experiment 
and usually after a 24 hour contact period.  AATCC 100 is well designed in terms 
of including neutralisation of the antimicrobial agent controls, however, for both 
methods there are no clear standards for pass or fail. 
AATCC 61 and AATCC 135 are used to condition samples prior to determine 
antimicrobial efficacy.  Commonly used with AATCC 100 efficacy testing to show 
antimicrobial durability after specified rounds of washing cycles. 
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5.2  Objectives 
 
 
 To screen the EO loaded synthetic textile coupons for bacteriostatic action 
using AATCC 147 parallel streak and zone of inhibition method. 
 To determine the dynamic contact killing potential of the EO loaded synthetic 
textile coupons during a 24 hour exposure, using AATCC 100 and ASTM E 
2149 methods as guides. 
 To investigate the wash durability of the antimicrobial finish on the synthetic 
textile coupons using a method based on AATCC 61 and 135. 
5.3  Materials  
 
 
5.3.1  Synthetic textile coupons 
 
White synthetic textile cut into 25 mm x 25 mm coupons (65% polyester, 35% 
cotton, supplied by Alexandra) were used for experiments. 
5.3.2  Culture media 
 
Vide supra Section 2.3.1.1, in addition, phosphate buffered solution (PBS). 
5.3.3  Microorganisms 
 
All five test microorganisms were used. 
Vide supra Section 2.3.1.2 
5.3.4  Essential oils 
 
Cinnamon and clove oil were used in a 1:1 blend (>94% eugenol and 4.75% 
eugenyl acetate content).  
Vide supra Section 2.3.1.3 
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5.4  Experimental  
 
 
Two antimicrobial testing methods are widely used; the first is based on 
measurement / examination of zones of inhibition on agar plates, and consists of 
the immersion of treated material in an agar culture media inoculated with 
microorganisms.  The second method is based on quantification of bacterial 
populations and the effect the antimicrobial has on the latter.  This is achieved 
via determination of bacteriostatic activity of the treated material that has been 
autoclaved and subsequently inoculated with a known quantity of 
microorganisms under investigation.  The AATCC offers a variety of test 
methods that are useful for evaluation of antimicrobial finishes on textiles 
(Coman 2010). 
 
5.4.1  Antibacterial activity assessment of textile materials: Parallel streak 
method (AATCC 147) 
 
 
Cultures of the test microorganisms were incubated overnight at 37°C in ISB, 
and then adjusted to 0.1 OD wavelength, via dilution with ISB.  An inoculation 
loop was fully loaded with the microbial culture; five, 1 cm spaced parallel 
streaks were then drawn across the surface of the agar in the petri dish.  For 
each microorganism, textile coupons were tested in duplicate (n=2).  25 mm x 25 
mm coupons were cut from the samples of synthetic textile.  The samples 
assessed were as follows: untreated controls, 2% (v/v) EO (cinnamon and clove 
1:1) loaded MSN layer-by-layer treated coupons (see Section 4.4.2.3), and 
untreated coupons that were immersed in 2% (v/v) EO blend (Clove and 
cinnamon 1:1) for 3 minutes and dried at 60°C for 30 minutes.  The test coupons 
were gently pressed into the centre of the petri dish, across the five streaks of 
microbial culture, in order to ensure intimate contact between the textile coupon 
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and the inoculated agar surface.  The test coupons were then incubated for 24 
hours at 37°C before analysis.  The test enables rapid assessment of whether 
(or not) a textile finish possesses bacteriostatic activity.  A simple qualitative 
rating system was used to record results.  The following numeric ratings were 
given for antimicrobial activity according to effect of the samples on the parallel 
streaks and the contact area of the sample with the agar:   
(1) Represents samples that were able to stop growth beyond the area of 
contact with the agar 
(2) Denotes no growth on textile samples contact area with the agar, 
(3) Denotes limited growth on the fabric sample contact area with the agar 
(4) Indicates that the fabric sample contact area with the agar is over-grown 
(≥50% coverage). 
 
5.4.2  Zone of inhibition  
 
 
A more advanced agar diffusion method was performed in order to provide a 
quantitative assessment of the bacteriostatic activity of the treated textiles.  The 
test microorganisms were prepared as in (Section 5.4.1), after which, the 
selected culture (20 µL) was pipetted onto the ISA surface and evenly spread 
over it.  25 mm x 25 mm coupons were cut from the synthetic textile samples.  
Samples included, untreated controls, 2% (v/v) EO loaded MSN (applied using 
the layer-by-layer method (Section 4.4.2.3)) treated coupons and previously 
untreated coupons that were immersed in 2% (v/v) EO blend (Clove and 
cinnamon 1:1) for 3 minutes and dried at 60°C for 30 minutes.  The latter 
coupons were gently pressed into the centre of their respective petri dish, 
ensuring intimate contact between the coupon and the microorganism inoculated 
agar surface.  Coupons were assessed in triplicate (n=3).  The plates were then 
incubated at 37°C for 24 hours.   
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5.4.3  Dynamic killing assay  
 
 
This antimicrobial test method (AATCC 100 / ASTM E2149) provides a 
quantitative evaluation of the antimicrobial activity of the test coupons.  It 
determines both bacteriostatic (inhibition of multiplication) and bactericidal 
activity (killing of bacteria) of the EO loaded synthetic textile test coupons.   
Test microorganisms were prepared in stationary growth phase, as described in 
(Section 5.4.1), and also in exponential growth phase, as described previously in 
(Section 2.3.2.2).  25 mm x 25mm coupons were cut from the synthetic textile 
samples.  As before the samples included; an untreated control, layer-by-layer 
2% (v/v) EO loaded MSN treated coupons and untreated coupons that were 
immersed in 2% (v/v) EO blend (Clove and cinnamon 1:1) for 3 minutes and 
dried at 60°C for 30 minutes.  Each test coupon was shaken at 230 rpm for 24 
hours at 37°C, in ISB based microorganism culture (10 mL) which had been 
adjusted to 0.1 OD, or an PBS microorganism culture (also 10 mL) which had 
been adjusted to the same initial OD (i.e. CFU/mL).  The antimicrobial activity of 
the test samples was expressed as the percentage reduction of the 
microorganisms in the test broth.  The percentage reduction was calculated 
using (Equation 5.1). 
Equation 5.1.  Calculation to determine the percentage reduction in bacterial 
viability, after 24 hours exposure to antimicrobial textile. 
 
𝑅 =  
(𝐴 – 𝐵)
𝐴
 
Where A is the number of microorganisms in the broth inoculated with treated 
test coupons immediately after inoculation (zero contact time).   
B is the number of microorganisms in the broth inoculated with treated test 
coupons after the contact period of 24 hours.   
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R is the percentage reduction.   
These calculations were carried out for the test microorganisms in both 
stationary and exponential phases of growth.  At time 0 and at 24 hours, a 1 mL 
aliquot was serially diluted in PBS and CFU/mL determined for each test 
microorganism.  The experiment was performed once, with triplicate bacterial 
enumerations for CFU/mL reductions. 
5.4.4  Wash durability  
 
 
The durability of the treated textile finish was tested after 1, 2, 5 and 10 washes, 
based on AATCC 61 and 135, as a guide.  Samples were placed in a 250 mL 
beaker on a hotplate set to 30°C, with stirring set to level 4.  A neutral soap (Bio-
D non-biological perfume free washing powder) was added (0.1 g) to the beaker 
containing the test coupons, with the hotplate set at 30°C for 30 minutes, 
followed by rinsing in deionised water and drying in a fume cupboard at ambient 
temperature (air flow of 0.53 m3 s-1) for 30 minutes, with the test coupons spread 
flat on absorbent tissue.  Samples were tested for antimicrobial activity after 
specified number of washing cycles (1,2,5 and 10) using the method described in 
(Section 5.4.3).  The experiment was performed once, with triplicate bacterial 
enumerations for CFU/mL reductions. 
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5.5  Results and Discussion 
 
 
5.5.1  Antibacterial activity assessment of textile materials: Parallel streak 
method (AATCC 147)  
 
The antimicrobial activity of the finished synthetic textile samples were assessed 
qualitatively by parallel streak and agar diffusion methods.  The Parallel streak 
method is designed to rapidly screen whether (or not) a coated / finished textile 
shows any bacteriostatic activity.  A numeric grading system was used as 
described in (Section 5.4.1) and the footnote to (Table 5.1) where the data is 
presented. 
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Table 5.1.  Summary table of test coupon outcomes for the parallel streak 
method  
Fabric 
Treatment 
Microorganism Rating 
  Run 1 Run 2 
Untreated 
coupons 
(Control) 
S.aureus 3 3 
MRSA 3 3 
E.coli 3 3 
P.aeruginosa 4 4 
C.albicans 3 3 
EO MSN 
treated 
textile 
coupons 
S.aureus 1 1 
MRSA 1 1 
E.coli 1 1 
P.aeruginosa 2 2 
C.albicans 1 2 
EO 
immersed 
textile 
coupons 
S.aureus 1 1 
MRSA 1 1 
E.coli 1 1 
P.aeruginosa 2 2 
C.albicans 1 1 
 
(1) Represents samples that were able to stop growth beyond the area of 
contact with the agar 
(2) Denotes no growth on textile samples contact area with the agar, 
(3) Denotes limited growth on the fabric sample contact area with the agar 
(4) Indicates that the fabric sample contact area with the agar is over-grown 
(≥50% coverage). 
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Figure 5.1.  Showing an EO MSN treated textile coupon inoculated with S.aureus 
after 24 hour incubation.  The black lines denote the zone of inhibition through 
the parallel bacterial streaks around the EO MSN treated synthetic textile 
coupon. 
 
It is evident that the untreated control coupons displayed no antimicrobial 
activity, and hence failed to inhibit microbial growth within the contact area on the 
inoculated agar that is bounded by the textile coupon.  In such cases scores 
between 3 and 4 were attained.  Both EO treated textile coupons displayed 
bacteriostatic activity against the test microorganisms (Figure 5.1), only differing 
in efficacy against the yeast C.albicans by one rating score, on one replicate.  In 
a study by Walentowska et al, a fabric based on a 55% linen, 45% cotton blend, 
treated with 8% thyme essential oil displayed no fungal growth, with a zone of 
inhibition around the sample.  By comparison, the untreated reference sample 
was completely covered by mould spores (Walentowska and Foksowicz-Flaczyk 
2013).  The weaknesses of this method include the lack of quantitative analysis, 
making comparisons with other methods and textile finishes difficult.  
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Furthermore, the conditions in the sealed petri dish during the length of 
incubation are not generally representative of those during actual service of the 
textile.  
5.5.2.  Zone of inhibition  
 
 
ZOI were recorded for untreated, EO MSN treated and EO immersed synthetic 
textile coupons (Figure 5.2) 
 
 
Figure 5.2.  Zones of inhibition for untreated, EO MSN treated and EO immersed 
synthetic textile coupons against five test microorganisms.  
 
Again, the untreated control coupons displayed no antimicrobial effect against 
the five test microorganisms.  Interestingly, the EO immersed coupons, produced 
larger zones of inhibition, compared to the EO MSN coupons.  This is likely to be 
due to greater diffusion of free EO and vapour in the confined and tape sealed 
petri dish during the elevated temperature of incubation (37°C).  Gram-negative 
bacteria proved to be more resistant to the antimicrobial effect of the CIN-CLO 
blend, than Gram-positive bacteria.  Chinta et al reported ZoIs for clove oil on 
100% viscose hydroentangled non-woven fibre, at concentrations ranging from 
1-10 wt% (Chinta et al 2012).  At 2 wt% clove oil, ZoIs of 4 mm were reported for 
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S.aureus and E. coli. (Chinta et al 2012).  Clove oil is comprised of roughly 70% 
eugenol, however, the EO blend used in this study is a 1:1 cinnamon / clove oil 
blend, comprising >94% eugenol (Section 2.4.6).  This increase in eugenol level 
led to increased mean ZoIs of 8 mm and 6 mm, being observed for S.aureus and 
E.coli inoculated EO immersed textile coupons, respectively. The same EO 
blend encapsulated within layer-by-layer (4.4.2.3) fixed MSNs gave mean ZoIs of 
3 mm (Figure 5.3) and 1 mm for for S.aureus and E. coli, respectively. 
 
Figure 5.3.  Showing an EO MSN textile coupon inoculated with S.aureus after 
24 hours incubation. 
 
Whilst it can be said both agar diffusion methods are relatively inexpensive and 
quick, Tanner noted fabrics must normally have considerable activity levels to 
demonstrate ‘zones of inhibition’ (Tanner, 2009).  Although quantitative values 
can be assigned for ZOI, the nature of the method causes difficulties in terms of 
attempting comparison with other products or technologies.  The method cannot 
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differentiate microbial cell death from inhibition of growth.  The microbial 
inoculum generally only contacts the surface of the fabric, furthermore the wet 
surface of the agar artificially extends the time over which the microbial cells are 
in a wet and nutritive environment.  As the latter is generally longer than 
expected under actual service conditions, it may be argued that the method is 
not entirely representative. 
 
5.5.3  Dynamic kill assessment  
 
Test and control fabric coupons were saturated with nutritive ISB media, but 
inoculated with a dilute suspension of microorganisms at a specific OD of 0.1, in 
static and exponential growth phases (Section 2.3.2.2).  The method was based 
on (AATCC 100/ASTM E2149).  Phosphate buffered saline (PBS) was also used 
as suspending medium for the microorganisms, as it provides the necessary 
buffered conditions for microorganisms to survive for a limited time, as there are 
no nutrients to support growth.  It was considered this would provide a nutrient-
deprived test environment for the EO treated test coupons, relative to the ISB.  
Microbial concentrations on the fabrics were immediately determined to provide 
a ‘time 0’ value and after a 24 h contact period.  The percentage difference 
between the CFU/mL values at the two time periods was used to calculate an 
antimicrobial activity level (microbial reduction or growth inhibition).  These 
values are displayed in (Figures 5.4 and 5.5). 
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Figure 5.4.  % CFU/mL reduction for unwashed EO MSN and EO immersed 
coupons (EO IMM) after 24 hours contact time in ISB, with test microorganisms 
in static (S) and exponential (E) phases of growth. 
 
 
Figure 5.5.  CFU/mL % reduction for unwashed EO MSN and EO immersed 
coupons (EO IMM) after 24 hours contact time in PBS, with test microorganisms 
in static (S) and exponential (E) phases of growth. 
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The data show slightly greater % reductions for the EO immersed coupons in 
comparison to the EO MSN coupons.  This is not surprising, considering the free 
EO diffusion possible from the EO immersed coupons.  The concept behind the 
EO loaded MSNs was to provide slower release of the antimicrobial, thereby 
allowing for greater durability of the antimicrobial effect, such that it can be 
maintained after cycles of washing.  Un-washed textile coupons, treated using 
both EO application methods, led to percentage reductions (in CFU/mL) of over 
90% for S. aureus, MRSA and E.coli (in both ISB and PBS).  The same effect 
was observed at both phases of microbial growth and in nutritive and non-
nutritive environments.  It was considered that the latter changes may affect the 
post-washing efficacy of the two EO treatment methods.  Use of such a time kill 
method for EO treated textiles has not been widely reported in the literature.  
However, Thilagavathi and Kannaian (2010) investigated woven 100% cotton 
fabrics with three different treatments; pure geranium extract, microencapsulated 
geranium by coacervation-spray drying and microencapsulated geranium by 
spray drying.  With unwashed test coupons, reductions in S. aureus 
concentration of 100%, 92% and 94%, respectively, were reported for the three 
treatments.  The respective reductions for E. coli. were 78%, 55% and 60% 
(Thilagavathi and Kannaian, 2010).  The latter trends are consistent with those 
observed in the present study for un-washed coupons.  AATCC 100 and ASTM 
E2149 are quantitative methods that are well designed in terms of technicalities 
related to the testing of antimicrobial agents (Tanner 2009).  It is worth noting 
that there are no clear standards set for ‘pass’ or ‘fail’ levels of performance in 
these method specifications.  However, the test is very realistic in terms of 
prevention of microbial growth, or kill, of microorganisms in wet fabrics.  Though 
if dry conditions are anticipated during service of the textile, it may be argued 
that the test is unrealistic as the fabrics are kept wet for the full contact period, as 
it is argued that most antimicrobial agents work best in the presence of liquid.  
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Furthermore, the incubation for 24 hours at elevated temperature, with agitation 
is also not realistic.  Reductions in activity associated with dried microbial 
inoculum on textiles in real life may not be as strong as results might suggest for 
these experiments, as antimicrobials seem to be more efficacious in a liquid 
medium.
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5.5.4  Wash durability testing  
 
 
The wash durability of the EO treated coupons was assessed based on 
AATCC 61 and 135 (see Section 5.4.4 for method).  The EO 
encapsulated in MSNs by the layer-by-layer treatment (EO MSN) and 
free EO immersion (EO IMM) treated coupons were subjected to 
antimicrobial efficacy assessment (Section 5.5.3) after 1, 2, 5 and 10 
washing cycles (Figures 5.6 – 5.13).  As the untreated control textile 
coupons displayed no antimicrobial activity (Section 5.5.2), they were not 
subjected to wash durability testing.   
 
5.5.4.1 Reduction in %CFU/mL for five test microorganisms in static and 
exponential growth phase exposed to EO MSN and EO IMM in ISB 
 
 
The trend of decreasing antimicrobial activity displayed by both EO MSN 
and EO IMM coupons with increasing washing cycles was consistent 
irrespective of the microorganisms phase of growth, or test media (ISB or 
PBS).   
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Figure 5.6.  CFU/mL % reduction for test microorganisms in static growth 
phase, exposed to EO MSN coupons after 1, 2, 5 and 10 wash cycles, 
after 24 hours contact time in ISB.  
 
  
Figure 5.7.  CFU/mL % reduction for test microorganisms in static growth 
phase, exposed to EO IMM coupons after 1, 2, 5 and 10 wash cycles, 
after 24 hours contact time in ISB.  
 
After one washing cycle, the antimicrobial activity of the EO immersed 
coupons had clearly diminished in relation to the EO MSN treated 
coupons.  The latter maintained a high level of activity, with %CFU/mL 
reductions ranging from 42% to 90% across all five microorganisms.  In 
fact, for S. Aureus, MRSA, and E. Coli the levels of activity were only 
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slightly reduced relative to the unwashed samples (Figures 5.4 and 5.5).  
The differences in % CFU/mL reduction between static and exponential 
phase and nutritive versus non-nutritive test environments were not 
noticeable.  It is possible the potential for differences between these 
parameters were negated by the length of contact time (24 hours).  
 
  
Figure 5.8.  CFU/mL % reduction for test microorganisms in exponential 
growth phase, exposed to EO MSN coupons after 1, 2, 5 and 10 wash 
cycles, after 24 hours contact time in ISB.  
  
Figure 5.9.  CFU/mL % reduction for test microorganisms in exponential 
growth phase, exposed to EO IMM coupons after 1, 2, 5 and 10 wash 
cycles, after 24 hours contact time in ISB.  
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The % reductions in CFU/mL show the Gram-positive bacteria are more 
susceptible to the EO blend, compared to the Gram-negative bacteria.  
This finding is documented in the literature for the antibacterial activity of 
EOs (Nazzaro et al 2013).  The outer cell wall present in Gram-negative 
bacteria acts as a barrier to EO integration/penetration and subsequent 
cell wall lysis, seen with Gram-positive bacteria.  This may be the reason 
for the lower % reductions in CFU/mL seen for E.coli and P.aeruginosa in 
comparison to the Gram-positive test bacteria.  The yeast, C.albicans is 
also seen to be robust to the antimicrobial actions of the EO blend, 
relative to Gram-positive bacteria.  This could be due to the protective 
effects of the cell wall, acting as a barrier to the cytoplasmic membrane, 
which Chen et al (2013) noted as the primary target of EO antifungal 
action. 
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5.5.4.2  Reduction in %CFU/mL for five test microorganisms in static and 
exponential growth phase exposed to EO MSN and EO IMM in PBS 
 
 
After five cycles of washing, Thilagavathi and Kannaian reported bacterial 
reduction percentages of 92% and 55% for S. aureus and E. coli, 
respectively, for microencapsulated geranium oil on 100% cotton test 
samples (Thilagavathi and Kannaian, 2010).  By comparison, the EO 
MSN samples produced % reductions in CFU/mL of 44% and 19% after 
five wash cycles, for the same bacteria. 
 
  
Figure 5.10.  CFU/mL % reduction for test microorganisms in static 
growth phase, exposed to EO MSN coupons after 1, 2, 5 and 10 wash 
cycles, after 24 hours contact time in PBS.  
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Figure 5.11.  CFU/mL % reduction for test microorganisms in static 
growth phase, exposed to EO IMM coupons after 1, 2, 5 and 10 wash 
cycles, after 24 hours contact time in PBS.  
 
The use of the cinnamon / clove oil blend in the present study and use of 
100 % geranium oil in Thilagavathi and Kannaian’s study renders direct 
comparison of performance impossible.  However, the use of these three 
EOs (CIN, CLO and GER) individually at the same concentrations against 
the same microorganisms show they are similar in terms of antimicrobial 
activity (Section 2.4.3). 
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Figure 5.12.  CFU/mL % reduction for test microorganisms in exponential 
growth phase, exposed to EO MSN coupons after 1, 2, 5 and 10 wash 
cycles, after 24 hours contact time in PBS.  
 
 
Figure 5.13.  CFU/mL % reduction for test microorganisms in exponential 
growth phase, exposed to EO IMM coupons after 1, 2, 5 and 10 wash 
cycles, after 24 hours contact time in PBS.  
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2010).  There are few investigations of wash durability of EO treated 
textiles reported in the literature.  In contrast, there are rather more 
reported investigations of silver and zinc oxide nanoparticle finishes on 
textiles and their wash durability.  For example, Rajendran reported 
significant antimicrobial after 10 wash cycles for cotton coupons treated 
with ZnO nanoparticles.  After 10 wash cycles, bacterial population 
reductions of 74% and 70% were reported for S.aureus and E.coli, 
respectively.  Significant antibacterial activity was also observed after 20 
wash cycles (Rajendran, 2010). 
 
When investigating and reporting ‘antimicrobial activity’ it is important to 
define and understand the broad use of the term.  For the current work, 
antimicrobial is understood to mean anything that has a negative effect 
on the unchecked growth of microorganisms (Tanner 2009).  On the 
lowest end of the antimicrobial spectrum, in terms of different 
antimicrobials and their respective strengths or toxicity, a treated textile 
may slow the rate of growth of a few, or perhaps one microorganism.  To 
deter growth may aid in the control of odour on textiles, or even the visual 
aesthetics of a garment, in terms of discolouration.  However, it is not 
likely to impact the spread of potentially infectious or antimicrobial 
resistant microorganisms through a healthcare environment.  More 
significant antimicrobial effects may cause microorganism growth to 
become static, with even stronger antimicrobials, which display low MICs, 
killing a percentage of microorganisms over time.  The most potent end of 
the antimicrobial spectrum generally refers to toxic chemicals that 
disinfect, or render surfaces sterile within 10 minutes of contact, such as 
Quaternary ammonium compounds (QACs) and glutaraldehyde 
(Ballantyne and Jordan 2001).  The latter will have broad-spectrum 
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activity against all viruses, bacteria and spore-formers.  Few antimicrobial 
textiles kill large percentages of microorganisms in under ten minutes of 
contact.  The standard methods of testing antimicrobial textile finishes, in 
general, analyse low level antimicrobial activity over a longer period of 
time (usually 24 hours), whereas methods used to test liquid chemical 
disinfectants and sterilisers, look for high level antimicrobial activity over 
a short period of time (usually up to 10 minutes).  
 
The results show the EO MSN treated test coupons displayed good 
antimicrobial activity up to five wash cycles, with insignificant activity 
remaining after 10 wash cycles, whereas the antimicrobial activity of the 
EO immersed textile coupons diminished significantly over one to two 
washing cycles.  The results show that coating of textile fibres with an 
MSN encapsulated EO blend (using the layer-by-layer application 
method, described in Section 4.4.2.3) leads to a much more sustained 
antimicrobial activity that is able to withstand several wash cycles.  
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5.6  Conclusions 
 
 The test coupons were screened for bacteriostatic activity against the 
five test microorganisms qualitatively using parallel streak and 
quantitatively using zone of inhibition methods.  The EO-MSN and EO 
immersion treated coupons displaying bacteriostatic activity against 
all five microorganisms and recording zones of inhibition. 
 The EO-MSN and EO immersed test coupons (without being 
subjected to washing) were evaluated for CFU/mL reductions over a 
24 hour period, with agitation.  Both EO treatment methods led to 
high levels of reduction in CFU/mL after 24 hours exposure to the five 
test microorganisms. The microbial growth phase or liquid medium 
conditions (i.e. nutritive or non-nutritive) had no influence on the 
trends observed. 
 The EO-MSN treated coupons showed useful antimicrobial activity 
after five wash cycles, though antimicrobial activity was barely 
noticeable after 10 wash cycles.  In contrast, the antimicrobial activity 
of the EO immersed coupons (i.e. un-bound EO) was noticeably 
diminished after one to two was cycles, though ca. 10 % CFU/mL 
reductions were observed for the more vulnerable organisms (S. 
aureus and MRSA) after five wash cycles. 
 The results show that the EO-MSN coating (applied using the layer-
by-layer method) confers sustained antimicrobial activity to the 
synthetic textile.  Such sustained activity was not possible using un-
bound EO. 
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Chapter 6 
 
Overall conclusions and further work 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 201 
6.1  Overall conclusions 
 
There are concluding summaries given at the end of each preceding 
chapter.  This section will provide overall conclusions and summarise the 
degree to which the original aims were achieved.   
 
The primary objective of the work was to investigate the potential for the 
use of natural antimicrobials to add antimicrobial efficacy to synthetic 
textiles.  Cinnamon, clove and lemongrass demonstrated good 
antimicrobial efficacy individually against the Gram-positive 
microorganisms and E.coli of the panel of microorganisms tested, as 
others have shown (Hammer 1999, Loughlin 2008, Cox 2001, Kwiecinski 
2009), however lacked efficacy against the Gram-negative P.aeruginosa 
at less than 2% (v/v).  It was thought blending the EOs may produce a 
synergistic effect against the microorganisms.  Numerous blends 
displayed a reduction in the concentration (v/v) of oil necessary to inhibit 
microbial growth, and several blends displayed synergy against 
P.aeruginosa, which showed poor results with individual EOs.  A 1:1 
blend of Cinnamon-clove registered the best FIC results across the five 
microorganisms tested and producing the lowest MIC against the most 
robust microorganism, P.aeruginosa.  For the selected blend of clove and 
cinnamon (1:1), the percentage of the main antimicrobial constituent 
increased from 82.85 and 76.39, respectively, to 94.84 when in 
combination. 
 
MSNs were synthesised and investigated as potential encapsulants for 
the selected EO blend.  Lu (2007) had shown hydrophobic compounds 
were able to load into MSN pores.  A loading level of ca. 70% was 
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achieved using an immersion loading technique, after the initial solvent 
evaporation technique returned a loading level of roughly 30-35%.  
GCMS analysis of solvent washed EO loaded MSNs confirmed the ability 
of the EO antimicrobial components to leave the MSN pores.  After 
confirming the blank MSNs exerted no antimicrobial effect, the EO loaded 
MSNs displayed bactericidal capacity against the five microorganisms 
tested between (25-50 mg/mL).   
A range of different techniques were investigated to chemically affix the 
MSNs to synthetic fibres.  A 3:1 formulation of ormosil precursors 
(MTEOS:TEOS) at pH 2 was chosen to provide a flexible yet robust thin 
film coverage of the synthetic fibres, allowing bending of the textile and a 
large surface area for MSNs to attach on to (Estella 2007, Perrera 2013). 
While one pot synthesis and silane grafted MSNs failed to affix the MSNs 
to the synthetic fibres without occluding the MSN pores (Pardal 2009), a 
layer-by-layer technique allowed the MSNs to be chemically affixed to the 
synthetic fibres with no occlusion of the MSN pores.  The layer-by-layer 
treated samples were also subjected to headspace sampling to ensure 
the EO antimicrobial components could diffuse from the pores, with 
eugenol still diffusing after a sampling time of 24 hours.  
The EO-MSN treated coupons showed useful antimicrobial activity after 
five wash cycles, though antimicrobial activity was barely noticeable after 
10 wash cycles.  In contrast, the antimicrobial activity of the EO 
immersed coupons (i.e. un-bound EO) was noticeably diminished after 
one to two was cycles, though ca. 10 % CFU/mL reductions were 
observed for the more vulnerable organisms (S. Aureus and MRSA) after 
five wash cycles.  The results show that the EO-MSN coating (applied 
using the layer-by-layer method) confers sustained antimicrobial activity 
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to the synthetic textile.  Such sustained activity was not possible using 
un-bound EO, as found previously by (Thilagavathi and Kannaian 2010). 
 
The project set out to investigate a controlled release system for EOs that 
could be used as a coating for synthetic textile fibres, and thereby confer 
antimicrobial activity to the textile.  The successful product was targeted 
for use in healthcare environments to combat the spread of HCAIs.  The 
project was broken down into a number of key areas to enable fulfilment 
of the primary aims.  EO MSN synthetic textile coupons (treated using the 
layer-by-layer method developed in this project) displayed good 
antimicrobial activity up to five wash cycles, whereas the antimicrobial 
activity of the EO immersed textile coupons diminished significantly over 
one to two washing cycles.  
 
6.2  Further work 
 
The initial antimicrobial screening investigated the efficacy of natural 
antimicrobial EOs individually and in blends.  In addition, GC-MS was 
used to analyse their chemical composition.  There was not time during 
the project to fully consider the changes in chemical composition when 
EOs are blended and subsequent changes in antimicrobial activity.  
GCMS analysis of EO blends ranging from synergistic to antagonistic 
should be undertaken to provide understanding of how the abundance of 
the main antimicrobial constituents for an individual oil change when 
blended.  This may lead to understanding why certain EOs are more 
efficacious in their antimicrobial activity against microorganisms 
associated with HCAIs.  It would also be interesting to combine other 
liquid biocides with the EOs, in the quest to find antimicrobial synergy.  
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Antiseptics, such as triclosan, and polyhexamethylene biguanide could 
be used for this purpose. 
The range of microorganisms tested in this study could be broadened, 
with anaerobic bacteria, such as C.difficile.  In addition, the planktonic 
work could be complemented by challenging biofilms with the 
antimicrobials. 
 
The antimicrobial activity of blank and EO loaded MSNs was 
investigated.  It would have been worthwhile imaging the EO loaded 
MSNs and the test microorganisms in confinement, to gain an 
understanding of the MSN interaction with the bacterial or yeast cell wall, 
or capsule.  Chemical fixatives used in such procedures would be toxic 
for the microorganisms and possibly cause lysing of the cells.  It is 
possible dehydration via increasing concentrations of ethanol could be 
used, to preserve the microbial interaction with the MSNs.  The work 
could again be broadened by the use of amorphous SBA-15 MSNs, or 
the use of different surfactants for the TEOS to adsorb on and 
polymerise.  This would allow different pore size, surface area and 
antimicrobial loading levels, which could impact antimicrobial activity and 
the ability to control the release. 
 
It has been shown in the literature that the skeletal structure and 
subsequent porosity of ormosil gels can be controlled via pH during 
synthesis.  Producing gels of increased porosity, which could then be 
BET and BJH analysed, would possibly allow further investigation of 
loading these porous matrices with antimicrobials. 
The EO MSN treated synthetic textile coupons were shown to have good 
antimicrobial activity for up to five washes, demonstrating the wash 
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durability of the antimicrobial finish.  It was suggested the coupons could 
also have undergone challenge testing after increasing lengths of time, 
having been subjected to different environments commonly encountered 
in healthcare settings. 
Finally, the initial aim of producing antimicrobial synthetic textiles 
intended for upholstery coverings or tunics / uniforms, could conceivably 
be used in wound dressings.  Currently, expensive silver impregnated 
wound dressings are used (Boateng and Catanzano 2015), there could 
potentially be scope for wound dressings with natural antimicrobials 
encapsulated (Liakos et al 2014). 
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Appendix I 
 
Citral, main constituent of lemongrass oil 
 
Citronellol, main constituent of geranium oil 
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Eucalyptol, main constituent of eucalyptus oil 
 
Limonene, main constituent of lime oil 
 229 
 
Terpinen-4-ol, main constituent of tea tree oil 
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Appendix II 
 
 
 
Example of sizing MSN sample 1, using image J.  The diameter of 100 
nanoparticles (bottom left corner of the image) were recorded and 
averaged.
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Appendix III 
A 
 
B 
 
C 
 
D 
 
E 
 
F 
 
232 
 
G 
 
H 
 
I 
 
J 
 
Thermogravimetric analysis (solid line) and derivative thermogravimetric curve (dotted line) of 
surfactant intact MSN samples 1-5 – A, C, E, G, I.  Also, MSN samples 1-5 post calcination, B, D, 
F, H, J. 
 
 
 
 
 
